Document:

<PAGE>

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,
HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                                                   EXHIBIT 10.11

                              PHARSIGHT CORPORATION

                           DATA SET LICENSE AGREEMENT

This Data Set License Agreement (this "Agreement") is made and entered into as
of March 1, 2000 (the "Effective Date") by and between Pharsight Corporation, a
California corporation, (hereinafter "Pharsight") and the Lovelace Respiratory
Research Institute (hereinafter "Lovelace").

                                    RECITALS

Pharsight is engaged in the sale of software and services relating to clinical
trial design and modeling to pharmaceutical and biotechnology companies and
desires to have the right to use certain data sets developed by Lovelace both as
a data resource for an Internet-based query-response product and internally in
its professional consulting practice.

Lovelace is the owner of all rights to the data set necessary to carry out this
Agreement and is willing to grant to Pharsight a non-exclusive right and license
to use, reproduce, modify, and create derivatives of the subject data set on the
terms and conditions set forth herein.

NOW, THEREFORE, IN CONSIDERATION OF THESE PREMISES, AS WELL AS THE OBLIGATIONS
HEREIN MADE AND UNDERTAKEN, THE PARTIES HERETO DO HEREBY AGREE AS FOLLOW, WITH
THE CAPITALIZED TERMS HAVING THE MEANING SET FORTH IN APPENDIX A:

1. DATA SET DELIVERY, TESTING, AND UPDATES

1.1 DELIVERY OF INITIAL DATA SET. Lovelace will pool patient-level healthcare
data from the members of the Lovelace Data Consortium (the "Consortium") to
create the Data Set in accordance with the specifications in Appendix B and the
quality assurance procedures in Appendix C and will test the Data Set against
the Acceptance Criteria in Appendix D. As a first step, Lovelace will prepare
and deliver to Pharsight electronically within four (4) weeks of the Effective
Date a sample data set based on the Data Set that Pharsight can use for testing
and marketing purposes. The complete Data Set will be delivered within twelve
(12) weeks of the Effective Date.

1.2 ACCEPTANCE. Pharsight will have thirty (30) working days from receipt of the
Data Set to test for adherence to the Acceptance Criteria and will notify
Lovelace promptly if the Data Set fails to conform to such criteria. Lovelace
will have twenty (20) working days to correct such nonconformity, and upon
redelivery Pharsight will again test the Data Set against the Acceptance
Criteria. This process will be repeated (except that each subsequent test period
and repair period will be limited to fifteen (15) working days) until Pharsight
either provides Lovelace with written notice of acceptance of the Data Set or is
deemed to have accepted the Data Set under the provisions of this section,
provided, however, that if the Data Set fails to meet the Acceptance Criteria on
the third delivery, Pharsight shall have the right to terminate this Agreement
and receive a full refund of any royalty or license payments made to

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       1
<PAGE>

Lovelace prior to such termination. Pharsight shall be deemed to have accepted
the Data Set if it fails to notify Lovelace of any nonconformity therein within
thirty (30) working days of delivery (or within fifteen (15) working days of
redelivery in the case of nonconformities in the original delivery).

1.3 PATIENT ANONYMITY. The Data Set will be totally anonymous as to the identity
of individual patients, the study, if any, in which those patients participated,
and the identity of medical practitioners and institutions providing treatment
and health plans covering treatment. Pharsight will not make any attempt to
ascertain such information or any other information that was rendered
confidential by substituting codes for identifying information before Lovelace
provided the Data Set to Pharsight. The parties will follow the confidentiality
protocol described in Appendix E hereto.

1.4 DATA ACCESS. Customers using the Product will have access only to summary
statistics presented in numeric, tabular, and graphical form. The Product will
be constructed so that it is not possible for Customers to access data records
for individual patients. Pharsight will maintain sufficient security measures,
including firewalls and secure transmission protocols, to ensure that patient
records from the Data Set are always under Pharsight's control and cannot be
accessed by its Customers. Pharsight will provide its consulting services
Customers with tabular, graphical, numerical or narrative results based upon
statistical analysis of data extracted from the Data Set by its own consultants.
All results provided to Customers will be in summary and non-patient specific
form, and Pharsight's consultants will not share data from individual patient
records in the Data Set with Customers unless required to do so by the FDA, in
which case Pharsight will notify Lovelace.

1.5 UPDATES. During the term of this Agreement, Lovelace will provide Pharsight
with an Update for the Data Set within thirty (30) days after the beginning of
each year of this Agreement (including any renewal terms). The Update will be
subject to quality assurance testing in accordance with the criteria established
by the parties.

1.6 COSTS. Lovelace will be fully responsible for all development and extraction
costs of the Data Set and any Updates, including any royalties or payments due
to third parties.

2. GRANT OF LICENSE

2.1 LICENSE GRANT FOR PRODUCT. Subject to the payment of royalties as set forth
in Section 4.2, Lovelace hereby grants Pharsight a world-wide right and license
(a) to use, reproduce, modify, and create derivatives of the Data Set and
Documentation internally for development of the Product; (b) to license the
Product to its Customers; (c) to license its Customers to use results obtained
through the use of the Product for research in support of therapeutic innovation
in drug development and related marketing activities, including regulatory
submissions and research publications; (d) to use the Data Set and the
Documentation for purposes of technical support for Customers; (e) to use a
reasonable number of copies of the Product and Data Set for purposes of
marketing, training, and demonstrations.

2.2 LICENSE GRANT FOR CONSULTING. Pharsight will have unrestricted access to the
Data Set for use in its consulting activities related to research in support of
therapeutic innovation in drug development and related marketing activities and,
subject to the royalty obligations of Section 4.3 and the confidentiality
clauses of Appendix E, Lovelace hereby grants Pharsight a world-wide right and
license (a) to use the Data Set and Documentation to prepare statistical results
and conclusions based on the Data Set under consulting contracts with Customers;
(b) to distribute to such Customers models, other analyses, and

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       2
<PAGE>

conclusions based on its analysis of the data in the Data Set; and (c) to allow
such Customers to use such models, analyses, and conclusions for drug
development and related marketing activities, including regulatory submissions
and research publications. Pharsight will provide Lovelace with an anonymized
summary list of the types of analyses performed for Customers every six months.

2.3 OWNERSHIP. Lovelace will retain ownership of the Data Set and the underlying
data. Pharsight will own all right, title, and interest in and to the query,
user interface, and other software developed by or for Pharsight as part of the
Product, as well as all models and analyses created for Customers as part of its
consulting activities.

2.4 LIMITED EXCLUSIVITY. During the term of this Agreement, Lovelace will not
sell or license the Data Set or any other data set from the Consortium to any
third party for use in or development of Internet-based software systems related
to clinical drug development or for providing services related to clinical trial
simulation or clinical drug development in the biopharmaceutical industry.

3. PRODUCT DEVELOPMENT, MARKETING AND DISTRIBUTION

3.1 PRODUCT DEVELOPMENT. Pharsight will develop the query, user interface, and
other software for the Product that will allow licensed Customers to access the
information in the Data Set, as described in the application overview in
Appendix B. The target date for commercial release of the Product is June 2000.

3.2 PRODUCT MARKETING ACTIVITIES. Pharsight will be responsible for all
decisions and costs involved in the marketing and distribution of the Product
and consulting services utilizing the Data Set, including pricing, end-user
license terms, promotional materials, packaging, distribution channels, and
customer evaluation and training. Pharsight may distribute the Product through
Distributors so long as such Distributors have no direct access to the Data Set.
Pharsight may authorize its Distributors to use the Product for marketing,
training, and demonstrations.

3.3 DATA SET SOURCE IDENTIFICATION. Pharsight may identify the Data Set as
having been prepared by Lovelace, but will not represent that use of the Data
Set represents any endorsement of the Pharsight product by Lovelace or any
member of the consortium. Pharsight agrees to adhere to the organizational
confidentiality clauses stipulated in Appendix E. Any marketing materials
containing references to Lovelace other than identification of the source of the
Data Set, as set forth in Appendix E, will be submitted to Lovelace (to the
attention of Patricia J. Marx, Chief Operating Officer, via certified mail) for
advance approval at least thirty (30) days prior to their intended use. Lovelace
shall be deemed to have approved the marketing materials if it fails to notify
Pharsight of any problems therein within thirty (30) days of submission.

3.4 CUSTOMER SUPPORT. Pharsight will provide customer support for the Product.
Lovelace will make one or more persons familiar with the Data Set available to
assist Pharsight personnel in the resolution of problems they may encounter from
time to time in use of the Data Set. For each [ * ] in royalties paid by
Pharsight to Lovelace (including the annual license fee), Lovelace will provide
one day of problem resolution assistance to Pharsight personnel without charge;
further assistance will be provided as reasonably necessary at [ * ] per day,
prorated on an hourly basis for usage of less than a full day.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       3
<PAGE>

3.5 PRESS ANNOUNCEMENTS. Pharsight will issue a press release announcing the
relationship between Pharsight and Lovelace (target release date: March 28,
2000), which announcement shall be subject to approval by Lovelace and subject
to Sections 3.2, 3.3 and Appendix E. Lovelace agrees that it will supply a
quotation for the press release. The parties agree that as further news about
the relationship is generated in the future, they will cooperate with each other
to issue appropriate press releases to cover such news.

4. PAYMENTS

4.1 ANNUAL LICENSE FEE. To allow Lovelace to cover up-front expenses associated
with the preparation of the Data Set, Pharsight will make a lump-sum, minimum
royalty payment to Lovelace as follows: (a) [ * ] upon execution of this
Agreement and (b) [ * ] upon delivery of the Data Set. To cover the up-front
expenses for creating the Updates, Pharsight will make lump-sum, minimum royalty
payments to Lovelace as follows: (a) [ * ] at the start of each subsequent year
of this Agreement (including renewal terms); and (b) [ * ] upon the delivery of
the Updates in accordance with Section 1.5. These non-refundable payments will
be credited against actual royalties due in each year under Section 4.2 and 4.3
below. Should the royalties due under Sections 4.2 and 4.3 for a year be less
than these minimum payments, then Lovelace shall be entitled to retain the full
minimum payment.

4.2 PRODUCT ROYALTY. Pharsight will pay Lovelace a royalty of [ * ] for each
annual Customer subscription license allowing use of the Product. No royalty
will be due for evaluation licenses allowing a Customer limited use of the
Product, provided Pharsight receives no revenue for such evaluation licenses, or
for use of the Product in Customer training programs.

4.3 SERVICE USE ROYALTY. Pharsight will pay Lovelace a royalty of [ * ] for each
Customer project for which Pharsight's staff accesses the Data Set in connection
with providing consulting services to the Customer. No royalty will be due for
use of the Data Set for Pharsight staff training.

4.4 PAYMENTS. Royalty payments will be made on a quarterly basis with payment
due thirty (30) days after the end of each calendar quarter for all Product
license revenue received during such quarter and all consulting service revenue
recognizable (under generally accepted accounting principles) during such
quarter. Each payment will be accompanied by a report setting forth the
calculation of such payment amount.

4.5 DELIVERY BONUS. Should Lovelace deliver the Data Set meeting the
Acceptance Criteria to Pharsight by May 15, 2000, Lovelace shall receive a
Delivery Bonus of [ * ]. Should Lovelace deliver the Data Set meeting the
Acceptance Criteria to Pharsight by April 30, 2000, Lovelace shall receive a
Delivery Bonus of [ * ]. The Delivery Bonus is a one-time payment and need
not be credited against any other royalty payments.

4.6 ADDITIONAL CONSORTIUM MEMBERS. For additional Consortium members in excess
of three (3) members, up to and including six (6) members, Lovelace will receive
the following payment increases: (a) the minimum annual royalty in Section 4.1
will be increased by [ * ] per new member to a maximum of [ * ], with [ * ] paid
at signing or renewal of the Agreement, and [ * ] paid at delivery of the Data
Set or Updates; (b) the product royalty in Section 4.2 will be increased by [ *
] per new member to a maximum of [ * ]; and (c) the service use royalty in
Section 4.3 will be increased by [ * ] per new member to a maximum of [ * ].
These increased payments will apply only to minimum annual royalties,

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       4
<PAGE>

annual Customer subscription license royalties, or Customer consulting project
royalties accrued after the Data Set has been contributed to by such added
Consortium member(s).

4.7 AUDIT. Pharsight will, upon written request, during normal business hours,
but not more frequently than once each calendar year, provide access for
purposes of audit to pertinent records relating to royalties payable in
connection with the Data Set to an independent accounting firm chosen and
compensated (other than on a contingent fee basis) by Lovelace and reasonably
acceptable to Pharsight. Such accounting firm will be authorized to report to
Lovelace only the amount of royalties due and payable for the period examined.
If the amount under-reported by Pharsight is equal to or greater than ten
percent (10%) of the total payment due to Lovelace for the payment period so
audited, then the cost of the audit shall be borne by Pharsight.

4.8 CONFIDENTIALITY. Lovelace will not disclose to any third party any sales or
customer information received from Pharsight in connection with royalty payments
and will use such information solely for the purpose of carrying out its
obligations under this Agreement.

5. WARRANTIES; INDEMNIFICATION; LIMITATION OF LIABILITY

5.1 WARRANTY. Lovelace represents and warrants to Pharsight (a) that Lovelace
will obtain prior to delivery of the Data Set, all rights and authority
necessary for the grant of rights and licenses pertaining to this Agreement; (b)
that the Data Set as supplied to Pharsight will be developed in substantial
accordance with the quality assurance procedures described in Appendix C for
generating and validating the data; (c) that no consents are required to use and
redistribute the data in the Data Set as authorized in this Agreement; and (d)
that agreements between Lovelace and the Consortium to use and redistribute the
data in the Data Set will be obtained prior to delivery of the Data Set and will
be available for review by Pharsight. If Pharsight is required to cancel any
Customer license for the Product because of Lovelace's breach of one of the
foregoing warranties, Lovelace will refund to Pharsight any royalties paid with
respect to such cancelled licenses.

5.2 INDEMNIFICATION. Pharsight will defend, indemnify, and hold Lovelace
harmless from and against any action or other proceeding brought against
Lovelace arising from Pharsight's use of the Data Set, except where such action
arises from negligence or willful misconduct on the part of Lovelace or from
Lovelace's breach of the representations and warranties set forth in Section
5.1. Lovelace will defend, indemnify, and hold Pharsight harmless from and
against any action or other proceeding brought against Pharsight to the extent
that it is based on (i) Lovelace's negligence or willful misconduct; (ii) a
claim that any part of the Data Set or Documentation infringes any copyright or
patent or incorporates any misappropriated trade secrets of any third party; or
(iii) a claim that use or distribution of the Data Set as authorized herein
violates federal or state patient-privacy laws or regulations or the privacy
rights of any patient included in the Data Set as such laws were in effect at
the time of delivery of the version of the Data Set that is the subject of such
claim.

5.3 CONDITIONS OF INDEMNIFICATION. The indemnifying party will pay any and all
costs, damages, and expenses (including but not limited to reasonable attorneys'
fees) incurred by the indemnified party in any action or proceeding requiring
indemnification under section 5.2 (an "Action"). The indemnifying party will
have no obligation as to any Action unless (i) the indemnified party gives it
prompt notice of the Action; (ii) the indemnifying party has sole control of the
defense and settlement of the Action; and

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       5
<PAGE>

(iii) the indemnified party provides the indemnifying party, at the indemnifying
party's expense, with reasonable assistance in defense and settlement of the
Action.

5.4 LIMITATION ON LIABILITY. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE
OTHER FOR ANY INDIRECT, CONSEQUENTIAL, SPECIAL OR INCIDENTAL DAMAGES (INCLUDING
DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, LOSS OF BUSINESS
INFORMATION, AND THE LIKE) ARISING OUT OF THIS AGREEMENT EVEN IF SUCH PARTY HAS
BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. EXCEPT WITH RESPECT TO THE
INDEMNIFICATION OBLIGATIONS UNDER SECTIONS 5.2 AND 5.3, NEITHER PARTY'S
LIABILITY UNDER THIS AGREEMENT SHALL EXCEED THE AMOUNTS PAID TO LOVELACE UNDER
THIS AGREEMENT. BOTH PARTIES ACKNOWLEDGE THAT THE FOREGOING LIMITATION REFLECTS
A BARGAINED-FOR ALLOCATION OF RISK AND THAT THE ROYALTIES SET FORTH HEREIN
REFLECT SUCH RISK.

6.  TERM AND TERMINATION

6.1 TERM OF AGREEMENT. The initial term of this Agreement will be the period
beginning on the Effective Date of this Agreement and ending on the first
anniversary of the date on which Pharsight accepts (in accordance with Section
1.2) the Data Set. This Agreement may be renewed for two successive additional
one-year periods at Pharsight's option and beyond that may be renewed by mutual
agreement of the parties.

6.2 TERMINATION FOR NON-DELIVERY. If Lovelace fails to deliver the Data Set in a
form meeting the Acceptance Criteria within six (6) months of the Effective
Date, then Pharsight shall have the option to terminate this Agreement, return
any copies of the Data Set in its possession, and receive from Lovelace a refund
of any royalty or license payments made to Lovelace prior to such termination.
If Lovelace fails to deliver an Update meeting the Acceptance Criteria within
sixty (60) days of the start of the renewal term, then Pharsight shall have the
option to terminate this Agreement, return any copies of the Data Set in its
possession, and receive from Lovelace a refund of any royalty or license
payments made to Lovelace with respect to such renewal term prior to such
termination.

6.3 TERMINATION FOR BREACH. Each party has the right to terminate this Agreement
if the other party has materially breached any obligation herein and such breach
remains uncured for a period of thirty (30) days after written notice thereof is
sent to the other party.

6.4 LOSS OF DATA ACCESS. In the event that at any time during the term of this
Agreement there is a period of at least sixty (60) days in which the number of
Consortium members having access to data to contribute to the Data Set is less
than three (3), Lovelace shall so notify Pharsight and shall thereafter have no
obligation to provide Updates. Pharsight's rights with respect to the Data Set
shall continue for one year from the date of such notice, but the royalties due
under Sections 4.2 and 4.3 shall be reduced to fifty percent (50%) of the amount
set forth in such sections during such one-year period.

6.5 EFFECT OF TERMINATION. Upon termination or expiration of this Agreement, all
rights and licenses granted to Pharsight hereunder shall terminate. Termination
will have no effect on the rights of any Customer to continue to use the Product
or any information obtained from the Data Set or Product prior to such
termination in accordance with its original license for the Product or grant of
rights from Pharsight with respect to consulting services deliverables.
Notwithstanding any termination of this

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       6
<PAGE>

Agreement, Lovelace shall remain entitled to royalties owed pursuant to this
Agreement resulting from use or license of the Data Set or Product prior to
termination of this Agreement.

6.6 SURVIVAL. The provisions of Sections 2.3, 3.3, 4.7, 4.8, 5, 6.5, 6.6, 8, and
9 will survive any termination or expiration of this Agreement.

7. ADDITIONAL DATA SETS

If Pharsight identifies other therapeutic areas where Pharsight wishes to
license a data set for its Internet query-response product and consulting use,
Pharsight will propose specifications for data set development to Lovelace.
Lovelace will respond within sixty (60) days, and if Lovelace agrees that the
proposed data set is practicable to develop, the parties will then work together
to finalize the specifications. At the time such specifications are agreed upon
for a given data set, the parties will enter into an agreement similar to this
Agreement setting forth the provisions for delivery, quality assurance testing,
and licensing terms. The royalty provisions for any additional data set in any
such agreement that is entered into during the term of this Agreement will be
the same as those in this Agreement.

8. MEDIATION AND ARBITRATION

8.1 MEDIATION. Any dispute arising under this Agreement will be resolved through
a mediation and arbitration approach. The parties agree to select a mutually
agreeable, neutral third party to help them mediate any dispute that arises
under the terms of this Agreement. Costs and fees associated with the mediation
will be shared equally by the parties.

8.2 ARBITRATION. If the mediation is unsuccessful, the parties agree that the
dispute will be decided by binding arbitration under the rules of the American
Arbitration Association. The decision of the arbitrators will be final and
binding on the parties and may be entered and enforced in any court of competent
jurisdiction by either party. The prevailing party in the arbitration
proceedings will be awarded reasonable attorney fees, expert witness costs and
expenses, and all other reasonable costs and expenses incurred in connection
with the proceedings, unless the arbitrators for good cause determine otherwise.

9. GENERAL

9.1 NOTICES. Any notice required or permitted hereunder must be in writing, and
will be effective on the date of delivery when delivered personally, the next
business day after dispatch when sent by Federal Express or other recognized
overnight courier service, or the fifth business day after dispatch when sent by
certified mail, postage prepaid, return receipt requested. Notices should be
addressed to the other party at the address shown below or at such other address
as a party may designate by ten days' advance written notice to the other party:

 Pharsight Corporation                   Lovelace Respiratory Research Institute
 800 West El Camino Real, Suite 200      P.O. Box 5890
 Mountain View, CA  94040                Albuquerque, NM 87185-5890
 Attention:  Chief Financial Officer     Attention: Patricia J. Marx,

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       7
<PAGE>

 Phone: (650) 314-3800                   Chief Operating Officer
 Fax: (650) 314-3810                     Phone:  (505) 845-1193
                                         Fax:   (505) 845-1067

9.2 ENTIRE AGREEMENT; MODIFICATIONS. This Agreement, including all appendices,
constitutes the entire agreement of the parties with respect to the subject
matter hereof and supersedes all prior representations, proposals, discussions,
and communications, whether oral or in writing. This Agreement may be modified
or amended only by a writing executed by a duly authorized representative of
each party.

9.3 FORCE MAJEURE. Neither party will be liable to the other for any failure or
delay caused by events beyond such party's control, including, without
limitation, sabotage, riots, insurrections, fires, flood, storm, explosions,
war, or earthquakes. However, if such events shall continue for thirty (30) days
or more, the other party shall have the option of terminating this Agreement by
giving written notice of termination.

9.4 CHANGE IN LAW; CHANGE IN CIRCUMSTANCES. No party shall make or receive any
payment or take any action under this Agreement if any judicial decision,
legislative action, or regulatory or other administrative interpretation,
whether federal or state, would render illegal the conduct of either party under
this Agreement. If performance by either party of any term of this Agreement
should be deemed illegal by any party or third party who is essential to
performance of this Agreement for any such reason, either party shall have the
right to require that the other party renegotiate the terms of this Agreement.
If the parties fail to reach an agreement satisfactory to both parties within
fifteen (15) days after the receipt of any request for renegotiation, either
party may terminate this Agreement upon ten (10) days prior written notice to
the other party, or sooner if required by law.

9.5 ASSIGNMENT. This Agreement will be binding upon and inure to the benefit of
the parties hereto, their successors and permitted assigns. Either party may
assign this Agreement in its entirety to a successor corporation upon notice to
the other party in the event of a merger or an acquisition of all or
substantially all of the assets of the assigning party.

9.6 GOVERNING LAW. All questions concerning the validity, operation,
interpretation, and construction of this Agreement will be governed by and
determined in accordance with the laws of the State of New Mexico, without
regard to its conflict of laws provisions. Application of the United Nations
Convention on Contracts for the International Sale of Goods is specifically
excluded.

9.7 SEVERABILITY. If a court of competent jurisdiction determines that any
provision of this Agreement is invalid, illegal, or otherwise unenforceable,
such provision shall be replaced with a valid, enforceable provision as nearly
as possible in accordance with the stated intention of the parties, while the
remainder of this Agreement shall remain in full force and effect. To the extent
any provision cannot be enforced in accordance with the stated intentions of the
parties, such provision shall be deemed not to be a part of this Agreement.

9.8 COUNTERPARTS. This Agreement may be executed in any number of counterparts,
all of which together will constitute one and the same instrument.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       8
<PAGE>

IN WITNESS THEREOF, THE PARTIES HAVE CAUSED THIS AGREEMENT TO BE EXECUTED BY
THEIR RESPECTIVE DULY AUTHORIZED REPRESENTATIVES AS SET FORTH BELOW:

PHARSIGHT CORPORATION                  LOVELACE RESPIRATORY RESEARCH INSTITUTE

By: /s/ ROBIN KEHOE                    By:   /s/ PATRICIA J. MARX
   ----------------------------            ------------------------------------
Robin A. Kehoe                         Name:  Patricia J. Marx
Chief Financial Officer                Title:  Chief Operating Officer

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       9
<PAGE>

                                   APPENDIX A

                                   DEFINITIONS

DATA SET means the anonymized database in the diabetes therapeutic area
described in Appendix B and all Updates when and as delivered to Pharsight.

DOCUMENTATION means any and all materials provided to Pharsight by Lovelace
describing the features, structure, functions, fields, contents, collection
methods, etc. of the Data Set.

CUSTOMER means a customer of Pharsight or of its distributors to whom Pharsight
has licensed the use of the Product or to whom Pharsight has provided consulting
services utilizing the Data Set.

ACCEPTANCE CRITERIA means the specifications for the Data Set set forth in
Appendix B and the quality requirements for the Data Set set forth in Appendix D
or otherwise agreed upon in writing by the parties.

PRODUCT means Pharsight's Internet query-response product, and all updates,
upgrades, and new versions thereof, utilizing the Data Set or any Updates.

DISTRIBUTOR means a third-party sales and marketing organization contracted by
Pharsight to market and sell Product subscriptions in selected geographic
regions or market segments.

UPDATE means a new version of the Data Set, consisting of a new statistical
extraction made from the most recent provider database according to the
specifications defined in Appendix B.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       10
<PAGE>

                                   APPENDIX B

               SPECIFICATION AND APPLICATION FOR INITIAL DATA SET

APPLICATION OVERVIEW

The Data Set is intended for use with the Pharsight Internet query-response
system, which 1) allows users to ask detailed drug development questions, 2)
acts as an intelligent interface to find and extract the relevant information
from the database, 3) performs relevant numerical analysis to produce summary
results, and 4) presents the aggregate results to the users via lists, graphs
and plots. Typical question areas include incidence and statistical
distributions of specific patient characteristics in anonymous patient databases
and determination of the time course of medical condition and status in both
normal aging and pathological disease states. The system and its methods produce
reports that can be used to improve the process of developing new medical
therapeutics, including new drugs, drug delivery systems, and medical devices
and supplies. The system uses secure Internet technology, allowing users to
access the system 24-hours/day.

OUTLINE OF SPECIFICATIONS FOR DATA SET

DIABETES DATA SET SPECIFICATIONS

1. Diabetes patients will be identified as follows: During the calendar years
[ * ], select all [ * ] patients with 1) at least [ * ] outpatient visits coded
as [ * ] or 2) [ * ] hospital admission coded as [ * ], or 3) [ * ] or more
[ * ]. The date [ * ] on which each patient first meets the diabetes eligibility
criteria shall be their [ * ].

2. Those diabetes patients who have [ * ] in their files [ * ] will be excluded
from the sample.

3. The following data will be extracted for the [ * ]

I. ENROLLMENT [ * ]
Anonymized, unique patient ID number
[ * ]
II. DEMOGRAPHICS [ * ]
Anonymized, unique patient ID number
Year of birth
Sex
[ * ]
III. [ * ]
Anonymized, unique patient ID number
[ * ]

IV.  [ * ]
Anonymized patient ID number

[ * ]

[ * ]
Anonymized patient ID number

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       11
<PAGE>

[ * ]
Anonymized patient ID number
[ * ]

FILE FORMAT: The data shall be provided to Pharsight in the form of ascii files,
with multiple files or tables acceptable [ * ]. If multiple files are provided,
all individual patient records shall be linkable across all files by a common
encrypted patient identification number.

DATA SETS IN OTHER THERAPEUTIC AREAS
Should the Lovelace Data Consortium agree to provide databases to Pharsight
Corporation in additional therapeutic areas, the data elements to be provided
shall be substantively the same as those described above for the Diabetes Data;
however, a different, mutually agreed upon algorithm appropriate to the
therapeutic area will be used for identifying patients and laboratory values to
be provided will be relevant to the therapeutic area.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       12
<PAGE>

                                   APPENDIX C

                      DATABASE QUALITY ASSURANCE PROCEDURES

For the purposes of this Appendix C, the variable "X" as it appears below is to
be determined and agreed upon by the parties at a later date. Before providing
the Data to Pharsight, Lovelace will perform the following quality assurance
procedures:

1)   UNIQUENESS OF PATIENT IDENTIFIERS: Data across all [ * ] plans/panels will
     be sorted to ensure there is no duplication of patient identifiers.

2)   ACCURACY OF GENDER: Selected procedures that are sex-specific will be
     tested to ensure the sex variable is correct in X% of cases (for example,
     files will be checked to ensure no pregnancy or pelvic exam procedures
     occur in males). If more than X% of records appear to be incorrect, the
     contributing organization will be asked to investigate their demographic
     files for a systematic or programming error. If indicated, the contributing
     organization will be asked to re-extract their demographic data.

3)   COMPLETENESS OF FILES: A count will be performed to determine if the number
     of records is consistent from month to month for a given plan/panel. This
     process will help ensure that no large blocks of records are missing. Total
     number of records per month will be counted for: [ * ]. Some seasonal
     variation in health care utilization can be anticipated; however if a
     discrepancy of more than X% from month to month in a given category [ * ]
     is found, the contributing organization will be asked to verify
     completeness of the files. If indicated, the contributing organization will
     be asked to re-extract their data set or to supply a patch file to Lovelace
     containing the missing data.

4)   COMPLETENESS OF INDIVIDUAL RECORDS: For the [ * ] categories of health care
     utilization, the total number of missing fields will be counted to
     ascertain completeness of individual encounter records. If more than X% of
     records are missing one or more data elements (an example would be a [ * ]
     record that is missing the [ * ] variable), an investigation will be
     conducted to ascertain whether this is due to a systematic programming or
     extraction error or due to incomplete data entry/capture at the source
     (which cannot be corrected). If due to a programming/extraction error, the
     error will be [ * ].

5)   COMPLETENESS OF LABORATORY RECORDS: The ratio of lab procedures to [ * ]
     will be computed for each [ * ] for each plan/panel. A variation of more
     than X will be investigated to ensure that all laboratory records have been
     captured.

6)   UNIQUENESS OF LABORATORY RECORDS: To eliminate duplication of laboratory
     outcomes records, laboratory results reported both as part of a panel
     report and as an individual result will be collapsed into one record. To do
     this, any laboratory records for the same test, done on the same day, and
     reporting the exact same result will be collapsed into one record.

7)   QUALITY ASSURANCE CHECKLIST: A Quality Assurance checklist will be
     submitted to Pharsight. The checklist will contain summaries of the
     investigations and counts described in items 1-5 above.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       13
<PAGE>

                                   APPENDIX D

                               ACCEPTANCE CRITERIA

1.   A completed Quality Assurance Checklist (as stipulated in Appendix C) is
     received from Lovelace with the delivered Data package.

2.   The Quality Assurance Checklist indicates the Data conforms to the criteria
     outlined in Appendix C, Quality Assurance Procedures

3.   The Data contains the following content files:

         [ * ]

4.   The Data contain the individual data elements described in Appendix B.

5.   The Data package contains the following dictionaries:

         [ * ]

6.   The Data package contains a text file describing the contents and structure
     of the delivered Data files (a "ReadMe" file).

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       14
<PAGE>

                                   APPENDIX E

                            CONFIDENTIALITY PROTOCOL

The purpose of this confidentiality protocol is to describe the means by which
patient and organizational confidentiality will be protected during the term of
Lovelace's agreement with Pharsight.

I.   PROTECTION OF PATIENT CONFIDENTIALITY

A.   Data Transfer from Lovelace to Pharsight

1.   Data provided to Pharsight will be stripped of any patient identifiers
     before the Data is shipped to Pharsight. These patient identifiers include:

-    Name
-    Home address, including street number, building name, apartment number,
     city and zip code
-    Home phone number
-    Medical record number
-    Plan ID number
-    Plan guarantor ID number
-    Social security number
-    Complete birth date
-    Physician name (primary care or other physician)
-    Physician address
-    Physician phone number
-    Employer group or name
-    Work address
-    Work phone number
-    Any other identifier identified by the contributing organization

-    [ * ]

3.   If Pharsight inadvertently receives a data file that contains any of the
     identifying information listed in item 1 above, the Pharsight staff person
     working with the file will:

-    Immediately note the location of the electronic file(s)
-    Delete any electronic copies of the record(s) from Pharsight computers,
     floppy disks or tapes
-    Shred any hard copies of the file output
-    Provide written notification to Lovelace describing the identifying file
     information
-    Place written documentation of the incident in Pharsight files

II.  PROTECTION OF ORGANIZATIONAL CONFIDENTIALITY

A.   The merged data file provided by Lovelace to Pharsight will contain no data
     element(s) that can be used to identify the organization that contributed
     the data for a given patient or group of patients.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       15
<PAGE>

B.   In its marketing, client consulting activities, or other activities,
     Pharsight will be prohibited from divulging the names of the contributing
     organizations, except when given prior written authorization by the
     appropriate Consortium member.

C.   Pharsight may describe the source of the Data as follows

         "The health care data which underlie the Pharsight (PRODUCT/CONSULTING
         SERVICE) are derived from three health care organizations that are
         members of the Lovelace Data Consortium. This Consortium was created
         and is managed by the Southwest Center for Managed Care Research of the
         Lovelace Respiratory Research Institute. The patient-level data from
         these three organizations have been merged into one combined database.
         One of the contributing organizations is a managed care organization in
         the southwestern United States. The second organization is a provider
         group with a capitated outpatient population in the southwestern United
         States. The third organization is a network model managed health care
         plan in the mid-Atlantic region of the United States."

In addition to using the above language as a whole, Pharsight may alternatively
use the first two sentences alone or the first three sentences alone. Any other
wording that Pharsight uses to describe the source of the Data must first be
approved by Lovelace in writing in accordance with Section 3.3.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       16<PAGE>

Exhibit 4.1

                                                                  EXECUTION COPY

================================================================================

                          CFW COMMUNICATIONS COMPANY,
                                           Issuer

                                      and

                             THE BANK OF NEW YORK,
                                           Trustee

                                _______________

                                   Indenture

                           Dated as of July 26, 2000
                             ____________________

                           13% Senior Notes due 2010

================================================================================
<PAGE>

                                       i

                             CROSS-REFERENCE TABLE

<TABLE>
<CAPTION>
TIA Sections                                                  Indenture Sections
------------                                                  ------------------
<S>                                                      <C>
(S) 310(a)(1)..........................................               7.10
       (a)(2)..........................................               7.10
       (b).............................................         7.03; 7.08
(S) 311(a).............................................               7.03
       (b).............................................               7.03
(S) 312(a).............................................               2.04
       (b).............................................              10.02
       (c).............................................              10.02
(S) 313(a).............................................               7.06
       (b)(2)..........................................               7.07
       (c).............................................  7.05; 7.06; 10.02
       (d).............................................               7.06
(S) 314(a).............................................        7.05; 10.02
       (a)(4)..........................................        4.17; 10.02
       (c)(1)..........................................              10.03
       (c)(2)..........................................              10.03
       (e).............................................        4.17; 10.04
(S) 315(a).............................................               7.02
       (b).............................................        7.05; 10.02
       (c).............................................               7.02
       (d).............................................               7.02
       (e).............................................               6.11
(S) 316(a)(1)(A).......................................               6.05
       (a)(1)(B).......................................               6.04
       (b).............................................               6.07
       (c).............................................               9.03
(S) 317(a)(1)..........................................               6.08
       (a)(2)..........................................               6.09
       (b).............................................               2.05
(S) 318(a).............................................              10.01
       (c).............................................              10.01
</TABLE>

Note:  The Cross-Reference Table shall not for any purpose be deemed to be a
part of this Indenture.
<PAGE>

                                      ii

                               TABLE OF CONTENTS
<TABLE>
<CAPTION>
                                                                                                         Page
                                                                                                         ----
<S>                                                                                                      <C>
                              ARTICLE ONE DEFINITIONS AND INCORPORATION BY REFERENCE

SECTION 1.01.    Definitions...........................................................................    1
SECTION 1.02.    Incorporation by Reference of Trust Indenture Act.....................................   22
SECTION 1.03.    Rules of Construction.................................................................   22

                                               ARTICLE TWO THE NOTES

SECTION 2.01.    Form and Dating.......................................................................   23
SECTION 2.02.    Restrictive Legends...................................................................   24
SECTION 2.03.    Execution, Authentication and Denominations...........................................   26
SECTION 2.04.    Registrar and Paying Agent............................................................   26
SECTION 2.05.    Paying Agent to Hold Money in Trust...................................................   27
SECTION 2.06.    Transfer and Exchange.................................................................   28
SECTION 2.07.    Book-Entry Provisions for Global Notes................................................   38
SECTION 2.08.    Special Transfer Provisions...........................................................   30
SECTION 2.09.    Replacement Notes.....................................................................   33
SECTION 2.10.    Outstanding Notes.....................................................................   33
SECTION 2.11.    Temporary Notes.......................................................................   33
SECTION 2.12.    Cancellation..........................................................................   34
SECTION 2.13.    CUSIP Numbers.........................................................................   34
SECTION 2.14.    Defaulted Interest....................................................................   34
SECTION 2.15.    Issuance of Additional Notes..........................................................   34

                                               ARTICLE THREE REDEMPTION

SECTION 3.01.    Right of Redemption...................................................................   35
SECTION 3.02.    Notices to Trustee....................................................................   36
SECTION 3.03.    Selection of Notes to Be Redeemed.....................................................   36
SECTION 3.04.    Notice of Redemption..................................................................   36
SECTION 3.05.    Effect of Notice of Redemption.........................................................  38
SECTION 3.06.    Deposit of Redemption Price or Special Redemption Price...............................   38
SECTION 3.07.    Payment of Notes Called for Redemption................................................   39
SECTION 3.08.    Notes Redeemed in Part................................................................   39

                                                ARTICLE FOUR COVENANTS

SECTION 4.01.    Payment of Notes.......................................................................  39
SECTION 4.02.    Maintenance of Office or Agency........................................................  39
SECTION 4.03.    Limitation on Indebtedness.............................................................  40
SECTION 4.04.    Limitation on Restricted Payments......................................................  43
</TABLE>
<PAGE>

                                      iii

<TABLE>
<S>                                                                                                      <C>
SECTION 4.05.    Limitation on Dividend and Other Payment Restrictions
                 Affecting Restricted Subsidiaries......................................................  46
SECTION 4.06.    Limitation on the Issuance and Sale of Capital Stock of
                 Restricted Subsidiaries................................................................  47
SECTION 4.07.    Limitation on Issuances of Guarantees by Restricted
                 Subsidiaries...........................................................................  48
SECTION 4.08.    Limitation on Transactions with Stockholders and Affiliates............................  49
SECTION 4.09.    Limitation on Liens....................................................................  50
SECTION 4.10.    Limitation on Sale-Leaseback Transactions..............................................  50
SECTION 4.11.    Limitation on Asset Sales..............................................................  51
SECTION 4.12.    Repurchase of Notes upon a Change of Control...........................................  52
SECTION 4.13.    Existence..............................................................................  52
SECTION 4.14.    Payment of Taxes and Other Claims......................................................  52
SECTION 4.15.    Maintenance of Properties and Insurance................................................  53
SECTION 4.16.    Notice of Defaults.....................................................................  53
SECTION 4.17.    Compliance Certificates................................................................  53
SECTION 4.18.    Commission Reports and Reports to Holders..............................................  54
SECTION 4.19.    Waiver of Stay, Extension or Usury Laws................................................  54
SECTION 4.20.    Calculation of Original Issue Discount.................................................  54

                                     ARTICLE FIVE SUCCESSOR CORPORATION

SECTION 5.01.    When Company May Merge, Etc. ..........................................................  55
SECTION 5.02.    Successor Substituted..................................................................  56

                                      ARTICLE SIX DEFAULT AND REMEDIES

SECTION 6.01.    Events of Default......................................................................  56
SECTION 6.02.    Acceleration...........................................................................  57
SECTION 6.03.    Other Remedies.........................................................................  58
SECTION 6.04.    Waiver of Past Defaults................................................................  58
SECTION 6.05.    Control by Majority....................................................................  59
SECTION 6.06.    Limitation on Suits....................................................................  59
SECTION 6.07.    Rights of Holders to Receive Payment...................................................  59
SECTION 6.08.    Collection Suit by Trustee.............................................................  59
SECTION 6.09.    Trustee May File Proofs of Claim.......................................................  60
SECTION 6.10.    Priorities.............................................................................  60
SECTION 6.11.    Undertaking for Costs..................................................................  60
SECTION 6.12.    Restoration of Rights and Remedies.....................................................  61
SECTION 6.13.    Rights and Remedies Cumulative.........................................................  61
SECTION 6.14.    Delay or Omission Not Waiver...........................................................  61

                                         ARTICLE SEVEN TRUSTEE

SECTION 7.01.    General................................................................................  61
SECTION 7.02.    Certain Rights of Trustee..............................................................  62
</TABLE>
<PAGE>

                                      iv

<TABLE>
<S>                                                                                                      <C>
SECTION 7.03.    Individual Rights of Trustee...........................................................  63
SECTION 7.04.    Trustee's Disclaimer...................................................................  63
SECTION 7.05.    Notice of Default......................................................................  63
SECTION 7.06.    Reports by Trustee to Holders..........................................................  63
SECTION 7.07.    Compensation and Indemnity.............................................................  64
SECTION 7.08.    Replacement of Trustee.................................................................  64
SECTION 7.09.    Successor Trustee by Merger, Etc. .....................................................  65
SECTION 7.10.    Eligibility............................................................................  66
SECTION 7.11.    Money Held in Trust....................................................................  66

                                     ARTICLE EIGHT DISCHARGE OF INDENTURE

SECTION 8.01.    Termination of Company's Obligations...................................................  66
SECTION 8.02.    Defeasance and Discharge of Indenture..................................................  67
SECTION 8.03.    Defeasance of Certain Obligations......................................................  69
SECTION 8.04.    Application of Trust Money.............................................................  70
SECTION 8.05.    Repayment to Company...................................................................  71
SECTION 8.06.    Reinstatement..........................................................................  71

                                ARTICLE NINE AMENDMENTS, SUPPLEMENTS AND WAIVERS

SECTION 9.01.    Without Consent of Holders.............................................................  71
SECTION 9.02.    With Consent of Holders................................................................  72
SECTION 9.03.    Revocation and Effect of Consent.......................................................  73
SECTION 9.04.    Notation on or Exchange of Notes.......................................................  73
SECTION 9.05.    Trustee to Sign Amendments, Etc........................................................  74
SECTION 9.06.    Conformity with Trust Indenture Act....................................................  74

                                            ARTICLE TEN MISCELLANEOUS

SECTION 10.01.   Trust Indenture Act of 1939...........................................................   74
SECTION 10.02.   Notices...............................................................................   74
SECTION 10.03.   Certificate and Opinion as to Conditions Precedent....................................   75
SECTION 10.04.   Statements Required in Certificate or Opinion.........................................   76
SECTION 10.05.   Rules by Trustee, Paying Agent or Registrar...........................................   76
SECTION 10.06.   Payment Date Other Than a Business Day................................................   76
SECTION 10.07.   Governing Law.........................................................................   76
SECTION 10.08.   No Adverse Interpretation of Other Agreements.........................................   77
SECTION 10.09.   No Recourse Against Others............................................................   77
SECTION 10.10.   Successors............................................................................   77
SECTION 10.11.   Duplicate Originals...................................................................   77
SECTION 10.12.   Separability..........................................................................   77
SECTION 10.13.   Table of Contents, Headings, Etc......................................................   77

EXHIBIT A        Form Of Note..........................................................................  A-1
</TABLE>
<PAGE>

                                       v

<TABLE>
<S>                                                                                                     <C>
EXHIBIT B         Form of Certificate..................................................................  B-1
EXHIBIT C         Form of Certificate to Be Delivered in Connection with Transfers
                  Pursuant to Non-QIB Accredited Investors.............................................  C-1
EXHIBIT D         Form of Certificate to Be Delivered in Connection with Transfers
                  Pursuant to Regulation S.............................................................  D-1
</TABLE>
<PAGE>

Exhibit 4.1

     INDENTURE, dated as of July 26, 2000 between CFW Communications Company, a
Virginia corporation (the "Company"), and THE BANK OF NEW YORK, a New York
                           -------
banking corporation, trustee (the "Trustee").
                                   -------

                                   RECITALS

     The Company has duly authorized the execution and delivery of this
Indenture to provide for the issuance initially of up to $280,000,000 aggregate
principal amount of the Company's 13% Senior Notes due 2010 (the "Notes")
                                                                  -----
issuable as provided in this Indenture.  All things necessary to make this
Indenture a valid agreement of the Company, in accordance with its terms, have
been done, and the Company has done all things necessary to make the Notes, when
executed by the Company and authenticated and delivered by the Trustee hereunder
and duly issued by the Company, valid obligations of the Company as hereinafter
provided.

     This Indenture is subject to, and shall be governed by, the provisions of
the Trust Indenture Act of 1939, as amended, that are required to be a part of
and to govern indentures qualified under the Trust Indenture Act of 1939, as
amended.

                     AND THIS INDENTURE FURTHER WITNESSETH

     For and in consideration of the premises and the purchase of the Notes by
the Holders thereof, it is mutually covenanted and agreed, for the equal and
proportionate benefit of all Holders, as follows.

                                  ARTICLE ONE
                  DEFINITIONS AND INCORPORATION BY REFERENCE

              .1.   Definitions
              -----------------

     "Acquired Indebtedness" means Indebtedness of a Person (1) existing at the
      ---------------------
time such Person becomes a Restricted Subsidiary or (2) assumed in connection
with an Asset Acquisition by a Restricted Subsidiary; provided that Indebtedness
of such Person which is redeemed, defeased, retired or otherwise repaid at the
time of or immediately upon consummation of the transactions by which such
Person becomes a Restricted Subsidiary or such Asset Acquisition shall not be
Acquired Indebtedness.

     "Adjusted Consolidated Net Income" means, for any period, the aggregate net
      --------------------------------
income (or loss) of the Company and its Restricted Subsidiaries for such period
determined in conformity with GAAP; provided that the following items shall be
excluded in computing Adjusted Consolidated Net Income (without duplication):

          (1)  the net income of any Person that is not a Restricted Subsidiary,
     except to the extent of the amount of dividends or other distributions
     actually paid to the Company or any of its Restricted Subsidiaries by such
     Person during such period;
<PAGE>

                                       2

          (2)  the net income (or loss) of any Person accrued prior to the date
     it becomes a Restricted Subsidiary or is merged into or consolidated with
     the Company or any of its Restricted Subsidiaries or all or substantially
     all of the property and assets of such Person are acquired by the Company
     or any of its Restricted Subsidiaries;

          (3)  the net income of any Restricted Subsidiary to the extent that
     the declaration or payment of dividends or similar distributions by such
     Restricted Subsidiary of such net income is not at the time permitted by
     the operation of the terms of its charter or any agreement, instrument,
     judgment, decree, order, statute, rule or governmental regulation
     applicable to such Restricted Subsidiary;

          (4)  any gains or losses (on an after-tax basis) attributable to Asset
     Sales;

          (5)  solely for purposes of calculating the amount of Restricted
     Payments that may be made pursuant to clause (C) of Section 4.04, any
     amount paid or accrued as dividends on Preferred Stock of the Company owned
     by Persons other than the Company and any of its Restricted Subsidiaries;
     and

          (6)  all extraordinary gains and extraordinary losses.

     "Adjusted Consolidated Net Tangible Assets" means the total amount of
      -----------------------------------------
assets of the Company and its Restricted Subsidiaries (less applicable
depreciation, amortization and other valuation reserves), except to the extent
resulting from write-ups of capital assets (excluding write-ups in connection
with accounting for acquisitions in conformity with GAAP), after deducting
therefrom (1) all current liabilities of the Company and its Restricted
Subsidiaries (excluding intercompany payables and receivables) and (2) all
goodwill, trade names, trademarks, patents, unamortized debt discount and
expense and other like intangibles, other than licenses, all as set forth on the
most recent quarterly or annual consolidated balance sheet of the Company and
its Restricted Subsidiaries, prepared in conformity with GAAP and filed with the
Commission or provided to the Trustee.

     "Affiliate" means, as applied to any Person, any other Person directly or
      ---------
indirectly controlling, controlled by, or under direct or indirect common
control with, such Person. For purposes of this definition, "control"
(including, with correlative meanings, the terms "controlling," "controlled by"
and "under common control with"), as applied to any Person, means the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities, by contract or otherwise.

     "Agent" means any Registrar, Co-Registrar, Paying Agent or authenticating
      -----
agent.

     "Agent Members" has the meaning provided in Section 2.07(a).
      -------------

     "Asset Acquisition" means (1) an Investment by the Company or any of its
      -----------------
Restricted Subsidiaries in any other Person pursuant to which such Person shall
become a Restricted Subsidiary or shall be merged into or consolidated with the
Company or any of its Restricted
<PAGE>

                                       3

Subsidiaries; provided that such Person's primary business is related, ancillary
or complementary to the businesses of the Company and its Restricted
Subsidiaries on the date of such Investment or (2) an acquisition by the Company
or any of its Restricted Subsidiaries of the property and assets of any Person
other than the Company or any of its Restricted Subsidiaries that constitute
substantially all of a division or line of business of such Person; provided
that the property and assets acquired are related, ancillary or complementary to
the businesses of the Company and its Restricted Subsidiaries on the date of
such acquisition.

     "Asset Disposition" means the sale or other disposition by the Company or
      -----------------
any of its Restricted Subsidiaries (other than to the Company or another
Restricted Subsidiary) of (1) all or substantially all of the Capital Stock of
any Restricted Subsidiary or (2) all or substantially all of the assets that
constitute a division or line of business of the Company or any of its
Restricted Subsidiaries.

     "Asset Sale" means any sale, transfer or other disposition (including by
      ----------
way of merger, consolidation or sale-leaseback transaction) after the Closing
Date in one transaction or a series of related transactions by the Company or
any of its Restricted Subsidiaries to any Person other than the Company or any
of its Restricted Subsidiaries of (1) all or any of the Capital Stock of any
Restricted Subsidiary, (2) all or substantially all of the property and assets
of an operating unit or business of the Company or any of its Restricted
Subsidiaries or (3) any other property and assets (other than the Capital Stock
or other Investment in an Unrestricted Subsidiary) of the Company or any of its
Restricted Subsidiaries outside the ordinary course of business of the Company
or such Restricted Subsidiary and, in each case, that is not governed by the
provisions of this Indenture applicable to mergers, consolidations and sales of
assets of the Company; provided that "Asset Sale" shall not include (a) sales or
other dispositions of inventory, receivables and other current assets, (b)
sales, transfers or other dispositions of assets constituting a Restricted
Payment permitted to be made pursuant to Section 4.04, (c) sales or other
dispositions of assets for consideration at least equal to the fair market value
of the assets sold or disposed of, to the extent that the consideration received
would satisfy clause (B) of Section 4.11 or (d) sales or other dispositions of
obsolete or worn out equipment or equipment that is no longer useful in the
conduct of the business of the Company and its Restricted Subsidiaries and that
is disposed of in each case in the ordinary course of business.

     "Average Life" means, at any date of determination with respect to any debt
      ------------
security, the quotient obtained by dividing (1) the sum of the products of (a)
the number of years from such date of determination to the dates of each
successive scheduled principal payment of such debt security and (b) the amount
of such principal payment by (2) the sum of all such principal payments.

     "Board of Directors" means the Board of Directors of the Company or any
      ------------------
committee of such Board of Directors duly authorized to act under this
Indenture.

     "Board Resolution" means a copy of a resolution certified by the Secretary
      ----------------
or an Assistant Secretary of the Company to have been duly adopted by the Board
of Directors and to be in full force and effect on the date of such
certification, and delivered to the Trustee.
<PAGE>

                                       4

     "Business Day" means any day except a Saturday, Sunday or other day on
      ------------
which commercial banks in The City of New York, or in the city of the Corporate
Trust Office of the Trustee, are authorized by law or other governmental action
to close.

     "Capital Stock" means, with respect to any Person, any and all shares,
      -------------
interests, participations or other equivalents (however designated, whether
voting or non-voting) in equity of such Person, whether outstanding on the
Closing Date or issued thereafter, including, without limitation, all Common
Stock and Preferred Stock.

     "Capitalized Lease" means, as applied to any Person, any lease of any
      -----------------
property (whether real, personal or mixed) of which the discounted present value
of the rental obligations of such Person as lessee, in conformity with GAAP, is
required to be capitalized on the balance sheet of such Person.

     "Capitalized Lease Obligations" means the discounted present value of the
      -----------------------------
rental obligations under a Capitalized Lease.

     "Cash Equivalents" means (1) securities issued or directly and fully
      ----------------
guaranteed or insured by the United States of America or any agency or
instrumentality thereof (provided that the full faith and credit of the United
States of America is pledged in support thereof) in each case maturing within
one year after the date of acquisition, (2) time deposits and certificates of
deposit and commercial paper issued by the parent corporation of any domestic
commercial bank of recognized standing having capital and surplus in excess of
$500.0 million and commercial paper issued by others rated at least A-2 or the
equivalent thereof by S&P or at least P-2 or the equivalent thereof by Moody's
and in each case maturing within one year after the date of acquisition and (3)
investments in money market funds substantially all of whose assets comprise
securities of the types described in clauses (1) and (2) above.

     "Change of Control" means such time as (1) a "person" or "group" (within
      -----------------
the meaning of Sections 13(d) and 14(d)(2) of the Exchange Act), other than the
Permitted Holders, becomes the ultimate "beneficial owner" (as defined in Rule
13d-3 under the Exchange Act) of more than 35% of the total voting power of the
Voting Stock of the Company on a fully diluted basis and such total voting power
is more than WCAS's total voting power of the Voting Stock of the Company on a
fully diluted basis; or (2) individuals who on the Closing Date constitute the
Board of Directors (together with any new directors whose election by the Board
of Directors or whose nomination by the Board of Directors for election by the
Company's stockholders was approved by a vote of at least a majority of the
members of the Board of Directors then in office who either were members of the
Board of Directors on the Closing Date or whose election or nomination for
election was previously so approved) cease for any reason to constitute a
majority of the members of the Board of Directors then in office.

     "Closing Date" means the date on which the Notes are originally issued
      ------------
under this Indenture.

     "Collateral" has the meaning ascribed thereto in the Escrow Agreement.
      ----------
<PAGE>

                                       5

     "Collateral Account" means an account established with the Trustee pursuant
      ------------------
to the terms of the Escrow Agreement for the deposit of the Collateral to be
purchased by the Company with a portion of the net proceeds from the sale of the
Notes.

     "Commission" means the Securities and Exchange Commission, as from time to
      ----------
time constituted, created under the Exchange Act or, if at any time after the
execution of this instrument such Commission is not existing and performing the
duties now assigned to it under the TIA, then the body performing such duties at
such time.

     "Common Stock" means, with respect to any Person, any and all shares,
      ------------
interests, participations or other equivalents (however designated, whether
voting or non-voting) of such Person's equity, other than Preferred Stock of
such Person, whether outstanding on the Closing Date or issued thereafter,
including, without limitation, all series and classes of such common stock.

     "Company" means the party named as such in the first paragraph of this
      -------
Indenture until a successor replaces it pursuant to Article Five of this
Indenture and thereafter means the successor.

     "Company Order" means a written request or order signed in the name of the
      -------------
Company (i) by its Chairman, a Vice Chairman, its President or a Vice President
and (ii) by its Treasurer, an Assistant Treasurer, its Secretary or an Assistant
Secretary and delivered to the Trustee; provided, however, that such written
request or order may be signed by any two of the officers or directors listed in
clause (i) above in lieu of being signed by one of such officers or directors
listed in such clause (i) and one of the officers listed in clause (ii) above.

     "Consolidated EBITDA" means, for any period, Adjusted Consolidated Net
      -------------------
Income for such period plus, to the extent such amount was deducted in
calculating such Adjusted Consolidated Net Income:  (1) Consolidated Interest
Expense, (2) income taxes (other than income taxes (either positive or negative)
attributable to extraordinary and non-recurring gains or losses or sales of
assets), (3) depreciation expense, (4) amortization expense, (5) for purposes of
determining the Company's ability to Incur Indebtedness, non-recurring severance
and transaction costs incurred in connection with any acquisition (including any
Transaction) by the Company or its Restricted Subsidiaries and (6) all other
non-cash items reducing Adjusted Consolidated Net Income (other than items that
will require cash payments and for which an accrual or reserve is, or is
required by GAAP to be, made), less all non-cash items increasing Adjusted
Consolidated Net Income, all as determined on a consolidated basis for the
Company and its Restricted Subsidiaries in conformity with GAAP; provided that,
if any Restricted Subsidiary is not a Wholly Owned Restricted Subsidiary,
Consolidated EBITDA shall be reduced (to the extent not otherwise reduced in
accordance with GAAP) or increased (to the extent not otherwise increased in
accordance with GAAP) by an amount equal to (A) the amount of the Adjusted
Consolidated Net Income (whether positive or negative) attributable to such
Restricted Subsidiary multiplied by (B) the percentage ownership interest in the
income of such Restricted Subsidiary not owned on the last day of such period by
the Company or any of its Restricted Subsidiaries.
<PAGE>

                                       6

     "Consolidated Interest Expense" means, for any period, the aggregate amount
      -----------------------------
of interest in respect of Indebtedness (including, without limitation,
Indebtedness that is Guaranteed or secured by the Company or any of its
Restricted Subsidiaries, including, without limitation, amortization of original
issue discount on any Indebtedness and the interest portion of any deferred
payment obligation, calculated in accordance with the effective interest method
of accounting; all commissions, discounts and other fees and charges owed with
respect to letters of credit and bankers' acceptance financing; and the net
costs associated with Interest Rate Agreements) and all but the principal
component of rentals in respect of Capitalized Lease Obligations paid, accrued
or scheduled to be paid or to be accrued by the Company and its Restricted
Subsidiaries during such period; excluding, however, (1) any amount of such
interest of any Restricted Subsidiary if the net income of such Restricted
Subsidiary is excluded in the calculation of Adjusted Consolidated Net Income
pursuant to clause (3) of the definition thereof (but only in the same
proportion as the net income of such Restricted Subsidiary is excluded from the
calculation of Adjusted Consolidated Net Income pursuant to clause (3) of the
definition thereof) and (2) any premiums, fees and expenses (and any
amortization thereof) payable in connection with the offering of the Notes, all
as determined on a consolidated basis (without taking into account Unrestricted
Subsidiaries) in conformity with GAAP.

     "Corporate Trust Office" means the office of the Trustee at which the
      ----------------------
corporate trust business of the Trustee shall, at any particular time, be
principally administered, which office is, at the date of this Indenture,
located at 101 Barclay Street, Floor 21-W, New York, New York  10286; Attention:
Corporate Trust Administration, or such other address as the Trustee may
designate from time to time by notice to the Holders and the Company.

     "Credit Facility" means the Credit Agreement among the Company, Morgan
      ---------------
Stanley Senior Funding, Inc. and certain other financial institutions party
thereto, as such agreement, may be, in one or more agreements with one or more
lending groups, amended, renewed, extended, substituted, refinanced,
restructured, replaced, supplemented or otherwise modified, in whole or in part,
from time to time (including, without limitation, any successive renewals,
extensions, substitutions, refinancings, restructurings, replacements,
supplements or other modifications of the foregoing, including those that
increase the amount available thereunder in accordance with the terms of this
Indenture).

     "Currency Agreement" means any foreign exchange contract, currency swap
      ------------------
agreement or other similar agreement or arrangement.

     "Default" means any event that is, or after notice or passage of time or
      -------
both would be, an Event of Default.

     "Depositary" means The Depository Trust Company, its nominees, and their
      ----------
respective successors.

     "Disqualified Stock" means any class or series of Capital Stock of any
      ------------------
Person that by its terms or otherwise is (1) required to be redeemed prior to
the Stated Maturity of the Notes, (2) redeemable at the option of the holder of
such class or series of Capital Stock at any time prior to the Stated Maturity
of the Notes or (3) convertible into or exchangeable for Capital Stock
<PAGE>

                                       7

referred to in clause (1) or (2) above or Indebtedness having a scheduled
maturity prior to the Stated Maturity of the Notes; provided that any Capital
Stock that would not constitute Disqualified Stock but for provisions thereof
giving holders thereof the right to require such Person to repurchase or redeem
such Capital Stock upon the occurrence of an "asset sale" or "change of control"
occurring prior to the Stated Maturity of the Notes shall not constitute
Disqualified Stock if the "asset sale" or "change of control" provisions
applicable to such Capital Stock are no more favorable to the holders of such
Capital Stock than the provisions contained in Section 4.11 and Section 4.12 and
such Capital Stock specifically provides that such Person will not repurchase or
redeem any such stock pursuant to such provision prior to the Company's
repurchase of such Notes as are required to be repurchased pursuant to Section
4.11 and Section 4.12.

     "Escrow Agent" means The Bank of New York, a New York banking corporation.
      ------------

     "Escrow Agreement" means the Escrow and Security Agreement, dated as of the
      ----------------
Closing Date, among the Company, the Trustee and the Escrow Agent.

     "Event of Default" has the meaning provided in Section 6.01.
      ----------------

     "Excess Proceeds" has the meaning provided in Section 4.11.
      ---------------

     "Exchange Act" means the Securities Exchange Act of 1934, as amended.
      ------------

     "Exchange Notes" means any securities of the Company containing terms
      --------------
identical to the Notes (except that such Exchange Notes shall be registered
under the Securities Act and shall not have registration rights or interest
penalties pursuant to the Registration Rights Agreement) that are issued and
exchanged for the Notes pursuant to the Registration Rights Agreement and this
Indenture.

     "fair market value" means the price that would be paid in an arm's-length
      -----------------
transaction between an informed and willing seller under no compulsion to sell
and an informed and willing buyer under no compulsion to buy, as determined by
the Board of Directors, whose determination shall be conclusive if evidenced by
a Board Resolution; provided that with respect to any transaction or series of
related transactions having a value in excess of $10 million, such determination
is made by disinterested members of the Board of Directors.

     "GAAP" means generally accepted accounting principles in the United States
      ----
of America as in effect as of the Closing Date, including, without limitation,
those set forth in the opinions and pronouncements of the Accounting Principles
Board of the American Institute of Certified Public Accountants and statements
and pronouncements of the Financial Accounting Standards Board or in such other
statements by such other entity as approved by a significant segment of the
accounting profession. All ratios and computations contained or referred to in
this Indenture shall be computed in conformity with GAAP applied on a consistent
basis, except that calculations made for purposes of determining compliance with
the terms of the covenants and with other provisions of this Indenture shall be
made without giving effect to (1) the amortization of any expenses incurred in
connection with the Transactions and (2) except as otherwise
<PAGE>

                                       8

provided, the amortization of any amounts required or permitted by Accounting
Principles Board Opinion Nos. 16 and 17.

     "Global Notes" has the meaning provided in Section 2.01.
      ------------

     "Government Securities" means direct obligations of, obligations fully
      ---------------------
guaranteed by, or participations in pools consisting solely of obligations of or
obligations guaranteed by, the United States of America for the payment of which
guarantee or obligations the full faith and credit of the United States of
America is pledged and which are not callable or redeemable at the option of the
issuer thereof.

     "Guarantee" means any obligation, contingent or otherwise, of any Person
      ---------
directly or indirectly guaranteeing any Indebtedness of any other Person and,
without limiting the generality of the foregoing, any obligation, direct or
indirect, contingent or otherwise, of such Person (1) to purchase or pay (or
advance or supply funds for the purchase or payment of) such Indebtedness of
such other Person (whether arising by virtue of partnership arrangements, or by
agreements to keep-well, to purchase assets, goods, securities or services
(unless such purchase arrangements are on arm's-length terms and are entered
into in the ordinary course of business), to take-or-pay, or to maintain
financial statement conditions or otherwise) or (2) entered into for purposes of
assuring in any other manner the obligee of such Indebtedness of the payment
thereof or to protect such obligee against loss in respect thereof (in whole or
in part); provided that the term "Guarantee" shall not include endorsements for
collection or deposit in the ordinary course of business.  The term "Guarantee"
used as a verb has a corresponding meaning.

     "Guaranteed Indebtedness" has the meaning provided in Section 4.07.
      -----------------------

     "Holder" or "Noteholder" means the registered holder of any Note.
      ------      ----------

     "Incur" means, with respect to any Indebtedness, to incur, create, issue,
      -----
assume, Guarantee or otherwise become liable for or with respect to, or become
responsible for, the payment of, contingently or otherwise, such Indebtedness,
including an "Incurrence" of Acquired Indebtedness; provided that neither the
accrual of interest nor the accretion of original issue discount shall be
considered an Incurrence of Indebtedness.

     "Indebtedness" means, with respect to any Person at any date of
      ------------
determination (without duplication):

          (1)  all indebtedness of such Person for borrowed money;

          (2)  all obligations of such Person evidenced by bonds, debentures,
     Notes or other similar instruments;

          (3)  all obligations of such Person in respect of letters of credit or
     other similar instruments (including reimbursement obligations with respect
     thereto, but excluding obligations with respect to letters of credit
     (including trade letters of credit) securing obligations (other than
     obligations described in (1) or (2) above or (5), (6) or (7) below)
<PAGE>

                                       9

     entered into in the ordinary course of business of such Person to the
     extent such letters of credit are not drawn upon or, if drawn upon, to the
     extent such drawing is reimbursed no later than the third Business Day
     following receipt by such Person of a demand for reimbursement);

          (4)  all obligations of such Person to pay the deferred and unpaid
     purchase price of property or services, which purchase price is due more
     than six months (or one year in the case of earnouts for which the maximum
     non-contingent obligation does not exceed $25.0 million) after the date of
     placing such property in service or taking delivery and title thereto or
     the completion of such services, except Trade Payables;

          (5)  all Capitalized Lease Obligations;

          (6)  all Indebtedness of other Persons secured by a Lien on any asset
     of such Person, whether or not such Indebtedness is assumed by such Person;
     provided that the amount of such Indebtedness shall be the lesser of (A)
     the fair market value of such asset at such date of determination and (B)
     the amount of such Indebtedness;

          (7)  all Indebtedness of other Persons Guaranteed by such Person to
     the extent such Indebtedness is Guaranteed by such Person; and

          (8)  to the extent not otherwise included in this definition,
     obligations under Currency Agreements and Interest Rate Agreements.

     The amount of Indebtedness of any Person at any date shall be the
outstanding balance at such date of all unconditional obligations as described
above and, with respect to contingent obligations, the maximum net liability
upon the occurrence of the contingency giving rise to the obligation, provided
(A) that the amount outstanding at any time of any Indebtedness issued with
original issue discount is the face amount of such Indebtedness less the
remaining unamortized portion of the original issue discount of such
Indebtedness at such time as determined in conformity with GAAP, (B) that money
borrowed and set aside at the time of the Incurrence of any Indebtedness in
order to prefund the payment of the interest on such Indebtedness shall not be
deemed to be "Indebtedness" so long as such money is held to secure the payment
of such interest and (C) that Indebtedness shall not include any liability for
federal, state, local or other taxes.

     "Indebtedness to EBITDA Ratio" means, on any Transaction Date, the ratio of
      ----------------------------

          (1)  the aggregate amount of Indebtedness of the Company and its
     Restricted Subsidiaries on a consolidated basis outstanding on such
     Transaction Date to

          (2)  the aggregate amount of Consolidated EBITDA for the then most
     recent four fiscal quarters for which financial statements of the Company
     have been filed with the Commission or provided to the Trustee (such four
     fiscal quarter period being the "Four Quarter Period"); provided that, in
     making the foregoing calculation, (A) pro forma effect shall be given to
     any Indebtedness to be Incurred or repaid on the Transaction Date;
<PAGE>

                                      10

     (B) pro forma effect shall be given to Asset Dispositions and Asset
     Acquisitions (including giving pro forma effect to the application of
     proceeds of any Asset Disposition) that occur from the beginning of the
     Four Quarter Period through the Transaction Date (the "Reference Period"),
     as if they had occurred and such proceeds had been applied on the first day
     of such Reference Period; and (C) pro forma effect shall be given to Asset
     Dispositions and Asset Acquisitions (including giving pro forma effect to
     the application of proceeds of any Asset Disposition) that have been made
     by any Person that has become a Restricted Subsidiary or has been merged
     with or into the Company or any Restricted Subsidiary during such Reference
     Period and that would have constituted Asset Dispositions or Asset
     Acquisitions had such transactions occurred when such Person was a
     Restricted Subsidiary as if such asset dispositions or asset acquisitions
     were Asset Dispositions or Asset Acquisitions that occurred on the first
     day of such Reference Period; provided that to the extent that clause (B)
     or (C) of this sentence requires that pro forma effect be given to an Asset
     Acquisition or Asset Disposition, such pro forma calculation shall be based
     upon the four full fiscal quarters immediately preceding the Transaction
     Date of the Person, or division or line of business of the Person, that is
     acquired or disposed of for which financial information is available.

     "Indenture" means this Indenture as originally executed or as it may be
      ---------
amended or supplemented from time to time by one or more indentures supplemental
to this Indenture entered into pursuant to the applicable provisions of this
Indenture.

     "Institutional Accredited Investor" means an institution that is an
      ---------------------------------
"accredited investor" as that term is defined in Rule 501(a)(1), (2), (3) or (7)
under the Securities Act.

     "Interest Payment Date" means each semiannual interest payment date on
      ---------------------
February 15 and August 15 of each year, commencing February 15, 2001.

     "Interest Rate Agreement" means any interest rate protection agreement,
      -----------------------
interest rate future agreement, interest rate option agreement, interest rate
swap agreement, interest rate cap agreement, interest rate collar agreement,
interest rate hedge agreement, option or future contract or other similar
agreement or arrangement.

     "Investment" by the Company or any Restricted Subsidiary in any Person
      ----------
means any direct or indirect advance, loan or other extension of credit
(including, without limitation, by way of Guarantee or similar arrangement; but
excluding Permitted Advances and advances to customers in the ordinary course of
business that are, in conformity with GAAP, recorded as accounts receivable on
the balance sheet of the Company or its Restricted Subsidiaries) or capital
contribution to (by means of any transfer of cash or other property to others or
any payment for property or services for the account or use of others), or any
purchase or acquisition of Capital Stock, bonds, notes, debentures or other
similar instruments issued by, such Person and shall include (i) the designation
of a Restricted Subsidiary as an Unrestricted Subsidiary and (ii) the retention
of the Capital Stock (or any other Investment) by the Company or any of its
Restricted Subsidiaries, of (or in) any Person that has ceased to be a
Subsidiary, including without limitation, by reason of any transaction permitted
by clause (iii) of Section 4.06. For purposes of
<PAGE>

                                      11

the definition of "Unrestricted Subsidiary" and Section 4.04, the amount of or a
reduction in an Investment shall be equal to the fair market value thereof at
the time such Investment is made or reduced.

     "Lien" means any mortgage, pledge, security interest, encumbrance, lien or
      ----
charge of any kind (including, without limitation, any conditional sale or other
title retention agreement or lease in the nature thereof or any agreement to
give any security interest).

     "Moody's" means Moody's Investors Service, Inc. and its successors.
      -------

     "MSDW" means Morgan Stanley Dean Witter & Co. and its affiliates.
      ----

     "Net Cash Proceeds" means, (a) with respect to any Asset Sale, the proceeds
      -----------------
of such Asset Sale in the form of cash or Cash Equivalents, including payments
in respect of deferred payment obligations (to the extent corresponding to the
principal, but not interest, component thereof) when received in the form of
cash or Cash Equivalents and proceeds from the conversion of other property
received when converted to cash or Cash Equivalents, net of (i) brokerage
commissions and other fees and expenses (including fees and expenses of counsel
and investment bankers) related to such Asset Sale, (ii) provisions for all
taxes (whether or not such taxes will actually be paid or are payable) as a
result of such Asset Sale without regard to the consolidated results of
operations of the Company and its Restricted Subsidiaries, taken as a whole,
(iii) payments made to repay Indebtedness or any other obligation outstanding at
the time of such Asset Sale that either (A) is secured by a Lien on the property
or assets sold or (B) is required to be paid as a result of such sale and (iv)
appropriate amounts to be provided by the Company or any Restricted Subsidiary
as a reserve against any liabilities associated with such Asset Sale, including,
without limitation, pension and other post-employment benefit liabilities,
liabilities related to environmental matters and liabilities under any
indemnification obligations associated with such Asset Sale, all as determined
in conformity with GAAP and (b) with respect to any issuance or sale of Capital
Stock, the proceeds of such issuance or sale in the form of cash or Cash
Equivalents, including payments in respect of deferred payment obligations (to
the extent corresponding to the principal, but not interest, component thereof)
when received in the form of cash or Cash Equivalents and proceeds from the
conversion of other property received when converted to cash or Cash
Equivalents, net of attorney's fees, accountants' fees, underwriters' or
placement agents' fees, discounts or commissions and brokerage, consultant and
other fees incurred in connection with such issuance or sale and net of taxes
paid or payable as a result thereof.

     "Non-U.S. Person" means a person who is not a "U.S. person" (as defined in
      ---------------
Regulation S).

     "Notes" means any of the securities, as defined in the first paragraph of
      -----
the recitals hereof, that are authenticated and delivered under this Indenture.
For all purposes of this Indenture, the term "Notes" shall include the Notes
initially issued on the Closing Date, any Exchange Notes to be issued and
exchanged for any Notes pursuant to the Registration Rights Agreement and this
Indenture and any other Notes issued after the Closing Date under this
<PAGE>

                                      12

Indenture.  For purposes of this Indenture, all Notes shall vote together as one
series of Notes under this Indenture.

     "Offer to Purchase" means an offer to purchase Notes by the Company from
      -----------------
the Holders commenced by mailing a notice to the Trustee and each Holder
stating:

          (1)  the covenant pursuant to which the offer is being made and that
     all Notes validly tendered will be accepted for payment on a pro rata
     basis;

          (2)  the purchase price and the date of purchase (which shall be a
     Business Day no earlier than 30 days nor later than 60 days after the date
     such notice is mailed) (the "Payment Date");

          (3)  that any Note not tendered will continue to accrue interest
     pursuant to its terms;

          (4)  that, unless the Company defaults in the payment of the purchase
     price, any Note accepted for payment pursuant to the Offer to Purchase
     shall cease to accrue interest on and after the Payment Date;

          (5)  that Holders electing to have a Note purchased pursuant to the
     Offer to Purchase will be required to surrender the Note, together with the
     form entitled "Option of the Holder to Elect Purchase" on the reverse side
     of the Note completed, to the Paying Agent at the address specified in the
     notice prior to the close of business on the Business Day immediately
     preceding the Payment Date;

          (6)  that Holders will be entitled to withdraw their election if the
     Paying Agent receives, not later than the close of business on the third
     Business Day immediately preceding the Payment Date, a telegram, facsimile
     transmission or letter setting forth the name of such Holder, the principal
     amount of Notes delivered for purchase and a statement that such Holder is
     withdrawing his election to have such Notes purchased; and

          (7)  that Holders whose Notes are being purchased only in part will be
     issued new Notes equal in principal amount to the unpurchased portion of
     the Notes surrendered; provided that each Note purchased and each new Note
     issued shall be in a principal amount of $1,000 or integral multiples
     thereof.

     On the Payment Date, the Company shall (1) accept for payment on a pro rata
basis Notes or portions thereof tendered pursuant to an Offer to Purchase; (2)
deposit with the Paying Agent money sufficient to pay the purchase price of all
Notes or portions thereof so accepted; and (3) deliver, or cause to be
delivered, to the Trustee all Notes or portions thereof so accepted together
with an Officers' Certificate specifying the Notes or portions thereof accepted
for payment by the Company. The Paying Agent shall promptly mail to the Holders
of Notes so accepted payment in an amount equal to the purchase price, and the
Trustee shall promptly authenticate and mail to such Holders a new Note equal
in principal amount to any unpurchased portion of the Note surrendered;
provided that each Note purchased and each new Note issued
<PAGE>

                                      13

shall be in a principal amount of $1,000 or integral multiples thereof. The
Company will publicly announce the results of an Offer to Purchase as soon as
practicable after the Payment Date. The Trustee shall act as the Paying Agent
for an Offer to Purchase. The Company will comply with Rule 14e-1 under the
Exchange Act and any other securities laws and regulations thereunder to the
extent such laws and regulations are applicable, in the event that the Company
is required to repurchase Notes pursuant to an Offer to Purchase.

     "Officer" means, with respect to the Company, (i) the Chairman of the
      -------
Board, the Chief Executive Officer, the President, any Vice President or the
Chief Financial Officer, and (ii) the Treasurer or any Assistant Treasurer, or
the Secretary or any Assistant Secretary.

     "Officers' Certificate" means a certificate signed by one Officer listed in
      ---------------------
clause (i) of the definition thereof and one Officer listed in clause (ii) of
the definition thereof or two officers listed in clause (i) of the definition
thereof.  Each Officers' Certificate (other than certificates provided pursuant
to TIA Section 314(a)(4)) shall include the statements provided for in TIA
Section 314(e).

     "Offshore Global Note" has the meaning provided in Section 2.01.
      --------------------

     "Offshore Physical Notes" has the meaning provided in Section 2.01.
      -----------------------

     "Opinion of Counsel" means a written opinion signed by legal counsel, who
      ------------------
may be an employee of or counsel to the Company, that meets the requirements of
Section 10.04 hereof.  Each such Opinion of Counsel shall include the statements
provided for in TIA Section 314(e).

     "Paying Agent" has the meaning provided in Section 2.04, except that, for
      ------------
the purposes of Article Eight, the Paying Agent shall not be the Company or a
Subsidiary of the Company or an Affiliate of any of them.  The term "Paying
Agent" includes any additional Paying Agent.

     "Payment Date" has the meaning provided in the definition of Offer to
      ------------
Purchase.

     "Permitted Advances" means advances by the Company to the West Virginia PCS
      ------------------
Alliance on and after the Closing Date in an aggregate amount not to exceed
$104.0 million at any one time outstanding.

     "Permitted Holders" means WCAS and MSDW.
      -----------------

     "Permitted Investment" means:
      --------------------

          (1)  an Investment in the Company or a Restricted Subsidiary or a
     Person which will, upon the making of such Investment, become a Restricted
     Subsidiary or be merged or consolidated with or into or transfer or convey
     all or substantially all its assets to, the Company or a Restricted
     Subsidiary; provided that such person's primary business is related,
     ancillary or complementary to the businesses of the Company and its
     Restricted Subsidiaries on the date of such Investment;

          (2)  Temporary Cash Investments;
<PAGE>

                                      14

          (3)  payroll, travel and similar advances to cover matters that are
     expected at the time of such advances ultimately to be treated as expenses
     in accordance with GAAP;

          (4)  stock, obligations or securities received in satisfaction of
     judgments;

          (5)  an Investment in an Unrestricted Subsidiary consisting solely of
     an Investment in another Unrestricted Subsidiary;

          (6)  Interest Rate Agreements and Currency Agreements designed solely
     to protect the Company or its Restricted Subsidiaries against fluctuations
     in interest rates or foreign currency exchange rates;

          (7)  loans or advances to or guarantees of third-party loans or
     advances to employees of the Company or any Restricted Subsidiary in the
     normal course of business in an aggregate amount not to exceed $5.0 million
     in the aggregate at any one time outstanding;

          (8)  Strategic Telecommunications Investments made after the Closing
     Date in an aggregate amount not to exceed $11.25 million in the aggregate
     at any one time outstanding prior to the closing of the Company's
     acquisition of R&B Communications, Inc. (the "R&B Acquisition") and $15.0
                                                   ---------------
     million thereafter in the aggregate at any one time outstanding;

          (9)  Notwithstanding (8) above, Strategic Telecommunications
     Investments, to the extent that the payment for such Strategic
     Telecommunications Investments consists of (i) Common Stock of the Company
     or (ii) proceeds of a sale of Common Stock of the Company received by the
     Company within 60 days of the making of such Investment;

          (10) Investments, the payment for which consists of (i) Qualified
     Capital Stock of the Company or (ii) the proceeds of a sale of Qualified
     Capital Stock of the Company received by the Company within 60 days of the
     making of such Investment, in an aggregate amount not to exceed $37.5
     million at any one time outstanding prior to the closing of the R&B
     Acquisition and thereafter $50.0 million in the aggregate at any one time
     outstanding; and

          (11) Investments outstanding on the Closing Date or to be made as part
     of the Transactions, including without limitation, $7.5 million of
     investments in the RTFC to facilitate borrowings under the Credit Facility.

     "Permitted Liens" means:
      ---------------

          (1)  Liens for taxes, assessments, governmental charges or claims that
     are being contested in good faith by appropriate legal proceedings promptly
     instituted and diligently conducted and for which a reserve or other
     appropriate provision, if any, as shall be required in conformity with GAAP
     shall have been made;
<PAGE>

                                      15

          (2)  statutory and common law Liens of landlords and carriers,
     warehousemen, mechanics, suppliers, materialmen, repairmen or other similar
     Liens arising in the ordinary course of business and with respect to
     amounts not yet delinquent or being contested in good faith by appropriate
     legal proceedings promptly instituted and diligently conducted and for
     which a reserve or other appropriate provision, if any, as shall be
     required in conformity with GAAP shall have been made;

          (3)  Liens incurred or deposits made in the ordinary course of
     business in connection with workers' compensation, unemployment insurance
     and other types of social security;

          (4)  Liens incurred or deposits made to secure the performance of
     tenders, bids, leases, statutory or regulatory obligations, bankers'
     acceptances, surety and appeal bonds, government contracts, performance and
     return-of-money bonds and other obligations of a similar nature incurred in
     the ordinary course of business (exclusive of obligations for the payment
     of borrowed money);

          (5)  easements, rights-of-way, municipal and zoning ordinances and
     similar charges, encumbrances, title defects or other irregularities that
     do not materially interfere with the ordinary course of business of the
     Company and its Restricted Subsidiaries, taken as a whole;

          (6)  Liens (including extensions and renewals thereof) upon real or
     personal property acquired after the Closing Date; provided that (a) such
     Lien is created solely for the purpose of securing Indebtedness Incurred,
     in accordance with Section 4.03, to finance the cost (including the cost of
     improvement or construction) of the item of property or assets subject
     thereto and such Lien is created prior to, at the time of or within six
     months after the later of the acquisition, the completion of construction
     or the commencement of full operation of such property (b) the principal
     amount of the Indebtedness secured by such Lien does not exceed 100% of
     such cost and (c) any such Lien shall not extend to or cover any property
     or assets other than such item of property or assets and any improvements
     on such item;

          (7)  leases or subleases granted to others that do not materially
     interfere with the ordinary course of business of the Company and its
     Restricted Subsidiaries, taken as a whole;

          (8)  Liens encumbering property or assets under construction arising
     from progress or partial payments by a customer of the Company or its
     Restricted Subsidiaries relating to such property or assets;

          (9)  any interest or title of a lessor in the property subject to any
     Capitalized Lease or operating lease;

          (10) Liens arising from filing Uniform Commercial Code financing
     statements regarding leases;
<PAGE>

                                      16

          (11) Liens on property of, or on shares of Capital Stock or
     Indebtedness of, any Person existing at the time such Person becomes, or
     becomes a part of, any Restricted Subsidiary; provided that such Liens do
     not extend to or cover any property or assets of the Company or any
     Restricted Subsidiary other than the property or assets acquired;

          (12) Liens in favor of the Company or any Restricted Subsidiary;

          (13) Liens arising from the rendering of a final judgment or order
     against the Company or any Restricted Subsidiary that do not give rise to
     an Event of Default;

          (14) Liens securing reimbursement obligations with respect to letters
     of credit that encumber documents and other property relating to such
     letters of credit and the products and proceeds thereof;

          (15) Liens in favor of customs and revenue authorities arising as a
     matter of law to secure payment of customs duties in connection with the
     importation of goods;

          (16) Liens encumbering customary initial deposits and margin deposits,
     and other Liens that are within the general parameters customary in the
     industry and incurred in the ordinary course of business, in each case,
     securing Indebtedness under Interest Rate Agreements and Currency
     Agreements and forward contracts, options, future contracts, futures
     options or similar agreements or arrangements designed solely to protect
     the Company or any of its Restricted Subsidiaries from fluctuations in
     interest rates, currencies or the price of commodities;

          (17) Liens arising out of conditional sale, title retention,
     consignment or similar arrangements for the sale of goods entered into by
     the Company or any of its Restricted Subsidiaries in the ordinary course of
     business in accordance with the past practices of the Company and its
     Restricted Subsidiaries prior to the Closing Date;

          (18) Liens on shares of Capital Stock of any Unrestricted Subsidiary
     to secure Indebtedness of such Unrestricted Subsidiary; and

          (19) Liens on receivables.

     "Person" means an individual, a corporation, a partnership, a limited
      ------
liability company, joint venture, an association, joint-stock company, a trust
or any other entity or organization, including a government or political
subdivision or an agency or instrumentality thereof.

     "Physical Notes" has the meaning provided in Section 2.01.
      --------------

     "Preferred Share Documents" means (1) the Securities Purchase Agreement
      -------------------------
dated as of July 11, 2000 among the Company, WCAS, and the other purchasers
listed on the signature pages thereof (the "Purchasers"), with respect to the
                                            ----------
Series B Preferred Stock, (2) the Securities Purchase Agreement among the
Company and the Purchasers, with respect to the Series C and Series D Preferred
Stock, (3) the Shareholders Agreement among the Company and the
<PAGE>

                                      17

Purchasers entered into at the closing of the sale of the Series B Preferred
Stock, and (4) the Warrant Agreement among the Company and the Purchasers
entered into at the closing of the sale of the Series B Preferred Stock.

     "Preferred Stock" means, with respect to any Person, any and all shares,
      ---------------
interests, participations or other equivalents (however designated, whether
voting or non-voting) of such Person's preferred or preference equity, whether
outstanding on the Closing Date or issued thereafter, including, without
limitation, all series and classes of such preferred or preference stock.

     "principal" of a debt security, including the Notes, means the principal
      ---------
amount due on the Stated Maturity as shown on such debt security.

     "Private Placement Legend" means the legend initially set forth on the
      ------------------------
Notes in the form set forth in Section 2.02.

     "Public Equity Offering" has the meaning set forth in Section 3.01(b).
      ----------------------

     "QIB" means a "qualified institutional buyer" as defined in Rule 144A.
      ---

     "Qualified Capital Stock" means any Capital Stock of a Person that is not
      -----------------------
Disqualified Capital Stock.

     "R&B Acquisition" has the meaning set forth in the definition of "Permitted
      ---------------
Investments" in this Section 1.01.

     "Redemption Date" means, when used with respect to any Note or part thereof
      ---------------
to be redeemed, the date fixed for such redemption by or pursuant to this
Indenture.

     "Redemption Price" means, when used with respect to any Note or part
      ----------------
thereof to be redeemed, other than pursuant to Section 3.01(d), the price at
which such Note is to be redeemed pursuant to this Indenture.

     "Registrar" has the meaning provided in Section 2.04.
      ---------

     "Registration Rights Agreement" means the Registration Rights Agreement,
      -----------------------------
dated July 26, 2000 between the Company and Morgan Stanley & Co. Incorporated,
First Union Securities, Inc. and SunTrust Equitable Securities Corporation and
certain permitted assigns specified therein.

     "Registration Statement" means the Registration Statement as defined and
      ----------------------
described in the Registration Rights Agreement.

     "Regular Record Date" for the interest payable on any Interest Payment Date
      -------------------
means the February 1 or August 1 (whether or not a Business Day), as the case
may be, next preceding such Interest Payment Date.
<PAGE>

                                      18

     "Regulation S" means Regulation S under the Securities Act.
      ------------

     "Related Business" means any business related to, ancillary to, or
      ----------------
complementary to, the ownership, development, operation or acquisition of
communications systems or the provision of communications services, in each case
as determined in good faith by the Board of Directors.

     "Responsible Officer" when used with respect to the Trustee, means any vice
      -------------------
president, any assistant vice president, the secretary, any assistant secretary,
the treasurer, any assistant treasurer, any trust officer or assistant
treasurer, any trust officer or any other officer of the Trustee in its
corporate trust department customarily performing functions similar to those
performed by any of the above-designated officers and also means, with respect
to a particular corporate trust matter, any other officer to whom such matter is
referred because of his or her knowledge of and familiarity with the particular
subject.

     "Restricted Payments" has the meaning provided in Section 4.04.
      -------------------

     "Restricted Subsidiary" means any Subsidiary of the Company other than an
      ---------------------
Unrestricted Subsidiary, including, without limitation, the Virginia PCS
Alliance and the West Virginia PCS Alliance (after such Alliances become
Subsidiaries of the Company) so long as the Company has not designated either
Alliance as an Unrestricted Subsidiary in the manner provided for herein.

     "Richmond-Norfolk Acquisition" has the meaning set forth in the definition
      ----------------------------
of "Transactions" in this Section 1.01.

     "Rule 144A" means Rule 144A under the Securities Act.
      ---------

     "S&P" means Standard & Poor's Ratings Group, a division of The McGraw-Hill
      ---
Companies, and its successors.

     "Securities Act" means the Securities Act of 1933, as amended.
      --------------

     "Security Register" has the meaning provided in Section 2.04.
      -----------------

     "Shelf Registration Statement" means the Shelf Registration Statement as
      ----------------------------
defined in the Registration Rights Agreement.

     "Significant Subsidiary" means, at any date of determination, any
      ----------------------
Restricted Subsidiary that, together with its Subsidiaries, (1) for the most
recent fiscal year of the Company, accounted for more than 10% of the
consolidated revenues of the Company and its Restricted Subsidiaries or (2) as
of the end of such fiscal year, was the owner of more than 10% of the
consolidated assets of the Company and its Restricted Subsidiaries, all as set
forth on the most recently available consolidated financial statements of the
Company for such fiscal year.

     "Special Redemption" has the meaning provided in Section 3.01(d).
      ------------------

     "Special Redemption Date", when used with respect to any  Note to be
      -----------------------
redeemed, means the date fixed for such redemption by or pursuant to Section
3.01(d).
<PAGE>

                                      19

     "Special Redemption Price" has the meaning provided in Section 3.01(d).
      ------------------------

     "Stated Maturity" means, (1) with respect to any debt security, the date
      ---------------
specified in such debt security as the fixed date on which the final installment
of principal of such debt security is due and payable and (2) with respect to
any scheduled installment of principal of or interest on any debt security, the
date specified in such debt security as the fixed date on which such installment
is due and payable.

     "Strategic Telecommunications Investment" means the acquisition by the
      ---------------------------------------
Company or any of its Restricted Subsidiaries of 50.0% or less of the Common
Stock in a Related Business (1) over which the Company or its Restricted
Subsidiaries exerts operational or managerial influence or (2) which provides
services directly to the Company or its Restricted Subsidiaries; in each case,
as determined in good faith by the Board of Directors (when such Investment is
or exceeds $1.0 million) or as certified by an officer of the Company (when such
Investment is below $1.0 million).

     "Subsidiary" means, with respect to any Person, any corporation,
      ----------
association or other business entity of which more than 50% of the voting power
of the outstanding Voting Stock is owned, directly or indirectly, by such Person
and one or more other Subsidiaries of such Person.

     "Subsidiary Guarantee" has the meaning provided in Section 4.07.
      --------------------

     "Temporary Cash Investment" means any of the following:
      -------------------------

          (1)  direct obligations of the United States of America or any agency
     thereof or obligations fully and unconditionally guaranteed by the United
     States of America or any agency thereof;

          (2)  time deposit accounts, certificates of deposit and money market
     deposits maturing within 180 days of the date of acquisition thereof issued
     by a bank or trust company which is organized under the laws of the United
     States of America, any state thereof or any foreign country recognized by
     the United States of America, and which bank or trust company has capital,
     surplus and undivided profits aggregating in excess of $100 million (or the
     foreign currency equivalent thereof) and has outstanding debt which is
     rated "A" (or similar equivalent rating) or higher by at least one
     nationally recognized statistical rating organization (as defined in Rule
     436 under the Securities Act) or any money-market fund sponsored by a
     registered broker dealer or mutual fund distributor;

          (3)  repurchase obligations with a term of not more than 30 days for
     underlying securities of the types described in clause (1) above entered
     into with a bank or trust company meeting the qualifications described in
     clause (2) above;

          (4)  commercial paper, maturing not more than 90 days after the date
     of acquisition, issued by a corporation (other than an Affiliate of the
     Company) organized and in existence under the laws of the United States of
     America, any state thereof or any foreign country recognized by the United
     States of America with a rating at the time as of
<PAGE>

                                      20

     which any investment therein is made of "P-1" (or higher) according to
     Moody's or "A-1" (or higher) according to S&P; and

          (5)  securities with maturities of six months or less from the date of
     acquisition issued or fully and unconditionally guaranteed by any state,
     commonwealth or territory of the United States of America, or by any
     political subdivision or taxing authority thereof, and rated at least "A"
     by S&P or Moody's.

     "Termination Date" has the meaning provided in Section 3.01(d).
      ----------------

     "TIA" or "Trust Indenture Act" means the Trust Indenture Act of 1939 (15
      ---      -------------------
U.S. Code (S)(S) 77aaa-77bbbb), as in effect on the date this Indenture was
executed, except as provided in Section 9.06.

     "Trade Payables" means, with respect to any Person, any accounts payable or
      --------------
any other indebtedness or monetary obligation to trade creditors created,
assumed or Guaranteed by such Person or any of its Subsidiaries arising in the
ordinary course of business in connection with the acquisition of goods or
services.

     "Transaction Date" means, with respect to the Incurrence of any
      ----------------
Indebtedness by the Company or any of its Restricted Subsidiaries, the date such
Indebtedness is to be Incurred and, with respect to any Restricted Payment, the
date such Restricted Payment is to be made.

     "Transactions" means:
      ------------

          (1)  the issuance of the Notes and the $95,000,000 aggregate principal
     amount of 13.5% Subordinated Notes due 2011 (the "Subordinated Notes") by
                                                       ------------------
     the Company;

          (2)  the repayment of Indebtedness by the Company of the Alliances to
     the RTFC;

          (3)  the sale and issuance by the Company to the Permitted Holders of
     an aggregate amount of $250.0 million of Series B, Series C and Series D
     Preferred Stock (the "Preferred Shares");

          (4)  the acquisition by the Company of certain licenses and assets in
     the Richmond Major Trading Area held by PrimeCo PCS, L.P. (the "Richmond-
                                                                     --------
     Norfolk Acquisition");
     -------------------

          (5)  the borrowings by the Company under the Credit Facility; and

          (6)  the dispositions of assets of Virginia RSA6 and RSA5 in
     connection with the Richmond-Norfolk Acquisition.

     "Trustee" means the party named as such in the first paragraph of this
      -------
Indenture until a successor replaces it in accordance with the provisions of
Article Seven of this Indenture and thereafter means such successor.
<PAGE>

                                      21

     "United States Bankruptcy Code" means the Bankruptcy Reform Act of 1978, as
      -----------------------------
amended and as codified in Title 11 of the United States Code, as amended from
time to time hereafter, or any successor federal bankruptcy law.

     "Unrestricted Subsidiary" means (1) any Subsidiary of the Company that at
      -----------------------
the time of determination shall be designated an Unrestricted Subsidiary by the
Board of Directors in the manner provided below; and (2) any Subsidiary of an
Unrestricted Subsidiary. The Board of Directors may designate any Restricted
Subsidiary (including any newly acquired or newly formed Subsidiary of the
Company) to be an Unrestricted Subsidiary unless such Subsidiary owns any
Capital Stock of, or owns or holds any Lien on any property of, the Company or
any Restricted Subsidiary; provided that (A) any Guarantee by the Company or any
Restricted Subsidiary of any Indebtedness of the Subsidiary being so designated
shall be deemed an "Incurrence" of such Indebtedness and an "Investment" by the
Company or such Restricted Subsidiary (or both, if applicable) at the time of
such designation; (B) either (I) the Subsidiary to be so designated has total
assets of $1,000 or less or (II) if such Subsidiary has assets greater than
$1,000, such designation would be permitted under Section 4.04 and (C) if
applicable, the Incurrence of Indebtedness and the Investment referred to in
clause (A) of this proviso would be permitted under Sections 4.03 and 4.04. The
Board of Directors may designate any Unrestricted Subsidiary to be a Restricted
Subsidiary; provided that (1) no Default or Event of Default shall have occurred
and be continuing at the time of or after giving effect to such designation and
(2) all Liens and Indebtedness of such Unrestricted Subsidiary outstanding
immediately after such designation would, if Incurred at such time, have been
permitted to be Incurred (and shall be deemed to have been Incurred) for all
purposes of this Indenture. Any such designation by the Board of Directors shall
be evidenced to the Trustee by promptly filing with the Trustee a copy of the
Board Resolution giving effect to such designation and an Officers' Certificate
certifying that such designation complied with the foregoing provisions.

     "U.S. Global Notes" has the meaning provided in Section 2.01.
      -----------------

     "U.S. Government Obligations" means securities that are (i) direct
      ---------------------------
obligations of the United States of America for the payment of which its full
faith and credit is pledged or (ii) obligations of a Person controlled or
supervised by and acting as an agency or instrumentality of the United States of
America the payment of which is unconditionally guaranteed as a full faith and
credit obligation by the United States of America, which, in either case, are
not callable or redeemable at the option of the issuer thereof at any time prior
to the Stated Maturity of the Notes, and shall also include a depository receipt
issued by a bank or trust company as custodian with respect to any such U.S.
Government Obligation or a specific payment of interest on or principal of any
such U.S. Government Obligation held by such custodian for the account of the
holder of a depository receipt; provided that (except as required by law) such
custodian is not authorized to make any deduction from the amount payable to the
holder of such depository receipt from any amount received by the custodian in
respect of the U.S. Government Obligation or the specific payment of interest on
or principal of the U.S. Government Obligation evidenced by such depository
receipt.
<PAGE>

                                      22

     "U.S. Physical Notes" means the Notes issued in the form of permanent
      -------------------
certificated Notes in registered form in substantially the form set forth in
Exhibit A to Institutional Accredited Investors which are not QIBs (excluding
Non-U.S. Persons) who purchased Notes pursuant to Regulation D of the Securities
Act.

     "Voting Stock" means with respect to any Person, Capital Stock of any class
      ------------
or kind ordinarily having the power to vote for the election of directors,
managers or other voting members of the governing body of such Person.

     "WCAS" means Welsh, Carson, Anderson & Stowe VIII, L.P. and Welsh, Carson,
      ----
Anderson & Stowe IX, L.P. and their respective affiliates.

     "Wholly Owned" means with respect to any Subsidiary of any Person, the
      ------------
ownership of all of the outstanding Capital Stock of such Subsidiary (other than
any director's qualifying shares or Investments by foreign nationals mandated by
applicable law) by such Person or one or more Wholly Owned Subsidiaries of such
Person.

              .2.   Incorporation by Reference of Trust Indenture Act. Whenever
              -------------------------------------------------------
this Indenture refers to a provision of the TIA, the provision is incorporated
by reference in and made a part of this Indenture. The following TIA terms used
in this Indenture have the following meanings:

     "indenture securities" means the Notes;

     "indenture security holder" means a Holder or a Noteholder;

     "indenture to be qualified" means this Indenture;

     "indenture trustee" or "institutional trustee" means the Trustee; and

     "obligor" on the indenture securities means the Company or any other
obligor on the Notes.

     All other TIA terms used in this Indenture that are defined by the TIA,
defined by TIA reference to another statute or defined by a rule of the
Commission and not otherwise defined herein have the meanings assigned to them
therein.

              .3.   Rules of Construction. Unless the context otherwise
              ---------------------------
     requires:

              (i)   a term has the meaning assigned to it;

              (ii)  an accounting term not otherwise defined has the meaning
     assigned to it in accordance with GAAP;

              (iii) "or" is not exclusive;

              (iv)  words in the singular include the plural, and words in the
     plural include the singular;
<PAGE>

                                      23

          (v)     provisions apply to successive events and transactions;

          (vi)    "herein," "hereof" and other words of similar import refer to
     this Indenture as a whole and not to any particular Article, Section or
     other subdivision;

          (vii)   all ratios and computations based on GAAP contained in this
     Indenture shall be computed in accordance with the definition of GAAP set
     forth in Section 1.01;

          (viii)  all references to Sections or Articles refer to Sections or
     Articles of this Indenture unless otherwise indicated; and

          (ix)    "including" means including without limitation.

                                  ARTICLE TWO

                                   THE NOTES

              .1.   Form and Dating.  The Notes and the Trustee's certificate of
              ---------------------
authentication shall be substantially in the form annexed hereto as Exhibit A
with such appropriate insertions, omissions, substitutions and other variations
as are required or permitted by this Indenture. The Notes may have notations,
legends or endorsements which are appropriate and consistent with this Indenture
required by law, stock exchange agreements to which the Company is subject or
usage. The Company shall approve the form of the Notes and any notation, legend
or endorsement on the Notes. Each Note shall be dated the date of its
authentication.

     The terms and provisions contained in the form of the Notes annexed hereto
as Exhibit A shall constitute, and are hereby expressly made, a part of this
Indenture.  To the extent applicable, the Company and the Trustee, by their
execution and delivery of this Indenture, expressly agree to such terms and
provisions and to be bound thereby.

     Notes offered and sold in reliance on Rule 144A shall be issued initially
in the form of one or more permanent global Notes in registered form,
substantially in the form set forth in Exhibit A (the "U.S. Global Notes"),
                                                       -----------------
registered in the name of the nominee of the Depositary, deposited with the
Trustee, as custodian for the Depositary, duly executed by the Company and
authenticated by the Trustee as hereinafter provided.  The aggregate principal
amount of the U.S. Global Notes may from time to time be increased or decreased
by adjustments made on the records of the Trustee, as custodian for the
Depositary or its nominee, in accordance with the instructions given by the
Holder thereof, as hereinafter provided.

     Notes offered and sold in offshore transactions in reliance on Regulation S
shall be issued initially in the form of one or more permanent global Notes in
registered form substantially in the form set forth in Exhibit A (the "Offshore
                                                                       --------
Global Notes"), registered in the name of the nominee of the Depositary,
------------
deposited with the Trustee, as custodian for the Depositary, duly executed by
the Company and authenticated by the Trustee as hereinafter provided.  The
aggregate principal amount of the Offshore Global Notes may from time to time be
increased or decreased by adjustments made on the records of the Trustee, as
custodian for the Depositary or its nominee, as hereinafter provided.
<PAGE>

                                      24

     Notes issued pursuant to Section 2.07 in exchange for interests in the
Offshore Global Notes shall be in the form of permanent certificated Notes in
registered form substantially in the form set forth in Exhibit A (the "Offshore
                                                                       --------
Physical Notes").
--------------

     The Offshore Physical Notes and U.S. Physical Notes are sometimes
collectively herein referred to as the "Physical Notes."  The U.S. Global Notes
                                        --------------
and the Offshore Global Notes are sometimes referred to herein as the "Global
                                                                       ------
Notes."
-----

     The definitive Notes shall be typed, printed, lithographed or engraved or
produced by any combination of these methods or may be produced in any other
manner permitted by the rules of any securities exchange on which the Notes may
be listed, all as determined by the Officers executing such Notes, as evidenced
by their execution of such Notes.

              .2.   Restrictive Legends. Unless and until a Note is exchanged
              -------------------------
for an Exchange Note or sold in connection with an effective Registration
Statement pursuant to the Registration Rights Agreement, (i) the U.S. Global
Notes and U.S. Physical Notes shall bear the legend set forth below on the face
thereof and (ii) the Offshore Physical Notes and Offshore Global Notes shall
bear the legend set forth below on the face thereof until at least the 41st day
after the Closing Date and receipt by the Company and the Trustee of a
certificate substantially in the form of Exhibit B hereto.

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAW, AND ACCORDINGLY,
MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHIN THE UNITED
STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT AS SET FORTH
IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS
THAT (A) IT IS A "QUALIFIED INSTITUTIONAL BUYER" (AS DEFINED IN RULE 144A UNDER
THE SECURITIES ACT) OR (B) IT IS AN INSTITUTIONAL "ACCREDITED INVESTOR" (AS
DEFINED IN RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D UNDER THE SECURITIES
ACT) (AN "INSTITUTIONAL ACCREDITED INVESTOR") OR (C) IT IS NOT A U.S. PERSON AND
IS ACQUIRING THIS NOTE IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH RULE 903 OF
REGULATION S UNDER THE SECURITIES ACT, (2) AGREES THAT IT WILL NOT, WITHIN THE
TIME PERIOD REFERRED TO UNDER RULE 144(k) UNDER THE SECURITIES ACT AS IN EFFECT
ON THE DATE OF SUCH TRANSFER, RESELL OR OTHERWISE TRANSFER THIS NOTE EXCEPT (A)
TO CFW COMMUNICATIONS COMPANY OR ANY OF ITS SUBSIDIARIES, (B) TO A QUALIFIED
INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, (C)
INSIDE THE UNITED STATES TO AN INSTITUTIONAL ACCREDITED INVESTOR THAT, PRIOR TO
SUCH TRANSFER, FURNISHES TO THE TRUSTEE A SIGNED LETTER CONTAINING CERTAIN
REPRESENTATIONS AND AGREEMENTS RELATING TO THE RESTRICTIONS ON TRANSFER OF THIS
NOTE (THE FORM OF WHICH LETTER CAN BE OBTAINED FROM THE TRUSTEE) AND, IF SUCH
TRANSFER IS IN RESPECT OF AN AGGREGATE PRINCIPAL AMOUNT OF NOTES OF LESS THAN
$100,000, AN OPINION OF COUNSEL ACCEPTABLE TO CFW
<PAGE>

                                      25

COMMUNICATIONS COMPANY THAT SUCH TRANSFER IS IN COMPLIANCE WITH THE SECURITIES
ACT, (D) TO A PERSON OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN
COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT, (E) PURSUANT TO THE
EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF
AVAILABLE) OR (F) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT AND (3) AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THIS
NOTE IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. IN
CONNECTION WITH ANY TRANSFER OF THIS NOTE WITHIN THE TIME PERIOD REFERRED TO
ABOVE, THE HOLDER MUST CHECK THE APPROPRIATE BOX SET FORTH ON THE REVERSE HEREOF
RELATING TO THE MANNER OF SUCH TRANSFER AND SUBMIT THIS CERTIFICATE TO THE
TRUSTEE. IF THE PROPOSED TRANSFEREE IS AN INSTITUTIONAL ACCREDITED INVESTOR, THE
HOLDER MUST, PRIOR TO SUCH TRANSFER, FURNISH TO THE TRUSTEE AND CFW
COMMUNICATIONS COMPANY SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION
AS EITHER OF THEM MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING
MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. AS USED HEREIN, THE TERMS
"OFFSHORE TRANSACTION", "UNITED STATES" AND "U.S. PERSON" HAVE THE MEANINGS
GIVEN TO THEM BY REGULATION S UNDER THE SECURITIES ACT. THE INDENTURE CONTAINS
PROVISIONS REQUIRING THE TRUSTEE TO REFUSE TO REGISTER ANY TRANSFER OF THIS NOTE
IN VIOLATION OF THE FOREGOING RESTRICTIONS.

FOR UNITED STATES FEDERAL INCOME TAX PURPOSES, THIS SECURITY BEARS ORIGINAL
ISSUE DISCOUNT.  THE ISSUE PRICE WITH  RESPECT TO EACH $1,000 OF AGGREGATE
PRINCIPAL AMOUNT AT MATURITY OF THIS SECURITY IS $951.64, THE AMOUNT OF ORIGINAL
ISSUE DISCOUNT WITH RESPECT TO EACH $1,000 OF AGGREGATE PRINCIPAL AMOUNT AT
MATURITY OF THIS SECURITY IS $48.36, THE ISSUE DATE IS JULY 26, 2000 AND THE
YIELD TO MATURITY BASED ON SEMI-ANNUAL BOND EQUIVALENT COMPOUNDING IS 13.25%.

     Each Global Note, whether or not an Exchange Note, shall also bear the
following legend on the face thereof:

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE
DEPOSITORY TRUST COMPANY, TO CFW COMMUNICATIONS COMPANY OR ITS AGENT FOR
REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS
REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER ENTITY AS IS REQUESTED BY
AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT
HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE
OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
<PAGE>

                                      26

TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN
INTEREST HEREIN.

TRANSFERS OF THIS GLOBAL  NOTE SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT
IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR'S
NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL  NOTE SHALL BE LIMITED TO
TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN SECTION 2.08 OF
THE INDENTURE.

              .3.   Execution, Authentication and Denomination.  Subject to
              ------------------------------------------------
Article Four and applicable law, the aggregate principal amount of Notes which
may be authenticated and delivered under this Indenture is unlimited. The Notes
shall be executed by two Officers of the Company. The signature of these
Officers on the Notes may be by facsimile or manual signature in the name and on
behalf of the Company.

     If an Officer whose signature is on a  Note no longer holds that office at
the time the Trustee or authenticating agent authenticates the Note, the  Note
shall be valid nevertheless.

     A  Note shall not be valid until the Trustee or authenticating agent
manually signs the certificate of authentication on the Note.  The signature
shall be conclusive evidence that the  Note has been authenticated under this
Indenture.

     At any time and from time to time after the execution of this Indenture,
the Trustee or an authenticating agent shall upon receipt of a Company Order
authenticate for original issue Notes in the aggregate principal amount
specified in such Company Order; provided that the Trustee shall be entitled to
receive an Officers' Certificate and an Opinion of Counsel of the Company in
connection with such authentication of Notes.  Such Company Order shall specify
the amount of Notes to be authenticated and the date on which the original issue
of Notes is to be authenticated and, in case of an issuance of Notes pursuant to
Section 2.15, shall certify that such issuance is in compliance with Article
Four.

     The Trustee may appoint an authenticating agent reasonably acceptable to
the Company to authenticate Notes.  An authenticating agent may authenticate
Notes whenever the Trustee may do so.  Each reference in this Indenture to
authentication by the Trustee includes authentication by such authenticating
agent.  An authenticating agent has the same rights as an Agent to deal with the
Company or an Affiliate of the Company.

     The Notes shall be issuable only in registered form without coupons and
only in denominations of $1,000 in principal amount and any integral multiple
thereof.

              .4.   Registrar and Paying Agent. The Company shall maintain an
              --------------------------------
office or agency where Notes may be presented for registration of transfer or
for exchange (the "Registrar"), an office or agency where Notes may be presented
                   ---------
for payment (the "Paying Agent")an office or agency where notices and demands to
                  ------------
or upon the Company in respect of the Notes and this Indenture may be served,
which shall be in the Borough of Manhattan, The City of New York. The Company
shall cause the Registrar to keep a register of the Notes and of
<PAGE>

                                      27

their transfer and exchange (the "Security Register"). The Security Register
                                  -----------------
shall be in written form or other form capable of being converted into written
form within a reasonable time. The Company may have one or more co-Registrars
and one or more additional Paying Agents.

     The Company shall enter into an appropriate agency agreement with any Agent
not a party to this Indenture.  The agreement shall implement the provisions of
this Indenture that relate to such Agent.  The Company shall give prompt written
notice to the Trustee of the name and address of any such Agent and any change
in the address of such Agent.  If the Company fails to maintain a Registrar,
Paying Agent and/or agent for service of notices and demands, the Trustee shall
act as such Registrar, Paying Agent and/or agent for service of notices and
demands.  The Company may remove any Agent upon written notice to such Agent and
the Trustee; provided that no such removal shall become effective until (i) the
acceptance of an appointment by a successor Agent to such Agent as evidenced by
an appropriate agency agreement entered into by the Company and such successor
Agent and delivered to the Trustee or (ii) notification to the Trustee that the
Trustee shall serve as such Agent until the appointment of a successor Agent in
accordance with clause (i) of this proviso.  The Company, any Subsidiary of the
Company, or any Affiliate of any of them may act as Paying Agent, Registrar or
co-Registrar, and/or agent for service of notice and demands.

     The Company initially appoints the Trustee as Registrar, Paying Agent,
authenticating agent and agent for service of notice and demands.  The Trustee
shall preserve in as current a form as is reasonably practicable the most recent
list available to it of the names and addresses of Holders and shall otherwise
comply with TIA (S) 312(a).  If the Trustee is not the Registrar, the Company
shall furnish to the Trustee as of each Regular Record Date and at such other
times as the Trustee may reasonably request the names and addresses of Holders
as they appear in the Security Register, including the aggregate principal
amount of Notes held by each Holder.

              .5.   Paying Agent to Hold Money in Trust. Not later than 11:00
              -----------------------------------------
a.m. (New York City time) each due date of the principal, premium, if any, and
interest on any Notes, the Company shall deposit with the Paying Agent money in
immediately available funds sufficient to pay such principal, premium, if any,
and interest so becoming due. The Company shall require each Paying Agent other
than the Trustee to agree in writing that such Paying Agent shall hold in trust
for the benefit of the Holders or the Trustee all money held by the Paying Agent
for the payment of principal of, premium, if any, and interest on the Notes
(whether such money has been paid to it by the Company or any other obligor on
the Notes), and such Paying Agent shall promptly notify the Trustee of any
default by the Company (or any other obligor on the Notes) in making any such
payment. The Company at any time may require a Paying Agent to pay all money
held by it to the Trustee and account for any funds disbursed, and the Trustee
may at any time during the continuance of any payment default, upon written
request to a Paying Agent, require such Paying Agent to pay all money held by it
to the Trustee and to account for any funds disbursed. Upon doing so, the Paying
Agent shall have no further liability for the money so paid over to the Trustee.
If the Company or any Subsidiary of the Company or any Affiliate of any of them
acts as Paying Agent, it will, on or before each due date of any principal of,
premium, if any, or interest on the Notes, segregate and hold in a separate
trust fund for the benefit of the Holders a sum of money sufficient to pay such
principal, premium, if any, or interest so
<PAGE>

                                      28

becoming due until such sum of money shall be paid to such Holders or otherwise
disposed of as provided in this Indenture, and will promptly notify the Trustee
of its action or failure to act.

              .6.   Transfer and Exchange. The Notes are issuable only in
              ---------------------------
registered form. A Holder may transfer a Note only by written application to the
Registrar stating the name of the proposed transferee and otherwise complying
with the terms of this Indenture. No such transfer shall be effected until, and
such transferee shall succeed to the rights of a Holder only upon, final
acceptance and registration of the transfer by the Registrar in the Security
Register. Prior to the registration of any transfer by a Holder as provided
herein, the Company, the Trustee, and any agent of the Company shall treat the
person in whose name the Note is registered as the owner thereof for all
purposes whether or not the Note shall be overdue, and neither the Company, the
Trustee, nor any such agent shall be affected by notice to the contrary.
Furthermore, any Holder of a Global Note shall, by acceptance of such Global
Note, agree that transfers of beneficial interests in such Global Note may be
effected only through a book entry system maintained by the Holder of such
Global Note (or its agent) and that ownership of a beneficial interest in the
Note shall be required to be reflected in a book entry. When Notes are presented
to the Registrar or a co-Registrar with a request to register the transfer or to
exchange them for an equal principal amount of Notes of other authorized
denominations (including an exchange of Notes for Exchange Notes), the Registrar
shall register the transfer or make the exchange as requested if its
requirements for such transactions are met (including that such Notes are duly
endorsed or accompanied by a written instrument of transfer in form satisfactory
to the Trustee and Registrar duly executed by the Holder thereof or by an
attorney who is authorized in writing to act on behalf of the Holder); provided
that no exchanges of Notes for Exchange Notes shall occur until a Registration
Statement shall have been declared effective by the Commission and that any
Notes that are exchanged for Exchange Notes shall be cancelled by the Trustee.
To permit registrations of transfers and exchanges, the Company shall execute
and the Trustee shall authenticate Notes at the Registrar's request. No service
charge shall be made for any registration of transfer or exchange or redemption
of the Notes, but the Company may require payment of a sum sufficient to cover
any transfer tax or similar governmental charge payable in connection therewith
(other than any such transfer taxes or other similar governmental charge payable
upon exchanges pursuant to Section 2.11, 3.08 or 9.04).

     The Registrar shall not be required (i) to issue, register the transfer of
or exchange any  Note during a period beginning at the opening of business 15
days before the day of the mailing of a notice of redemption of Notes selected
for redemption under Section 3.03 and ending at the close of business on the day
of such mailing, or (ii) to register the transfer of or exchange any  Note so
selected for redemption in whole or in part, except the unredeemed portion of
any  Note being redeemed in part.

              .7.   Book-Entry Provisions for Global Notes. (a) The U.S. Global
              --------------------------------------------
Notes and Offshore Global Notes initially shall (i) be registered in the name of
the Depositary for such Global Notes or the nominee of such Depositary, (ii) be
delivered to the Trustee as custodian for such Depositary and (iii) bear legends
as set forth in Section 2.02.
<PAGE>

                                      29

     Members of, or participants in, the Depositary ("Agent Members") shall have
                                                      -------------
no rights under this Indenture with respect to any Global Note held on their
behalf by the Depositary, or the Trustee as its custodian, or under such Global
Note, and the Depositary may be treated by the Company,the Trustee and any agent
of the Company or the Trustee as the absolute owner of such Global Note for all
purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent
the Company, the Trustee or any agent of the Company or the Trustee, from giving
effect to any written certification, proxy or other authorization furnished by
the Depositary or impair, as between the Depositary and its Agent Members, the
operation of customary practices governing the exercise of the rights of a
holder of any Note.

     (b) Transfers of a Global  Note shall be limited to transfers of such
Global  Note in whole, but not in part, to the Depositary, its successors or
their respective nominees. Interests of beneficial owners in Global Notes may be
transferred in accordance with the rules and procedures of the Depositary and
the provisions of Section 2.08.  In addition, U.S. Physical Notes and Offshore
Physical Notes shall be transferred to all beneficial owners in exchange for
their beneficial interests in the U.S. Global Notes or the Offshore Global
Notes, as the case may be, if (i) the Depositary notifies the Company that it is
unwilling or unable to continue as Depositary for the U.S. Global Notes or the
Offshore Global Notes, as the case may be, and a successor depositary is not
appointed by the Company within 90 days of such notice, (ii) an Event of Default
has occurred and is continuing and the Registrar has received a request from the
Depositary or (iii) in accordance with the rules and procedures of the
Depositary and the provisions of Section 2.08.

     (c) Any beneficial interest in one of the Global Notes that is transferred
to a person who takes delivery in the form of an interest in another Global Note
will, upon transfer, cease to be an interest in such Global Note and become an
interest in such other Global Note and, accordingly, will thereafter be subject
to all transfer restrictions, if any, and other procedures applicable to
beneficial interests in such other Global Note for as long as it remains such an
interest.

     (d) In connection with any transfer of a portion of the beneficial
interests in a Global Note to beneficial owners pursuant to paragraph (b) of
this Section 2.07, the Registrar shall reflect on its books and records the date
and a decrease in the principal amount of such Global Note in an amount equal to
the principal amount of the beneficial interest in such Global Note to be
transferred, and the Company shall execute, and the Trustee shall authenticate
and deliver, one or more U.S. Physical Notes or Offshore Physical Notes, as the
case may be, of like tenor and amount.

     (e) In connection with the transfer of the U.S. Global Notes or the
Offshore Global Notes, in whole, to beneficial owners pursuant to paragraph (b)
of this Section 2.07, the U.S. Global Notes or Offshore Global Notes, as the
case may be, shall be deemed to be surrendered to the Trustee for cancellation,
and the Company shall execute, and the Trustee shall authenticate and deliver,
to each beneficial owner identified by the Depositary in exchange for its
beneficial interest in the U.S. Global Notes or Offshore Global Notes, as the
case may be, an equal
<PAGE>

                                      30

aggregate principal amount of U.S. Physical Notes or Offshore Physical Notes, as
the case may be, of authorized denominations.

     (f) Any U.S. Physical  Note delivered in exchange for an interest in the
U.S. Global Notes pursuant to paragraph (b), (d) or (e) of this Section 2.07
shall, except as otherwise provided by paragraph (e) of Section 2.08, bear the
legend regarding transfer restrictions applicable to the U.S. Physical  Note set
forth in Section 2.02.

     (g) Any Offshore Physical  Note delivered in exchange for an interest in
the Offshore Global Notes pursuant to paragraph (b), (d) or (e) of this Section
2.07 shall, except as otherwise provided by paragraph (e) of Section 2.08, bear
the legend regarding transfer restrictions applicable to the Offshore Physical
Note set forth in Section 2.02.

     (h) The registered holder of a Global  Note may grant proxies and otherwise
authorize any person, including Agent Members and persons that may hold
interests through Agent Members, to take any action which a Holder is entitled
to take under this Indenture or the Notes.

              .8.   Special Transfer Provisions. Unless and until a Note is
              ---------------------------------
exchanged for an Exchange Note or sold in connection with an effective
Registration Statement pursuant to the Registration Rights Agreement, the
following provisions shall apply:

     (a) Transfers to Non-QIB Institutional Accredited Investors.  The following
provisions shall apply with respect to the registration of any proposed transfer
of a  Note to any Institutional Accredited Investor which is not a QIB
(excluding Non-U.S. Persons):

              (i)  The Registrar shall register the transfer of any Note,
     whether or not such Note bears the Private Placement Legend, if (x) the
     requested transfer is after the time period referred to in Rule 144(k)
     under the Securities Act or (y) the proposed transferee has delivered to
     the Registrar (A) a certificate substantially in the form of Exhibit C
     hereto and (B) if the aggregate principal amount of the Notes being
     transferred is less than $100,000, an opinion of counsel acceptable to the
     Company that such transfer is in compliance with the Securities Act.

              (ii) If the proposed transferor is an Agent Member holding a
     beneficial interest in the U.S. Global Notes, upon receipt by the Registrar
     of (x) the documents, if any, required by paragraph (i) above and (y)
     instructions given in accordance with the Depositary's and the Registrar's
     procedures, the Registrar shall reflect on its books and records the date
     and a decrease in the principal amount of the U.S. Global Notes in an
     amount equal to the principal amount of the beneficial interest in the U.S.
     Global Notes to be transferred, and the Company shall execute, and the
     Trustee shall authenticate and deliver, one or more U.S. Physical Notes of
     like tenor and amount.

     (b) Transfers to QIBs.  The following provisions shall apply with respect
         -----------------
to the registration of any proposed transfer of a  Note to a QIB (excluding Non-
U.S. Persons):
<PAGE>

                                      31

          (i)  If the  Note to be transferred consists of (x) either Offshore
     Physical Notes prior to the removal of the Private Placement Legend or U.S.
     Physical Notes, the Registrar shall register the transfer if such transfer
     is being made by a proposed transferor who has checked the box provided for
     on the form of  Note stating, or has otherwise advised the Company and the
     Registrar in writing, that the sale has been made in compliance with the
     provisions of Rule 144A to a transferee who has signed the certification
     provided for on the form of  Note stating, or has otherwise advised the
     Company and the Registrar in writing, that it is purchasing the  Note for
     its own account or an account with respect to which it exercises sole
     investment discretion and that it and any such account is a QIB within the
     meaning of Rule 144A and is aware that the sale to it is being made in
     reliance on Rule 144A and acknowledges that it has received such
     information regarding the Company as it has requested pursuant to Rule 144A
     or has determined not to request such information and that it is aware that
     the transferor is relying upon its foregoing representations in order to
     claim the exemption from registration provided by Rule 144A or (y) an
     interest in the U.S. Global Notes, the transfer of such interest may be
     effected only through the book entry system maintained by the Depositary.

          (ii) If the proposed transferee is an Agent Member, and the  Note to
     be transferred consists of U.S. Physical Notes, upon receipt by the
     Registrar of the documents referred to in paragraph (i) above and
     instructions given in accordance with the Depositary's and the Registrar's
     procedures, the Registrar shall reflect on its books and records the date
     and an increase in the principal amount of U.S. Global Notes in an amount
     equal to the principal amount of the U.S. Physical Notes to be transferred,
     and the Trustee shall cancel the U.S. Physical Notes so transferred.

     (c) Transfers of Interests in the Offshore Global Notes or Unlegended
     --- -----------------------------------------------------------------
Offshore Physical Notes.  The following provisions shall apply with respect to
-----------------------
any transfer of interests in the Offshore Global Notes or unlegended Offshore
Physical Notes.  The Registrar shall register the transfer of any such  Note
without requiring any additional certification.

     (d) Transfers of Interests in the Offshore Global Notes or Offshore
     --- ---------------------------------------------------------------
Physical Notes.  The following provisions shall apply with respect to any
--------------
transfer of interests in Offshore Global Notes or Offshore Physical Notes:

          (i)  prior to the removal of the Private Placement Legend from the
     Offshore Global Notes or Offshore Physical Notes pursuant to Section 2.02,
     the Registrar shall refuse to register such transfer unless such transfer
     complies with Section 2.08(b) or Section 2.08(d), as the case may be, and

          (ii) after such removal, the Registrar shall register the transfer of
     any such  Note without requiring any additional certification.

     (e) Transfers to Non-U.S. Persons at Any Time.  The following provisions
     --- -----------------------------------------
shall apply with respect to any transfer of a  Note to a Non-U.S. Person:
<PAGE>

                                      32

          (i)   The Registrar shall register any proposed transfer to any Non-
     U.S. Person if the Note to be transferred is a U.S. Physical Note or an
     interest in U.S. Global Notes, upon receipt of a certificate substantially
     in the form of Exhibit D hereto from the proposed transferor.

          (ii)  (a) If the proposed transferor is an Agent Member holding a
     beneficial interest in the U.S. Global Notes, upon receipt by the Registrar
     of (x) the documents, if any, required by paragraph (ii) and (y)
     instructions in accordance with the Depositary's and the Registrar's
     procedures, the Registrar shall reflect on its books and records the date
     and a decrease in the principal amount of the U.S. Global Notes in an
     amount equal to the principal amount of the beneficial interest in the U.S.
     Global Notes to be transferred, and (b) if the proposed transferee is an
     Agent Member, upon receipt by the Registrar of instructions given in
     accordance with the Depositary's and the Registrar's procedures, the
     Registrar shall reflect on its books and records the date and an increase
     in the principal amount of the Offshore Global Notes in an amount equal to
     the principal amount of the U.S. Physical Notes or the U.S. Global Notes,
     as the case may be, to be transferred, and the Trustee shall cancel the
     Physical Note, if any, so transferred or decrease the amount of the U.S.
     Global Notes.

     (f) Private Placement Legend.  Upon the transfer, exchange or replacement
         ------------------------
of Notes not bearing the Private Placement Legend, the Registrar shall deliver
Notes that do not bear the Private Placement Legend. Upon the transfer, exchange
or replacement of Notes bearing the Private Placement Legend, the Registrar
shall deliver only Notes that bear the Private Placement Legend unless (i) the
Private Placement Legend is no longer required by Section 2.02, (ii) the
circumstances contemplated by paragraph (a)(i)(x) of this Section 2.08 exist or
(iii) there is delivered to the Registrar an Opinion of Counsel reasonably
satisfactory to the Company and the Trustee to the effect that neither such
legend nor the related restrictions on transfer are required in order to
maintain compliance with the provisions of the Securities Act.

     (g) General.  By its acceptance of any  Note bearing the Private Placement
         -------
Legend, each Holder of such a Note acknowledges the restrictions on transfer of
such Note set forth in this Indenture and in the Private Placement Legend and
agrees that it will transfer such Note only as provided in this Indenture. The
Registrar shall not register a transfer of any Note unless such transfer
complies with the restrictions on transfer of such Note set forth in this
Indenture. In connection with any transfer of Notes, each Holder agrees by its
acceptance of the Notes to furnish the Registrar or the Company such
certifications, legal opinions or other information as either of them may
reasonably require to confirm that such transfer is being made pursuant to an
exemption from, or a transaction not subject to, the registration requirements
of the Securities Act; provided that the Registrar shall not be required to
determine (but may conclusively rely on a determination made by the Company with
respect to) the sufficiency of any such certifications, legal opinions or other
information.

     The Registrar shall retain copies of all letters, notices and other written
communications received pursuant to Section 2.07 or this Section 2.08. The
Company shall have the right to
<PAGE>

                                      33

inspect and make copies of all such letters, notices or other written
communications at any reasonable time upon the giving of reasonable written
notice to the Registrar.

              .9.   Replacement Notes. If a mutilated Note is surrendered to the
              -----------------------
Trustee or if the Holder claims that the Note has been lost, destroyed or
wrongfully taken, then, in the absence of notice to the Company or the Trustee
that such Note has been acquired by a bona fide purchaser, the Company shall
issue and the Trustee shall authenticate a replacement Note of like tenor and
principal amount and bearing a number not contemporaneously outstanding;
provided that the requirements of this Section 2.09 are met. If required by the
Trustee or the Company, an indemnity bond must be furnished that is sufficient
in the judgment of both the Trustee and the Company to protect the Company, the
Trustee or any Agent from any loss that any of them may suffer if a Note is
replaced. The Company may charge such Holder for its expenses and the expenses
of the Trustee in replacing a Note. In case any such mutilated, lost, destroyed
or wrongfully taken Note has become or is about to become due and payable, the
Company in its discretion may pay such Note instead of issuing a new Note in
replacement thereof.

     Every replacement  Note is an additional obligation of the Company and
shall be entitled to the benefits of this Indenture.

              .10.   Outstanding Notes. Notes outstanding at any time are all
              ------------------------
Notes that have been authenticated by the Trustee except for those cancelled by
it, those delivered to it for cancellation and those described in this Section
2.10 as not outstanding.

     If a  Note is replaced pursuant to Section 2.09, it ceases to be
outstanding unless and until the Trustee and the Company receive proof
satisfactory to them that the replaced Note is held by a bona fide purchaser.

     If the Paying Agent (other than the Company or an Affiliate of the Company)
holds on the maturity date money sufficient to pay Notes payable on that date,
then on and after that date such Notes cease to be outstanding and interest on
them shall cease to accrue.

     A  Note does not cease to be outstanding because the Company or one of its
Affiliates holds such Note, provided, however, that in determining whether the
Holders of the requisite principal amount of the outstanding Notes have given
any request, demand, authorization, direction, notice, consent or waiver
hereunder, Notes owned by the Company or any other obligor upon the Notes or any
Affiliate of the Company or of such other obligor shall be disregarded and
deemed not to be outstanding, except that, in determining whether the Trustee
shall be protected in relying upon any such request, demand, authorization,
direction, notice, consent or waiver, only Notes which the Trustee has actual
knowledge to be so owned shall be so disregarded.  Notes so owned which have
been pledged in good faith may be regarded as outstanding if the pledgee
establishes to the satisfaction of the Trustee the pledgee's right so to act
with respect to such Notes and that the pledgee is not the Company or any other
obligor upon the Notes or any Affiliate of the Company or of such other obligor.

              .11.   Temporary Notes.  Until definitive Notes are ready for
              ----------------------
delivery, the Company may prepare and execute and the Trustee shall authenticate
temporary Notes.
<PAGE>

                                      34

Temporary Notes shall be substantially in the form of definitive Notes but
may have insertions, substitutions, omissions and other variations determined to
be appropriate by the Officers executing the temporary Notes, as evidenced by
their execution of such temporary Notes. If temporary Notes are issued, the
Company will cause definitive Notes to be prepared without unreasonable delay.
After the preparation of definitive Notes, the temporary Notes shall be
exchangeable for definitive Notes upon surrender of the temporary Notes at the
office or agency of the Company designated for such purpose pursuant to Section
4.02, without charge to the Holder. Upon surrender for cancellation of any one
or more temporory Notes the Company shall execute and the Trustee shall
authenticate and deliver in exchange therefor a like principal amount of
definitive Notes of authorized denominations. Until so exchanged, the temporary
Notes shall be entitled to the same benefits under this Indenture as definitive
Notes.
              .12.   Cancellation. The Company at any time may deliver to the
              -------------------
Trustee for cancellation any Notes previously authenticated and delivered
hereunder which the Company may have acquired in any manner whatsoever,and may
deliver to the Trustee for cancellation any Notes previously authenticated
hereunder which the Company has not issued and sold. The Registrar and the
Paying Agent shall forward to the Trustee any Notes surrendered to them for
transfer, exchange or payment. The Trustee shall cancel all Notes surrendered
for transfer, exchange, payment or cancellation and shall dispose of them in
accordance with its normal procedure.

              .13.   CUSIP Numbers. The Company in issuing the Notes may us
              --------------------
"CUSIP," "CINS" or "ISIN" numbers (if then generally in use), and the Company
and the Trustee shall use CUSIP, CINS or ISIN numbers, as the case may be, in
notices of redemption or exchange as a convenience to Holders; provided that any
such notice shall state that no representation is made as to the correctness of
such numbers either as printed on the Notes or as contained in any notice of
redemption or exchange and that reliance may be placed only on the other
identification numbers printed on the Notes. The Company shall promptly notify
the Trustee of any change in "CUSIP", "CINS" or "ISIN" numbers for the Notes.

              .14.   Defaulted Interest.  If the Company defaults in a payment
              -------------------------
of interest on the Notes, it shall pay, or shall deposit with the Paying Agent
money in immediately available funds sufficient to pay, the defaulted interest,
plus (to the extent lawful) any interest payable on the defaulted interest, to
the Persons who are Holders on a subsequent special record date. A special
record date, as used in this Section 2.14 with respect to the payment of any
defaulted interest, shall mean the 15th day next preceding the date fixed by the
Company for the payment of defaulted interest, whether or not such day is a
Business Day. At least 15 days before the subsequent special record date, the
Company shall mail to each Holder and to the Trustee a notice that states the
subsequent special record date, the payment date and the amount of defaulted
interest to be paid.

              .15.   Issuance of Additional Notes.  The Company may, subject to
              -----------------------------------
Article Four of this Indenture and applicable law, issue additional Notes under
this Indenture. The Notes issue don the Closing Date and any additional Notes
subsequently issued shall be treated as a single class for all purposes under
this Indenture.
<PAGE>

                                      35

                                 ARTICLE THREE
                                   REDEMPTION

              .1.   Right of Redemption.  (a) The Notes are redeemable, at the
              -------------------------
Company's option, in whole or in part, at any time or from time to time, on or
after August 15, 2005 and prior to maturity, upon not less than 30 nor more than
60 days' prior notice mailed by first-class mail to each Holder's last address,
as it appears in the Security Register, at the following Redemption Prices
(expressed in percentages of principal amount), plus accrued and unpaid
interest, if any, to the Redemption Date (subject to the right of Holders of
record on the relevant Regular Record Date that is on or prior to the Redemption
Date to receive interest due on an Interest Payment Date), if redeemed during
the 12month period commencing August 15 of the years set forth below:

                    Year                        Redemption
                                                  Price
                                             ________________

                    2005...................       106.500%
                    2006...................       104.333
                    2007...................       102.167
                    2008 and thereafter....       100.000%

          (b) In addition, at any time prior to August 15, 2003, the Company may
redeem up to 35% of the aggregate principal amount of the Notes with the Net
Cash Proceeds of one or more sales of Capital Stock of the Company (other than
Disqualified Stock) (each a "Public Equity Offering"), at any time as a whole or
from time to time in part, at a Redemption Price (expressed as a percentage of
principal amount) of 113.000%, plus accrued and unpaid interest to the
Redemption Date (subject to the rights of Holders of record on the relevant
Regular Record Date that is prior to the Redemption Date to receive interest due
on an Interest Payment Date); provided that (i) at least 65% of the aggregate
principal amount of Notes originally issued on the Closing Date remains
outstanding after each such redemption and (ii) notice of such redemption is
mailed within 60 days of the related Public Equity Offering.

          (c) In addition, the Notes will be subject to mandatory redemption
(the "Special Redemption") at 101% of the principal amount thereof plus accrued
      __________________
interest to the Redemption Date (the "Special Redemption Price") in the event
                                      ________________________
that the Escrow Agent has not received the Officers' Certificate (as defined in
the Escrow Agreement) provided for in the Escrow Agreement on or prior to
October 2, 2000, subject to an extension, in accordance with the provisions of
the Escrow Agreement, until December 17, 2000 (such date, as extended, being the
"Termination Date"). The redemption date for the Special Redemption (the
 ________________
"Special Redemption Date") will be five Business Days after the Termination
 _______________________
Date.

     If, on or prior to the Termination Date, the Escrow Agent received an
Officers' Certificate from the Company stating that (A) the occurrence of each
of (i) the borrowings under the Credit Facility, (ii) the repayment of
indebtedness of the Virginia PCS Alliance and the West Virginia
<PAGE>

                                      36

PCS Alliance to the Rural Telephone Finance Cooperative, (iii) the issuance and
sale by the Company of the Preferred Shares yielding gross proceeds to the
Company of $225.0 million in cash, (iv) the Richmond-Norfolk Acquisition and (v)
the dispositions of the analog cellular operations of Virginia RSA6 and RSA5 in
connection with the RichmondNorfolk Acquisition, will not contravene any
provision of applicable law or the certificate of incorporation or bylaws of the
Company or any agreement, indenture or other instrument binding upon the Company
or any of its subsidiaries that is material to the Company and its subsidiaries,
taken as a whole, or any judgment, order or decree of any governmental body,
agency or court having jurisdiction over the Company or any subsidiary, and no
consent, approval, authorization or order of, or qualification with, any
governmental body or agency (except any such consent, approval, authorization,
order or qualification that has been obtained or made and remains in full force
and effect as of the date of such certificate) is required for the performance
by the Company of any of its obligations with respect to each of the foregoing,
and (B) the RichmondNorfolk Acquisition will be consummated promptly upon
release of the escrowed funds, the Escrow Agreement provides that the Escrow
Agent will release the Collateral in accordance with the provisions of the
Escrow Agreement.

              .2.   Notices to Trustee.  If the Company elects to redeem Notes
              ------------------------
pursuant to Section 3.01, it shall notify the Trustee in writing of the
Redemption Date and the principal amount of Notes to be redeemed and the clause
of this Indenture pursuant to which redemption shall occur.

     The Company shall give each notice provided for in this Section 3.02 in an
Officers' Certificate at least 45 days before the Redemption Date (unless a
shorter period shall be satisfactory to the Trustee).

              .3.   Selection of Notes to Be Redeemed.  If less than all of the
              ---------------------------------------
Notes are to be redeemed at any time, the Trustee shall select the Notes to be
redeemed in compliance with the requirements, as certified to it by the Company,
of the principal national securities exchange, if any, on which the Notes are
listed or, if the Notes are not listed on a national securities exchange or
automated quotation system, by lot or by such other method as the Trustee in its
reasonable discretion shall deem fair and appropriate; provided that no Note of
$1,000 in principal amount or less shall be redeemed in part.

     The Trustee shall make the selection from the Notes outstanding and not
previously called for redemption.  Notes in denominations of $1,000 in principal
amount may only be redeemed in whole.  The Trustee may select for redemption
portions (equal to $1,000 in principal amount or any integral multiple thereof)
of Notes that have denominations larger than $1,000 in principal amount.
Provisions of this Indenture that apply to Notes called for redemption also
apply to portions of Notes called for redemption.  The Trustee shall notify the
Company and the Registrar promptly in writing of the Notes or portions of Notes
to be called for redemption.

              .4.   Notice of Redemption.  (a)  With respect to any redemption
              --------------------------
of Notes pursuant to Section 3.01, at least 30 days but not more than 60 days
before a Redemption Date, the
<PAGE>

                                      37

Company shall mail a notice of redemption by first-class mail to each Holder
whose Notes are to be redeemed.

     The notice shall identify the Notes to be redeemed (including CUSIP
numbers) and shall state:

          (i)  the Redemption Date;

          (ii)  the Redemption Price;

          (iii)  the name and address of the Paying Agent;

          (iv) that Notes called for redemption must be surrendered to the
     Paying Agent in order to collect the Redemption Price;

          (v) that, unless the Company defaults in making the redemption
     payment, interest on Notes called for redemption ceases to accrue on and
     after the Redemption Date and the only remaining right of the Holders is to
     receive payment of the Redemption Price plus accrued interest to the
     Redemption Date upon surrender of the Notes to the Paying Agent;

          (vi) that, if any  Note is being redeemed in part, the portion of the
     principal amount (equal to $1,000 in principal amount or any integral
     multiple thereof) of such  Note to be redeemed and that, on and after the
     Redemption Date, upon surrender of such Note, a new  Note or Notes in
     principal amount equal to the unredeemed portion thereof will be reissued;
     and

          (vii)  that, if any  Note contains a CUSIP, CINS or ISIN number as
     provided in Section 2.13, no representation is being made as to the
     correctness of the CUSIP, CINS or ISIN number either as printed on the
     Notes or as contained in the notice of redemption and that reliance may be
     placed only on the other identification numbers printed on the Notes.

     At the Company's request (which request may be revoked by the Company at
any time prior to the time at which the Trustee shall have given such notice to
the Holders), made in writing to the Trustee at least 45 days (or such shorter
period as shall be reasonable) before a Redemption Date, the Trustee shall give
the notice of redemption in the name and at the expense of the Company.  If,
however, the Company gives such notice to the Holders, the Company shall
concurrently deliver to the Trustee an Officers' Certificate stating that such
notice has been given.

     (b) With respect to any redemption of the Notes pursuant to Section
3.01(d), if the Escrow Agent does not receive the Officers' Certificate as
described in Section 3.01(d) prior to or by 5:00 P.M. local time on the
Termination Date, the Escrow Agent shall direct the Trustee to, and the Trustee
shall, in the name and at the expense of the Company, mail a notice of
redemption by first class mail to each Holder whose Notes are to be redeemed.
<PAGE>

                                    38

     The notice shall identify (including CUSIP or CINS number, as the case may
be) the Notes to be redeemed and shall state:

        (i)  the Special Redemption Date;

        (ii) the Special Redemption Price;

        (iii) the name and address of the Paying Agent;

        (iv)  that Notes called for redemption must be surrendered to the Paying
     Agent in order to collect the Special Redemption Price; and

        (v) that, unless the Company defaults in making the redemption payment,
     interest on Notes called for redemption ceases to accrue on and after the
     Special Redemption Date and the only remaining right of the Holders is to
     receive payment of the Special Redemption Price upon surrender of the Notes
     to the Paying Agent.

              .5.   Effect of Notice of Redemption. Once notice of redemption is
              ------------------------------------
mailed, Notes called for redemption become due and payable on the Redemption
Date, or the Special Redemption Date, at the Redemption Price or the Special
Redemption Price, as the case may be. Upon surrender of any Notes to the Paying
Agent, such Notes shall be paid at the Redemption Price, plus accrued interest,
if any, to the Redemption Date, or at the Special Redemption Price, as the case
may be.

     Notice of redemption shall be deemed to be given when mailed, whether or
not the Holder receives the notice.  In any event, failure to give such notice,
or any defect therein, shall not affect the validity of the proceedings for the
redemption of Notes held by Holders to whom such notice was properly given.

              .6.   Deposit of Redemption Price or Special Redemption Price. On
              -------------------------------------------------------------
or prior to 10:00 a.m. New York City time on any Redemption Date, the Company
shall deposit with the Paying Agent (or, if the Company is acting as its own
Paying Agent, shall segregate and hold in trust as provided in Section 2.05)
money sufficient to pay the Redemption Price of and accrued interest on all
Notes to be redeemed on that date other than Notes or portions thereof called
for redemption on that date that have been delivered by the Company to the
Trustee for cancellation.

     (b) On the Business Day prior to the Special Redemption Date, the Escrow
Agent will disburse all Collateral (subject to the provisions of the Escrow
Agreement) to the Trustee and the Trustee shall deposit such amount with the
Paying Agent.  In the event such amount deposited by the Trustee is insufficient
to pay the Redemption Price of and accrued interest on all Notes to be redeemed
on the Special Redemption Date, then the Company shall, on the Business Day
prior to the Special Redemption Date, deposit with the Paying Agent the amount
of money in U.S. dollars necessary to permit all outstanding Notes to be
redeemed at the Special Redemption Price in accordance with Section 3.01(d).
<PAGE>

                                      39

              .7.   Payment of Notes Called for Redemption. If notice of
              --------------------------------------------
redemption has been given in the manner provided above,the Notes or portion of
Notes specified in such notice to be redeemed shall become due and payable on
the Redemption Date or the Special Redemption Date at the Redemption Price
stated therein, together with accrued interest to such Redemption Date or the
Special Redemption Price, and on and after such date (unless the Company shall
default in the payment of such Notes at the Redemption Price and accrued
interest to the Redemption Date or at the Special Redemption Price, as the case
may be, in which case the principal, until paid, shall bear interest from the
Redemption Date or the Special Redemption Date, as the case may be, at the rate
prescribed in the Notes), such Notes shall cease to accrue interest. Upon
surrender of any Note for redemption in accordance with a notice of redemption,
such Note shall be paid and redeemed by the Company at the Redemption Price,
together with accrued interest, if any, to the Redemption Date or the Special
Redemption Price; provided that installments of interest whose Stated Maturity
is on or prior to the Redemption Date shall be payable to the Holders registered
as such at the close of business on the relevant Regular Record Date.

              .8.   Notes Redeemed in Part. Upon surrender of any Note that is
              ----------------------------
redeemed in part, the Company shall execute and the Trustee shall authenticate
and deliver to the Holder without service charge, a new Note equal in principal
amount to the unredeemed portion of such surrendered Note.

                                 ARTICLE FOUR
                                   COVENANTS

              .1.   Payment of Notes.  The Company shall pay the principal of,
              ----------------------
premium, if any, and interest on the Notes on the dates and in the manner
provided in the Notes and this Indenture. An installment of principal, premium,
if any, or interest shall be considered paid on the date due if the Trustee or
Paying Agent (other than the Company, a Subsidiary of the Company, or any
Affiliate of any of them) holds on that date money designated for and sufficient
to pay the installment. If the Company or any Subsidiary of the Company or any
Affiliate of any of them acts as Paying Agent, an installment of principal,
premium, if any, or interest shall be considered paid on the due date if the
entity acting as Paying Agent complies with the last sentence of Section 2.05.
As provided in Section 6.09, upon any bankruptcy or reorganization procedure
relative to the Company, the Trustee shall serve as the Paying Agent, if any,
for the Notes.

     The Company shall pay interest on overdue principal and premium, if any,
and interest on overdue installments of interest, to the extent lawful, at the
rate per annum specified in the Notes.

              .2.   Maintenance of Office or Agency. The Company will maintain
              -------------------------------------
in the Borough of Manhattan, The City of New York, an office or agency where
Notes may be surrendered for registration of transfer or exchange or for
presentation for payment and where notices and demands to or upon the Company in
respect of the Notes and this Indenture may be served. The Company will give
prompt written notice to the Trustee of the location, and any change in the
location, of such office or agency. If at any time the Company shall fail to
maintain any such required office or agency or shall fail to furnish the Trustee
with the address
<PAGE>

                                      40

thereof, such presentations, surrenders, notices and demands may be made or
served at the address of the Trustee set forth in Section 10.02.

     The Company may also from time to time designate one or more other offices
or agencies where the Notes may be presented or surrendered for any or all such
purposes and may from time to time rescind such designations; provided that no
such designation or rescission shall in any manner relieve the Company of its
obligation to maintain an office or agency in the Borough of Manhattan, The City
of New York, for such purposes.  The Company shall give prompt written notice to
the Trustee of any such designation or rescission and of any change in the
location of any such other office or agency.

     The Company hereby initially designates the Corporate Trust Office of the
Trustee as such office of the Company in accordance with Section 2.04.

              .3.   Limitation on Indebtedness. (a) The Company will not, and
              --------------------------------
will not permit any of its Restricted Subsidiaries to, Incur any Indebtedness
(other than the Notes and Indebtedness existing on the Closing Date); provided
that the Company may Incur Indebtedness if, after giving pro forma effect to the
Incurrence of such Indebtedness and the receipt and application of the proceeds
therefrom, the Indebtedness to EBITDA Ratio would be positive but (1) less than
7.0:1.0, if prior to August 15, 2004 and (2) less than 6.0:1.0, if on or after
August 15, 2004.

     Notwithstanding the foregoing, the Company and any Restricted Subsidiary
(except as specified below) may Incur each and all of the following:

          (1)       Indebtedness of the Company outstanding at any time in an
     aggregate principal amount (together with refinancings thereof) not to
     exceed $325.0 million, less any amount of such Indebtedness permanently
     repaid as provided in Section 4.11;

          (2)       Indebtedness owed (A) to the Company or (B) to any
     Restricted Subsidiary; provided that any event which results in any such
     Restricted Subsidiary ceasing to be a Restricted Subsidiary or any
     subsequent transfer of such Indebtedness (other than to the Company or
     another Restricted Subsidiary) shall be deemed, in each case, to constitute
     an Incurrence of such Indebtedness not permitted by this clause (2);

          (3)       Indebtedness issued in exchange for, or the net proceeds of
     which are used to refinance or refund, then outstanding Indebtedness and
     any refinancings thereof in an amount not to exceed the amount so
     refinanced or refunded (plus premiums, accrued interest, fees and
     expenses); provided that Indebtedness the proceeds of which are used to
     refinance or refund the Notes or Indebtedness that is pari passu with, or
     subordinated in right of payment to, the Notes shall only be permitted
     under this clause (3) if

               (A)       in case the Notes are refinanced in part or the
          Indebtedness to be refinanced is pari passu with the Notes, such new
          Indebtedness, by its terms or by the terms of any agreement or
          instrument pursuant to which such new
<PAGE>

                                      41

          Indebtedness is outstanding, is expressly made pari passu with, or
          subordinate in right of payment to, the remaining Notes;

               (B)       in case the Indebtedness to be refinanced is
          subordinated in right of payment to the Notes, such new Indebtedness,
          by its terms or by the terms of any agreement or instrument pursuant
          to which such new Indebtedness is issued or remains outstanding, is
          expressly made subordinate in right of payment to the Notes at least
          to the extent that the Indebtedness to be refinanced is subordinated
          to the Notes; and

               (C)       such new Indebtedness, determined as of the date of
          Incurrence of such new Indebtedness, does not mature prior to the
          Stated Maturity of the Indebtedness to be refinanced or refunded, and
          the Average Life of such new Indebtedness is at least equal to the
          remaining Average Life of the Indebtedness to be refinanced or
          refunded;

     and provided further that in no event may Indebtedness of the Company be
     refinanced by means of any Indebtedness of any Restricted Subsidiary
     pursuant to this clause (3);

          (4)  Indebtedness

               (A) in respect of performance, surety or appeal bonds provided in
          the ordinary course of business;

               (B) under Currency Agreements and Interest Rate Agreements;
          provided that such agreements (a) are designed solely to protect the
          Company or its Restricted Subsidiaries against fluctuations in foreign
          currency exchange rates or interest rates and (b) do not increase the
          Indebtedness of the obligor outstanding at any time other than as a
          result of fluctuations in foreign currency exchange rates or interest
          rates or by reason of fees, indemnities and compensation payable
          thereunder; and

               (C) arising from agreements providing for indemnification,
          adjustment of purchase price or similar obligations, or from
          Guarantees or letters of credit, surety bonds or performance bonds
          securing any obligations of the Company or any of its Restricted
          Subsidiaries pursuant to such agreements, in any case Incurred in
          connection with the disposition of any business, assets or Restricted
          Subsidiary (other than Guarantees of Indebtedness Incurred by any
          Person acquiring all or any portion of such business, assets or
          Restricted Subsidiary for the purpose of financing such acquisition),
          in a principal amount not to exceed the gross proceeds actually
          received by the Company or any Restricted Subsidiary in connection
          with such disposition;

          (5)  Indebtedness of the Company, to the extent the net proceeds
     thereof are promptly (A) used to purchase Notes tendered in an Offer to
     Purchase made as a result of
<PAGE>

                                      42

     a Change in Control or (B) deposited to defease the Notes as described in
     Section 8.02 and Section 8.03;

          (6)  Guarantees of the Notes and Subordinated Notes and Guarantees of
     Indebtedness of the Company by any Restricted Subsidiary provided the
     Guarantee of such Indebtedness is permitted by and made in accordance with
     Section 4.07;

          (7)  Acquired Indebtedness; provided that the Indebtedness to EBITDA
     Ratio, after giving effect to such Incurrence on a pro forma basis, is no
     greater than such ratio prior to giving pro forma effect to such
     Incurrence;

          (8)  The Incurrence by the Company or any of its Restricted
     Subsidiaries of Indebtedness to finance the cost (including the cost of
     design, development, improvement, acquisition, construction, installation,
     transportation or integration) to acquire equipment, inventory or network
     assets, in an aggregate principal amount not to exceed $10.0 million in any
     fiscal year; provided that amounts not so Incurred in any fiscal year may
     be accumulated and Incurred by the Company or any of its Restricted
     Subsidiaries in any subsequent fiscal year; and provided further that the
     aggregate amount of Indebtedness that may be outstanding under this clause
     (8) at any one time shall not exceed $75.0 million.

          (9)  Indebtedness of the Company not to exceed, at any one time
     outstanding, two times the sum of:

               (A) the Net Cash Proceeds received by the Company, other than
          from MSDW and WCAS up to an aggregate amount of $112.5 million, from
          the issuance and sale of its Capital Stock (other than Disqualified
          Stock) or options, warrants or other rights to acquire such Capital
          Stock to a Person that is not a Subsidiary of the Company, to the
          extent such Net Cash Proceeds have not been used pursuant to clause
          (C)(2) of the first paragraph or clause (3) or (4) of the second
          paragraph of Section 4.04 to make a Restricted Payment, and

               (B) 80% of the fair market value of property (other than cash or
          Cash Equivalents) received by the Company after the Closing Date
          (other than with respect to the R&B Acquisition) from the sale of its
          Capital Stock (other than Disqualified Stock) or options, warrants or
          other rights to acquire such Capital Stock to a person that is not a
          Subsidiary of the Company, to the extent such sale of Capital Stock
          has not been used pursuant to clause (3) or (4) of the second
          paragraph of Section 4.04 to make a Restricted Payment;

     provided that such Indebtedness Incurred pursuant to this clause (9) does
     not mature prior to the Stated Maturity of the Notes and has an Average
     Life longer than the Notes; or

          (10) Indebtedness of the Company (in addition to Indebtedness
     permitted under clauses (1) through (9) above) in an aggregate principal
     amount outstanding at any time (together with refinancings thereof) not to
     exceed $15.0 million at any time prior to
<PAGE>

                                      43

     closing of the R&B Acquisition and $25.0 million thereafter, less any
     amount of such Indebtedness permanently repaid as provided under Section
     4.11.

     (b)  Notwithstanding any other provision of this Section 4.03, the maximum
amount of Indebtedness that the Company or a Restricted Subsidiary may Incur
pursuant to this Section 4.03 shall not be deemed to be exceeded, with respect
to any outstanding Indebtedness due solely to the result of fluctuations in the
exchange rates of currencies.

     (c)  For purposes of determining any particular amount of Indebtedness
under this Section 4.03 (1) Indebtedness Incurred under the Credit Facility on
or prior to the Closing Date shall be treated as Incurred pursuant to clause (1)
of the second paragraph of this Section 4.03, (2) Guarantees, Liens or
obligations with respect to letters of credit supporting Indebtedness otherwise
included in the determination of such particular amount shall not be included
and (3) any Liens granted pursuant to the equal and ratable provisions referred
to in Section 4.09 shall not be treated as Indebtedness. For purposes of
determining compliance with this Section 4.03, in the event that an item of
Indebtedness meets the criteria of more than one of the types of Indebtedness
described in the above clauses (other than Indebtedness referred to in clause
(1) of the preceding sentence), the Company, in its sole discretion, shall
classify, and from time to time may reclassify, such item of Indebtedness and
only be required to include the amount and type of such Indebtedness in one of
such clauses.

     (d)  Notwithstanding anything herein to the contrary, if the Company or any
Restricted Subsidiary issues any security convertible into Indebtedness, the
documents governing such security shall provide that unless the Incurrence of
such Indebtedness would be permitted under this Section 4.03, such security may
not be converted into Indebtedness.

              .4.   Limitation on Restricted Payments.  The Company will not,
              ---------------------------------------
and will not permit any Restricted Subsidiary to, directly or indirectly, (1)
declare or pay any dividend or make any distribution on or with respect to its
Capital Stock (other than (x) dividends or distributions payable solely in
shares of its Capital Stock (other than Disqualified Stock) or in options,
warrants or other rights to acquire shares of such Capital Stock and (y) pro
rata dividends or distributions on Common Stock of Restricted Subsidiaries held
by minority stockholders) held by Persons other than the Company or any of its
Restricted Subsidiaries, (2) purchase, redeem, retire or otherwise acquire for
value any shares of Capital Stock of (A) the Company or an Unrestricted
Subsidiary (including options, warrants or other rights to acquire such shares
of Capital Stock) held by any Person or (B) a Restricted Subsidiary (including
options, warrants or other rights to acquire such shares of Capital Stock) held
by any Affiliate of the Company (other than a Wholly Owned Restricted
Subsidiary) or any holder (or any Affiliate of such holder) of 5% or more of the
Capital Stock of the Company, (3) make any voluntary or optional principal
payment, or voluntary or optional redemption, repurchase, defeasance, or other
acquisition or retirement for value, of Indebtedness of the Company that is
subordinated in right of payment to the Notes or (4) make any Investment, other
than a Permitted Investment, in any Person (such payments or any other actions
described in clauses (1) through (4) above being collectively "Restricted
                                                               ----------
Payments") if, at the time of, and after giving effect to, the proposed
--------
Restricted Payment:
<PAGE>

                                      44

          (A)  a Default or Event of Default shall have occurred and be
     continuing,

          (B)  the Company could not Incur at least $1.00 of Indebtedness under
     the first paragraph of Section 4.03 or

          (C)  the aggregate amount of all Restricted Payments (the amount, if
     other than in cash, to be determined in good faith by the Board of
     Directors, whose determination shall be conclusive and evidenced by a Board
     Resolution) made after the Closing Date shall exceed the sum of

               (1) the amount of (x) Consolidated EBITDA of the Company after
          June 30, 2003 through the end of the latest full fiscal quarter for
          which consolidated financial statements of the Company are available
          preceding the date of such Restricted Payment, treated as a single
          accounting period, less (y) 2.00 times the aggregate Consolidated
          Interest Expense of the Company after June 30, 2003 through the end of
          the latest full fiscal quarter for which consolidated financial
          statements of the Company are available preceding the date of such
          Restricted Payment treated as a single accounting period, plus

               (2) the aggregate Net Cash Proceeds and fair market value of
          property other than cash (to the extent not used to make a Permitted
          Investment), received by the Company after the Closing Date from the
          issuance and sale permitted by this Indenture of its Capital Stock
          (other than Disqualified Stock) to a Person who is not a Subsidiary of
          the Company, including an issuance or sale permitted by this Indenture
          of Indebtedness of the Company for cash subsequent to the Closing Date
          upon the conversion of such Indebtedness into Capital Stock (other
          than Disqualified Stock) of the Company, or from the issuance to a
          Person who is not a Subsidiary of the Company of any options, warrants
          or other rights to acquire Capital Stock of the Company (in each case,
          exclusive of any Disqualified Stock or any options, warrants or other
          rights that are redeemable at the option of the holder, or are
          required to be redeemed, prior to the Stated Maturity of the Notes)
          plus

               (3) an amount equal to the net reduction in Investments (other
          than reductions in Permitted Investments) in any Person resulting from
          payments of interest on Indebtedness, dividends, repayments of loans
          or advances, or other transfers of assets, in each case to the Company
          or any Restricted Subsidiary or from the Net Cash Proceeds from the
          sale of any such Investment (except, in each case, to the extent any
          such payment or proceeds are included in the calculation of Adjusted
          Consolidated Net Income), or from redesignations of Unrestricted
          Subsidiaries as Restricted Subsidiaries (valued in each case as
          provided in the definition of "Investments"), not to exceed, in each
          case, the amount of Investments previously made by the Company or any
          Restricted Subsidiary in such Person or Unrestricted Subsidiary.
<PAGE>

                                      45

The foregoing provision shall not be violated by reason of:

               (1)  the payment of any dividend within 60 days after the date of
          declaration thereof if, at said date of declaration, such payment
          would comply with the foregoing paragraph;

               (2)  the redemption, repurchase, defeasance or other acquisition
          or retirement for value of Indebtedness that is subordinated in right
          of payment to the Notes including premium, if any, and accrued and
          unpaid interest, with the proceeds of, or in exchange for,
          Indebtedness Incurred under clause (3) of the second paragraph of part
          (a) of Section 4.03;

               (3)  the repurchase, redemption or other acquisition of Capital
          Stock of the Company or an Unrestricted Subsidiary (or options,
          warrants or other rights to acquire such Capital Stock) in exchange
          for, or out of the proceeds of a substantially concurrent offering of,
          shares of Capital Stock (other than Disqualified Stock) of the Company
          (or options, warrants or other rights to acquire such Capital Stock);

               (4)  the making of any principal payment or the repurchase,
          redemption, retirement, defeasance or other acquisition for value of
          Indebtedness of the Company which is subordinated in right of payment
          to the Notes in exchange for, or out of the proceeds of, a
          substantially concurrent offering of, shares of the Capital Stock
          (other than Disqualified Stock) of the Company (or options, warrants
          or other rights to acquire such Capital Stock);

               (5)  payments or distributions, to dissenting stockholders
          pursuant to applicable law, pursuant to or in connection with a
          consolidation, merger or transfer of assets that complies with the
          provisions of this Indenture applicable to mergers, consolidations and
          transfers of all or substantially all of the property and assets of
          the Company;

               (6)  Investments acquired in exchange for, or out of the proceeds
          of a substantially concurrent offering of, Capital Stock (other than
          Disqualified Stock) of the Company;

               (7)  any purchase or redemption of Disqualified Stock of the
          Company or any of its Restricted Subsidiaries made by or in exchange
          for, or out of the proceeds of the substantially concurrent sale of,
          Disqualified Stock of the Company;

               (8)  upon the occurrence of a Change of Control and within 60
          days after the completion of the offer to repurchase the Notes
          pursuant to the provisions of Section 4.12 (including the purchase of
          any Notes tendered), any purchase or redemption of subordinated
          obligations required pursuant to the terms thereof as a result of such
          Change of Control at a purchase or redemption price
<PAGE>

                                  46

          not to exceed the outstanding principal amount thereof, plus any
          accrued or unpaid interest; provided, however, that at the time of
          such purchase or redemption no Default shall have occurred and be
          continuing;

               (9)  repurchases of Capital Stock deemed to occur upon the
          exercise of stock options if such options or Capital Stock represents
          a portion of the exercise price thereof;

               (10) payments not to exceed $250,000 in the aggregate solely to
          enable the Company to make payments to holders of its Capital Stock in
          lieu of the issuance of fractional shares of its Capital Stock; and

               (11) the repurchase of $95.0 million of subordinated notes with
          the proceeds of the issuance of additional senior Indebtedness having
          a Stated Maturity no earlier than the Stated Maturity of the notes,
          including without limitation, notes under the Indenture; provided that
          pro forma such transaction, the Company could Incur $1.00 of
          Indebtedness under the first paragraph of Section 4.03.

     provided that, except in the case of clauses (1) and (3), no Default or
     Event of Default shall have occurred and be continuing or occur as a
     consequence of the actions or payments set forth therein.

     Each Restricted Payment permitted pursuant to the preceding paragraph
(other than the Restricted Payment referred to in clause (2) thereof, an
exchange of Capital Stock for Capital Stock or Indebtedness referred to in
clause (3) or (4) thereof and an Investment acquired as a capital contribution
or in exchange for Capital Stock referred to in clause (4) thereof), and the Net
Cash Proceeds from any issuance of Capital Stock referred to in clauses (3) and
(4), shall be included in calculating whether the conditions of clause (C) of
the first paragraph of this Section 4.04 have been met with respect to any
subsequent Restricted Payments.  In the event the proceeds of an issuance of
Capital Stock of the Company are used for the redemption, repurchase or other
acquisition of the Notes, or Indebtedness that is pari passu with the Notes,
then the Net Cash Proceeds of such issuance shall be included in clause (C) of
the first paragraph of this Section 4.04 only to the extent such proceeds are
not used for such redemption, repurchase or other acquisition of Indebtedness.

     Any Restricted Payments made other than in cash shall be valued at fair
market value. The amount of any Investment "outstanding" at any time shall be
deemed to be equal to the amount of such Investment on the date made, less the
return of capital to the Company and its Restricted Subsidiaries with respect to
such Investment (up to the amount of the Investment on the date made).

              .5.   Limitation on Dividend and Other Payment Restrictions
              -----------------------------------------------------------
Affecting Restricted Subsidiaries. The Company will not, and will not permit any
---------------------------------
Restricted Subsidiary to, create or otherwise cause or suffer to exist or become
effective any consensual encumbrance or restriction of any kind on the ability
of any Restricted Subsidiary to (1) pay dividends or make any other
<PAGE>

                                      47

distributions permitted by applicable law on any Capital Stock of such
Restricted Subsidiary owned by the Company or any other Restricted Subsidiary,
(2) pay any Indebtedness owed to the Company or any other Restricted Subsidiary,
(3) make loans or advances to the Company or any other Restricted Subsidiary or
(4) transfer any of its property or assets to the Company or any other
Restricted Subsidiary.

     The foregoing provisions shall not restrict any encumbrances or
     restrictions:

          (1) existing on the Closing Date in the Credit Facility, this
     Indenture or any other agreements in effect on the Closing Date, and any
     extensions, refinancings, renewals or replacements of such agreements;
     provided that the encumbrances and restrictions in any such extensions,
     refinancings, renewals or replacements are no less favorable in any
     material respect to the Holders than those encumbrances or restrictions
     that are then in effect and that are being extended, refinanced, renewed or
     replaced;

          (2) existing under or by reason of applicable law;

          (3) existing with respect to any Person or the property or assets of
     such Person acquired by the Company or any Restricted Subsidiary, existing
     at the time of such acquisition and not incurred in contemplation thereof,
     which encumbrances or restrictions are not applicable to any Person or the
     property or assets of any Person other than such Person or the property or
     assets of such Person so acquired;

          (4) in the case of clause (4) of the first paragraph of this Section
     4.05, (A) that restrict in a customary manner the subletting, assignment or
     transfer of any property or asset that is a lease, license, conveyance or
     contract or similar property or asset, (B) existing by virtue of any
     transfer of, agreement to transfer, option or right with respect to, or
     Lien on, any property or assets of the Company or any Restricted Subsidiary
     not otherwise prohibited by this Indenture or (C) arising or agreed to in
     the ordinary course of business, not relating to any Indebtedness, and that
     do not, individually or in the aggregate, detract from the value of
     property or assets of the Company or any Restricted Subsidiary in any
     manner material to the Company and its Restricted Subsidiaries, taken as a
     whole; or

          (5) with respect to a Restricted Subsidiary and imposed pursuant to an
     agreement that has been entered into for the sale or disposition of all or
     substantially all of the Capital Stock of, or property and assets of, such
     Restricted Subsidiary.

     Nothing contained in this Section 4.05 shall prevent the Company or any
Restricted Subsidiary from (1) creating, incurring, assuming or suffering to
exist any Liens otherwise permitted in Section 4.09 or (2) restricting the sale
or other disposition of property or assets of the Company or any of its
Restricted Subsidiaries that secure Indebtedness of the Company or any of its
Restricted Subsidiaries.

          .6.   Limitation on the Issuance and Sale of Capital Stock of
          -------------------------------------------------------------
Restricted Subsidiaries.  The Company will not sell, and will not permit any
-----------------------
Restricted Subsidiary, directly
<PAGE>

                                      48

or indirectly, to issue or sell, any shares of Capital Stock of a Restricted
Subsidiary (including options, warrants or other rights to purchase shares of
such Capital Stock) except:

          (1) to the Company or a Wholly Owned Restricted Subsidiary;

          (2) issuances of director's qualifying shares or sales to foreign
     nationals of shares of Capital Stock of foreign Restricted Subsidiaries, to
     the extent required by applicable law;

          (3) if, immediately after giving effect to such issuance or sale, such
     Restricted Subsidiary would no longer constitute a Restricted Subsidiary
     and any Investment in such Person remaining after giving effect to such
     issuance or sale would have been permitted to be made under Section 4.04 if
     made on the date of such issuance or sale; or

          (4) the sale of Common Stock of Restricted Subsidiaries (other than
     Disqualified Stock), if the proceeds of such issuance and sale are applied
     in accordance with clauses 1(A) and 1(B) of Section 4.11.

          .7.   Limitation on Issuances of Guarantees by Restricted
          ---------------------------------------------------------
Subsidiaries.  The Company will not permit any Restricted Subsidiary, directly
------------
or indirectly, to Guarantee any Indebtedness of the Company which is pari passu
with or subordinate in right of payment to the Notes ("Guaranteed
                                                       ----------
Indebtedness"), unless (1) such Restricted Subsidiary simultaneously executes
------------
and delivers a supplemental indenture to this Indenture providing for a
Guarantee (a "Subsidiary Guarantee") of payment of the Notes by such Restricted
              --------------------
Subsidiary and (2) such Restricted Subsidiary waives and will not in any manner
whatsoever claim or take the benefit or advantage of, any rights of
reimbursement, indemnity or subrogation or any other rights against the Company
or any other Restricted Subsidiary as a result of any payment by such Restricted
Subsidiary under its Subsidiary Guarantee; provided that this paragraph shall
not be applicable to any Guarantee of any Restricted Subsidiary (x) that existed
at the time such Person became a Restricted Subsidiary and was not Incurred in
connection with, or in contemplation of, such Person becoming a Restricted
Subsidiary or (y) of the Indebtedness Incurred under the Credit Facility. If the
Guaranteed Indebtedness is (A) pari passu with the Notes, then the Guarantee of
such Guaranteed Indebtedness shall be pari passu with, or subordinated to, the
Subsidiary Guarantee or (B) subordinated to the Notes, then the Guarantee of
such Guaranteed Indebtedness shall be subordinated to the Subsidiary Guarantee
at least to the extent that the Guaranteed Indebtedness is subordinated to the
Notes.

     Notwithstanding the foregoing, any Subsidiary Guarantee by a Restricted
Subsidiary may provide by its terms that it shall be automatically and
unconditionally released and discharged upon (1) any sale, exchange or transfer,
to any Person not an Affiliate of the Company, of all of the Company's and each
Restricted Subsidiary's Capital Stock in, or all or substantially all the assets
of, such Restricted Subsidiary (which sale, exchange or transfer is not
prohibited by this Indenture) or (2) the release or discharge of the Guarantee
which resulted in the creation of such Subsidiary Guarantee, except a discharge
or release by or as a result of payment under such Guarantee.
<PAGE>

                                49

      .8.   Limitation on Transactions with Stockholders and Affiliates. The
      -----------------------------------------------------------------
Company will not, and will not permit any Restricted Subsidiary to, directly or
indirectly, enter into, renew or extend any transaction (including, without
limitation, the purchase, sale, lease or exchange of property or assets, or the
rendering of any service) with any holder (or any Affiliate of such holder) of
5% or more of any class of Capital Stock of the Company or with any Affiliate of
the Company or any Restricted Subsidiary, except upon fair and reasonable terms
no less favorable to the Company or such Restricted Subsidiary than could be
obtained, at the time of such transaction or, if such transaction is pursuant to
a written agreement, at the time of the execution of the agreement providing
therefor, in a comparable arm'slength transaction with a Person that is not such
a holder or Affiliate.

     The foregoing limitation does not limit, and shall not apply to:

          (1) transactions (A) approved by a majority of the disinterested
     members of the Board of Directors or (B) for which the Company or a
     Restricted Subsidiary delivers to the Trustee a written opinion of a
     nationally recognized investment banking firm or a nationally recognized
     firm having expertise in the specific area which is the subject of such
     determination stating that the transaction is fair to the Company or such
     Restricted Subsidiary from a financial point of view;

          (2) any transaction solely between the Company and any of its Wholly
     Owned Restricted Subsidiaries or solely between Wholly Owned Restricted
     Subsidiaries;

          (3) the payment of reasonable and customary regular fees to directors
     of the Company who are not employees of the Company;

          (4) any payments or other transactions pursuant to any taxsharing
     agreement between the Company and any other Person with which the Company
     files a consolidated tax return or with which the Company is part of a
     consolidated group for tax purposes;

          (5) any sale of shares of Capital Stock (other than Disqualified
     Stock) of the Company (or options, warrants or other rights to acquire such
     Capital Stock);

          (6) any Restricted Payments not prohibited by Section 4.04;

          (7) any purchase of Capital Stock of Restricted Subsidiaries approved
     by a majority of the disinterested members of the Board of Directors;
     provided, however, that such purchases shall not be made from (i) WCAS,
     (ii) management of the Company or (iii) family members of management of the
     Company; or

          (8) payments by the Company or any of its Restricted Subsidiaries to
     WCAS pursuant to the terms of the Preferred Share Documents, as they exist
     on the Closing Date, between the Company and WCAS relating to the issuance,
     sale and purchase of the Preferred Shares.
<PAGE>

                                      50

          Notwithstanding the foregoing, any transaction or series of related
transactions covered by the first paragraph of this Section 4.08 and not covered
by clauses (2) through (8) of this paragraph, (a) the aggregate amount of which
exceeds $1.0 million in value, must be approved or determined to be fair in the
manner provided for in clause (1)(A) or (B) above and (b) the aggregate amount
of which exceeds $10.0 million in value, must be determined to be fair in the
manner provided for in clause (1)(B) above.

              .9.   Limitation on Liens.  The Company will not, and will not
              -------------------------
permit any Restricted Subsidiary to, create, incur, assume or suffer to exist
any Lien on any of its assets or properties of any character, or any shares of
Capital Stock or Indebtedness of any Restricted Subsidiary, without making
effective provision for all of the Notes and all other amounts due under this
Indenture to be directly secured equally and ratably with (or, if the obligation
or liability to be secured by such Lien is subordinated in right of payment to
the Notes, prior to) the obligation or liability secured by such Lien.

     The foregoing limitation does not apply to:

          (1) Liens existing on the Closing Date;

          (2) Liens granted after the Closing Date on any assets or Capital
     Stock of the Company or its Restricted Subsidiaries created in favor of the
     Holders;

          (3) Liens with respect to the assets of a Restricted Subsidiary
     granted by such Restricted Subsidiary to the Company or a Wholly Owned
     Restricted Subsidiary to secure Indebtedness owing to the Company or such
     other Restricted Subsidiary;

          (4) Liens securing Indebtedness which is Incurred to refinance secured
     Indebtedness which is permitted to be Incurred under clause (3) of the
     second paragraph of Section 4.03; provided that such Liens do not extend to
     or cover any property or assets of the Company or any Restricted Subsidiary
     other than the property or assets securing the Indebtedness being
     refinanced;

          (5) Liens on any property or assets of a Restricted Subsidiary
     securing Indebtedness of such Restricted Subsidiary permitted under Section
     4.03;

          (6) Permitted Liens; or

          (7) Liens securing obligations under the Credit Facility.

              .10.   Limitation on SaleLeaseback Transactions.  The Company
              -----------------------------------------------
will not, and will not permit any Restricted Subsidiary to, enter into any
saleleaseback transaction involving any of its assets or properties whether now
owned or hereafter acquired, whereby the Company or a Restricted Subsidiary
sells or transfers such assets or properties and then or thereafter leases such
assets or properties or any part thereof or any other assets or properties which
the Company or such Restricted Subsidiary, as the case may be, intends to use
for substantially the same purpose or purposes as the assets or properties sold
or transferred.
<PAGE>

                                      51

     The foregoing restriction does not apply to any saleleaseback transaction
if (1) the lease is for a period, including renewal rights, of not in excess of
three years; (2) the lease secures or relates to industrial revenue or pollution
control bonds; (3) the transaction is solely between the Company and any Wholly
Owned Restricted Subsidiary or solely between Wholly Owned Restricted
Subsidiaries; or (4) the Company or such Restricted Subsidiary, within 12 months
after the sale or transfer of any assets or properties is completed, applies an
amount not less than the net proceeds received from such sale in accordance with
clauses (1)(A) or (1)(B) of Section 4.11.

          .11.   Limitation on Asset Sales.  The Company will not, and will
          --------------------------------
not permit any Restricted Subsidiary to, consummate any Asset Sale, unless (1)
the consideration received by the Company or such Restricted Subsidiary is at
least equal to the fair market value of the assets sold or disposed of and (2)
at least 75.0% of the consideration received consists of cash or Temporary Cash
Investments or the assumption of Indebtedness of the Company or any Restricted
Subsidiary (other than Indebtedness to the Company or any Restricted
Subsidiary), provided that the Company or such Restricted Subsidiary is
irrevocably and unconditionally released from all liability under such
Indebtedness.

     In the event and to the extent that the Net Cash Proceeds received by the
Company or any of its Restricted Subsidiaries from one or more Asset Sales
occurring on or after the Closing Date in any period of 12 consecutive months
exceed 10% of Adjusted Consolidated Net Tangible Assets (determined as of the
date closest to the commencement of such 12month period for which a
consolidated balance sheet of the Company and its Subsidiaries has been filed
with the Commission or provided to the Trustee), then the Company shall or shall
cause the relevant Restricted Subsidiary to:

          (1) within twelve months after the date Net Cash Proceeds so received
     exceed 10% of Adjusted Consolidated Net Tangible Assets

               (B) apply an amount equal to such excess Net Cash Proceeds to
          permanently repay unsubordinated Indebtedness of the Company or any
          Restricted Subsidiary providing a Subsidiary Guarantee pursuant to
          Section 4.07 or Indebtedness of any other Restricted Subsidiary, in
          each case owing to a Person other than the Company or any of its
          Restricted Subsidiaries or

               (C) invest an equal amount, or the amount not so applied pursuant
          to clause (A) (or enter into a definitive agreement committing so to
          invest within 12 months after the date of such agreement), in property
          or assets (other than current assets) of a nature or type or that are
          used in a business (or in a company having property and assets of a
          nature or type, or engaged in a business) similar or related to the
          nature or type of the property and assets of, or the business of, the
          Company and its Restricted Subsidiaries existing on the date of such
          investment and
<PAGE>

                                  52

               (1) apply (no later than the end of the 12month period referred
     to in clause (1)) such excess Net Cash Proceeds (to the extent not applied
     pursuant to clause (1)) as provided in the following paragraph of this
     Section 4.11.

     The amount of such excess Net Cash Proceeds required to be applied (or to
be committed to be applied) during such 12month period as set forth in clause
(1) of the preceding sentence and not applied as so required by the end of such
period shall constitute "Excess Proceeds."

     If, as of the first day of any calendar month, the aggregate amount of
Excess Proceeds not theretofore subject to an Offer to Purchase pursuant to this
Section 4.11 totals at least $10.0 million, the Company must commence, not later
than the fifteenth Business Day of such month, and consummate an Offer to
Purchase from the Holders (and if required by the terms of any Indebtedness that
is pari passu with the Notes ("Pari Passu Indebtedness"), from the holders of
                               -----------------------
such Pari Passu Indebtedness) on a pro rata basis an aggregate principal amount
of Notes (and Pari Passu Indebtedness) equal to the Excess Proceeds on such
date, at a purchase price equal to 100% of the principal amount thereof, plus,
in each case, accrued interest (if any) to the Payment Date.

     Notwithstanding anything herein to the contrary, the Company shall not, and
shall not permit its Restricted Subsidiaries to engage in any Asset Sale with
respect to licenses or plant, property and equipment used primarily by the
Company or its Restricted Subsidiaries to provide PCS and having a fair market
value in the aggregate in excess of $200.0 million.

               .12.   Repurchase of Notes upon a Change of Control. The Company
               ---------------------------------------------------
shall commence, within 30 days of the occurrence of a Change of Control, and
consummate an Offer to Purchase for all Notes then outstanding, at a purchase
price equal to 101% of the principal amount thereof, plus accrued interest, if
any, to the Payment Date.

               .13.   Existence.  Subject to Articles Four and Five of this
               ----------------
Indenture, the Company will do or cause to be done all things necessary to
preserve and keep in full force and effect its existence and the existence of
each of its Restricted Subsidiaries in accordance with the respective
organizational documents of the Company and each Restricted Subsidiary and the
rights (whether pursuant to charter, partnership certificate, agreement, statute
or otherwise), licenses and franchises of the Company and each Restricted
Subsidiary; provided that the Company shall not be required to preserve any such
right, license or franchise, or the existence of any Restricted Subsidiary, if
the maintenance or preservation thereof is no longer desirable in the conduct of
the business of the Company and its Restricted Subsidiaries taken as a whole.

               .14.   Payment of Taxes and Other Claims.  The Company will pay
               ----------------------------------------
or discharge and shall cause each of its Subsidiaries to pay or discharge, or
cause to be paid or discharged, before the same shall become delinquent (i) all
material taxes, assessments and governmental charges levied or imposed upon (a)
the Company or any such Subsidiary, (b) the income or profits of any such
Subsidiary which is a corporation or (c) the property of the Company or any such
Subsidiary and (ii) all material lawful claims for labor, materials and supplies
that, if unpaid, might by law become a lien upon the property of the Company or
any such Subsidiary; provided that the Company shall not be required to pay or
discharge, or cause to be paid or
<PAGE>

                                      53

discharged, any such tax, assessment, charge or claim the amount, applicability
or validity of which is being contested in good faith by appropriate
proceedings and for which adequate reserves have been established.

               .15.   Maintenance of Properties and Insurance. The Company will
               ----------------------------------------------
cause all properties used or useful in the conduct of its business or the
business of any of its Restricted Subsidiaries to be maintained and kept in good
condition, repair and working order and supplied with all necessary equipment
and will cause to be made all necessary repairs, renewals, replacements,
betterments and improvements thereof, all as in the judgment of the Company may
be necessary so that the business carried on in connection therewith may be
properly and advantageously conducted at all times; provided that nothing in
this Section 4.15 shall prevent the Company or any Restricted Subsidiary from
discontinuing the use, operation or maintenance of any of such properties or
disposing of any of them, if such discontinuance or disposal is, in the judgment
of the Company, desirable in the conduct of the business of the Company or such
Restricted Subsidiary.

     The Company will provide or cause to be provided, for itself and its
Restricted Subsidiaries, insurance (including appropriate selfinsurance)
against loss or damage of the kinds customarily insured against by corporations
similarly situated and owning like properties, including, but not limited to,
products liability insurance and public liability insurance, with reputable
insurers or with the government of the United States of America, or an agency or
instrumentality thereof, in such amounts, with such deductibles and by such
methods as shall be customary for corporations similarly situated in the
industry in which the Company or any such Restricted Subsidiary, as the case may
be, is then conducting business.

               .16.   Notice of Defaults. In the event that any Officer becomes
               -------------------------
aware of any Default or Event of Default, the Company shall promptly deliver to
the Trustee an Officers' Certificate specifying such Default or Event of
Default.

               .17.   Compliance Certificates. (a) The Company shall deliver to
               ------------------------------
the Trustee, within 45 days after the end of each fiscal quarter (90 days after
the end of the last fiscal quarter of each year), an Officers' Certificate
stating whether or not the signers know of any Default or Event of Default that
occurred during such fiscal quarter. In the case of the Officers' Certificate
delivered within 90 days after the end of the Company's fiscal year, such
certificate shall contain a certification from the principal executive officer,
principal financial officer or principal accounting officer of the Company that
a review has been conducted of the activities of the Company and its Restricted
Subsidiaries and the Company's and its Restricted Subsidiaries' performance
under this Indenture and that the Company has complied with all conditions and
covenants under this Indenture. For purposes of this Section 4.17, such
compliance shall be determined without regard to any period of grace or
requirement of notice provided under this Indenture. If any of the officers of
the Company signing such certificate has knowledge of such a Default or Event of
Default, the certificate shall describe any such Default or Event of Default and
its status. The first certificate to be delivered pursuant to this Section
4.17(a) shall be for the first fiscal quarter beginning after the execution of
this Indenture.
<PAGE>

                                      54

     (b) The Company shall deliver to the Trustee, within 90 days after the end
of each fiscal year, beginning with the fiscal year in which this Indenture was
executed, a certificate signed by the Company's independent certified public
accountants stating (i) that their audit examination has included a review of
the terms of this Indenture and the Notes as they relate to accounting matters,
(ii) that they have read the most recent Officers' Certificate delivered to the
Trustee pursuant to paragraph (a) of this Section 4.17 and (iii) whether, in
connection with their audit examination, anything came to their attention that
caused them to believe that the Company was not in compliance with any of the
terms, covenants, provisions or conditions of Article Four and Section 5.01 of
this Indenture as they pertain to accounting matters and, if any Default or
Event of Default has come to their attention, specifying the nature and period
of existence thereof; provided that such independent certified public
accountants shall not be liable in respect of such statement by reason of any
failure to obtain knowledge of any such Default or Event of Default that would
not be disclosed in the course of an audit examination conducted in accordance
with generally accepted auditing standards in effect at the date of such
examination.

               .18.   Commission Reports and Reports to Holders. Whether or not
               ------------------------------------------------
the Company is then required to file reports with the Commission, the Company
shall file with the Commission all such reports and other information as it
would be required to file with the Commission by Sections 13(a) or 15(d) under
the Exchange Act if it were subject thereto. The Company shall supply the
Trustee and each Holder or shall supply to the Trustee for forwarding to each
such Holder, without cost to such Holder, copies of such reports and other
information within 15 days after the date it would have been required to file
such reports or other information with the Commission had it been subject to
such Sections. The Company also shall comply with the other provisions of TIA
Section 314(a).

     Delivery of such reports, information and documents to the Trustee is for
informational purposes only and the Trustee's receipt of such shall not
constitute constructive notice of any information contained therein or
determinable from information contained therein, including the Company's
compliance with any of its covenants hereunder (as to which the Trustee is
entitled to rely exclusively on Officers' Certificates).

               .19.   Waiver of Stay, Extension or Usury Laws. The Company
               ----------------------------------------------
covenants (to the extent that it may lawfully do so) that it will not at any
time insist upon, or plead, or in any manner whatsoever claim or take the
benefit or advantage of, any stay or extension law or any usury law or other law
that would prohibit or forgive the Company from paying all or any portion of the
principal of, premium, if any, or interest on the Notes as contemplated herein,
wherever enacted, now or at any time hereafter in force, or that may affect the
covenants or the performance of this Indenture; and (to the extent that it may
lawfully do so) the Company hereby expressly waives all benefit or advantage of
any such law and covenants that it will not hinder, delay or impede the
execution of any power herein granted to the Trustee, but will suffer and permit
the execution of every such power as though no such law had been enacted.

               .20.   Calculation of Original Issue Discount. The Company shall
               ----------------------------------------------
file with the Trustee promptly at the end of each calendar year (i) a written
notice specifying the amount of original issue discount (including daily rates
and accrual periods) accrued on outstanding Notes
<PAGE>

                                      55

as of the end of such year and (ii) such other specific information relating to
such original issue discount as may then be relevant under the Internal Revenue
Code of 1986, as amended from time to time.

                                 ARTICLE FIVE
                             SUCCESSOR CORPORATION

               .1.   When Company May Merge, Etc. The Company will not
               ---------------------------------
consolidate with, merge with or into, or sell, convey, transfer, lease or
otherwise dispose of all or substantially all of its property and assets (as an
entirety or substantially an entirety in one transaction or a series of related
transactions) to, any Person or permit any Person to merge with or into the
Company unless:

               (1) the Company shall be the continuing Person, or the Person (if
     other than the Company) formed by such consolidation or into which the
     Company is merged or that acquired or leased such property and assets of
     the Company shall be a corporation organized and validly existing under the
     laws of the United States of America or any jurisdiction thereof and shall
     expressly assume, by a supplemental indenture, executed and delivered to
     the Trustee, all of the obligations of the Company on all of the Notes and
     under this Indenture;

               (2) immediately after giving effect to such transaction, no
     Default or Event of Default shall have occurred and be continuing;

               (3) immediately after giving effect to such transaction on a pro
     forma basis the Company, or any Person becoming the successor obligor of
     the Notes, as the case may be, could Incur at least $1.00 of Indebtedness
     under the first paragraph of Section 4.03; provided that this clause (3)
     shall not apply to a consolidation, merger or sale of all (but not less
     than all) of the assets of the Company if all Liens and Indebtedness of the
     Company or any Person becoming the successor obligor on the Notes, as the
     case may be, and its Restricted Subsidiaries outstanding immediately after
     such transaction would have been permitted (and all such Liens and
     Indebtedness, other than Liens and Indebtedness of the Company and its
     Restricted Subsidiaries outstanding immediately prior to the transaction,
     shall be deemed to have been Incurred) for all purposes of this Indenture;
     and

               (4) the Company delivers to the Trustee an Officers' Certificate
     (attaching the arithmetic computations to demonstrate compliance with
     clause (3)) and Opinion of Counsel, in each case stating that such
     consolidation, merger or transfer and such supplemental indenture complies
     with this provision and that all conditions precedent provided for herein
     relating to such transaction have been complied with;

provided, however, that clauses (3) and (4) above do not apply if, in the good
faith determination of the Board of Directors of the Company, whose
determination shall be evidenced by a Board Resolution, the principal purpose of
such transaction is to change the state of incorporation of the Company and any
such transaction shall not have as one of its purposes the evasion of the
foregoing limitations.
<PAGE>

                                      56

       .2.   Successor Substituted.  Upon any consolidation or merger, or any
       ---------------------------
 sale, conveyance, transfer, disposition of all or substantially a of the
 property and assets of the Company in accordance with Section 5.01 of this
 Indenture, the successor Person formed by such consolidation or into which the
 Company is merged or to which such sale, conveyance, transfer, lease or other
 disposition is made shall succeed to, and be substituted for, and may exercise
 every right and power of, the Company under this Indenture with the same effect
 as if such successor Person had been named as the Company herein; provided that
 the Company shall not be released from its obligation to pay the principal of,
 premium, if any, or interest on the Notes in the case of a lease of all or
 substantially all of its property and assets.

                                  ARTICLE SIX

                              DEFAULT AND REMEDIES

       .1.   Events of Default.  Any of the following events shall constitute an
       -----------------------
  "Event of Default" hereunder:

       (a)     default in the payment of principal of (or premium, if any, on)
any Note when the same becomes due and payable at maturity, upon acceleration,
redemption or otherwise;

       (b)     default in the payment of interest on any Note when the same
becomes due and payable, and such default continues for a period of 30 days;
provided that a failure to make any of the first four scheduled interest
payments on the Notes in a timely manner will constitute an Event of Default
with no grace or cure period;

       (c)     default in the performance or breach of the provisions of this
Indenture applicable to mergers, consolidations and transfers of all or
substantially all of the assets of the Company or the failure to make or
consummate an Offer to Purchase in accordance with Sections 4.11 and 4.12;

       (d)     the Company defaults in the performance of or breaches any other
covenant or agreement of the Company in this Indenture or under the Notes (other
than a default specified in clause (a), (b) or (c) above) and such default or
breach continues for a period of 30 consecutive days after written notice by the
Trustee or the Holders of 25% or more in aggregate principal amount of the
Notes;

       (e)     there occurs with respect to any issue or issues of Indebtedness
of the Company or any Significant Subsidiary having an outstanding principal
amount of $10.0 million or more in the aggregate for all such issues of all such
Persons, whether such Indebtedness now exists or shall hereafter be created, (I)
an event of default that has caused the holder thereof to declare such
Indebtedness to be due and payable prior to its Stated Maturity and such
Indebtedness has not been discharged in full or such acceleration has not been
rescinded or annulled within 30 days of such acceleration and/or (II) the
failure to make a principal payment at the final (but not any interim) fixed
maturity and such defaulted
<PAGE>

                                      57

payment shall not have been made, waived or extended within 30 days of such
payment default;

       (f)   any final judgment or order (not covered by insurance) for the
payment of money in excess of $10.0 million in the aggregate for all such final
judgments or orders against all such Persons (treating any deductibles, self
insurance or retention as not so covered) shall be rendered against the Company
or any Significant Subsidiary and shall not be paid or discharged, and there
shall be any period of 30 consecutive days following entry of the final judgment
or order that causes the aggregate amount for all such final judgments or orders
outstanding and not paid or discharged against all such Persons to exceed $10.0
million during which a stay of enforcement of such final judgment or order, by
reason of a pending appeal or otherwise, shall not be in effect;

       (g)   a court having jurisdiction in the premises enters a decree or
order for (A) relief in respect of the Company or any Significant Subsidiary in
an involuntary case under any applicable bankruptcy, insolvency or other similar
law now or hereafter in effect, (B) appointment of a receiver, liquidator,
assignee, custodian, trustee, sequestrator or similar official of the Company or
any Significant Subsidiary or for all or substantially all of the property and
assets of the Company or any Significant Subsidiary or (C) the winding up or
liquidation of the affairs of the Company or any Significant Subsidiary and, in
each case, such decree or order shall remain unstayed and in effect for a period
of 30 consecutive days;

       (h)   the Company or any Significant Subsidiary (A) commences a voluntary
case under any applicable bankruptcy, insolvency or other similar law now or
hereafter in effect, or consents to the entry of an order for relief in an
involuntary case under any such law, (B) consents to the appointment of or
taking possession by a receiver, liquidator, assignee, custodian, trustee,
sequestrator or similar official of the Company or any Significant Subsidiary or
for all or substantially all of the property and assets of the Company or any
Significant Subsidiary or (C) effects any general assignment for the benefit of
creditors; or

       (i)   the Escrow Agreement shall cease to be in full force and effect or
enforceable in accordance with its terms, other than in accordance with its
terms.

       .2.  Acceleration. If an Event of Default (other than an Event of Default
       -----------------
specified in clause (g) or (h) of Section 6.01 that occurs with respect to the
Company) occurs and is continuing under this Indenture, the Trustee or the
Holders of at least 25% in aggregate principal amount of the Notes then
outstanding, by written notice to the Company (and to the Trustee if such notice
is given by the Holders), may, and the Trustee at the request of such Holders
shall, declare the principal of, premium, if any, and accrued interest on the
Notes to be immediately due and payable. Upon a declaration of acceleration,
such principal, premium, if any, and accrued interest shall be immediately due
and payable. In the event of a declaration of
<PAGE>

                                      58

acceleration because an Event of Default set forth in clause (e) of Section 6.01
has occurred and is continuing, such declaration of acceleration shall be
automatically rescinded and annulled if the event of default triggering such
Event of Default pursuant to clause (e) shall be remedied or cured by the
Company or the relevant Significant Subsidiary or waived by the holders of the
relevant Indebtedness within 60 days after the declaration of acceleration with
respect thereto. If an Event of Default specified in clause (g) or (h) of
Section 6.01 occurs with respect to the Company, the principal of, premium, if
any, and accrued interest on the Notes then outstanding shall ipso facto become
and be immediately due and payable without any declaration or other act on the
part of the Trustee or any Holder.

       At any time after such declaration of acceleration, but before a judgment
or decree for the payment of the money due has been obtained by the Trustee, the
Holders of at least a majority in principal amount of the outstanding Notes by
written notice to the Company and to the Trustee, may waive all past Defaults
and rescind and annul a declaration of acceleration and its consequences if (a)
the Company has paid or deposited with the Trustee a sum sufficient to pay (i)
all sums paid or advanced by the Trustee hereunder and the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents
and counsel, (ii) all overdue interest on all Notes, (iii) the principal of and
premium, if any, on any Notes that have become due otherwise than by such
declaration or occurrence of acceleration and interest thereon at the rate
prescribed therefor by such Notes, and (iv) to the extent that payment of such
interest is lawful, interest upon overdue interest, if any, at the rate
prescribed therefor by such Notes, (b) all existing Events of Default, other
than the nonpayment of the principal of, premium, if any, and accrued interest
on the Notes that have become due solely by such declaration of acceleration,
have been cured or waived and (c) the rescission would not conflict with any
judgment or decree of a court of competent jurisdiction.

             .3.  Other Remedies.  If an Event of Default occurs and is
             -------------------
 continuing, the Trustee may, and at the direction of the Holders of at least a
 majority in principal amount of the outstanding Notes shall, pursue any
 available remedy by proceeding at law or in equity to collect the payment of
 principal of, premium, if any, or interest on the Notes or to enforce the
 performance of any provision of the Notes or this Indenture.

     The Trustee may maintain a proceeding even if it does not possess any of
the Notes or does not produce any of them in the proceeding.

             .4.  Waiver of Past Defaults.  Subject to Sections 6.02, 6.07 and
             ----------------------------
9.02, the Holders of at least a majority in principal amount of the outstanding
Notes, by notice to the Trustee, may waive an existing Default or Event of
Default and its consequences, except a Default in the payment of principal of,
premium, if any, or interest on any Note as specified in clause (a) or (b) of
Section 6.01 or in respect of a covenant or provision of this Indenture which
cannot be modified or amended without the consent of the Holder of each
outstanding Note affected. Upon any such waiver, such Default shall cease to
exist, and any Event of Default arising therefrom shall be deemed to have been
cured, for every purpose of this Indenture; but no such waiver shall extend to
any subsequent or other Default or Event of Default or impair any right
consequent thereto.
<PAGE>

                                      59

             .5.   Control by Majority.  The Holders of at least a majority in
             ------------------------
aggregate principal amount of the outstanding Notes may direct the time, method
and place of conducting any proceeding for any remedy available to the Trustee
or exercising any trust or power conferred on the Trustee; provided that the
Trustee may refuse to follow any direction that conflicts with law or this
Indenture, that may involve the Trustee in personal liability, or that the
Trustee determines in good faith may be unduly prejudicial to the rights of
Holders of Notes not joining in the giving of such direction; and provided
further that the Trustee may take any other action it deems proper that is not
inconsistent with any such direction received from Holders of Notes.

             .6.   Limitation on Suits.  A Holder may not institute any
             -------------------------
proceeding, judicial or otherwise, with respect to this Indenture or the Notes,
or for the appointment of a receiver or trustee, or for any other remedy
hereunder, unless:

             (i)   the Holder has previously given the Trustee written notice of
     a continuing Event of Default;

             (ii)  the Holders of at least 25% in aggregate principal amount of
     outstanding Notes shall have made a written request to the Trustee to
     pursue such remedy;

             (iii) such Holder or Holders offer the Trustee indemnity reasonably
     satisfactory to the Trustee against any costs, liability or expense;

             (iv)  the Trustee does not comply with the request within 60 days
     after receipt of the request and the offer of indemnity; and

             (v)   during such 60day period, the Holders of a majority in
     aggregate principal amount of the outstanding Notes do not give the Trustee
     a direction that is inconsistent with the request.

     For purposes of Section 6.05 of this Indenture and this Section 6.06, the
Trustee shall comply with TIA Section 316(a) in making any determination of
whether the Holders of the required aggregate principal amount of outstanding
Notes have concurred in any request or direction of the Trustee to pursue any
remedy available to the Trustee or the Holders with respect to this Indenture or
the Notes or otherwise under the law.

     A Holder may not use this Indenture to prejudice the rights of another
Holder or to obtain a preference or priority over such other Holder.

             .7.   Rights of Holders to Receive Payment.  Notwithstanding any
             ------------------------------------------
other provision of this Indenture, the right of any Holder of a Note to receive
payment of the principal of, premium, if any, or interest on, such Note or to
bring suit for the enforcement of any such payment, on after the due date
expressed in the Notes, shall not be impaired or affected without the consent of
such Holder.

             .8.   Collection Suit by Trustee.  If an Event of Default in
             --------------------------------
payment of principal, premium or interest specified in clause (a), (b) or (c) of
Section 6.01 occurs and is continuing, the
<PAGE>

                                      60

Trustee may recover judgment in its own name and as trustee of an express trust
against the Company or any other obligor of the Notes for the whole amount of
principal, premium, if any, and accrued interest remaining unpaid, together with
interest on overdue principal, premium, if any, and, to the extent that payment
of such interest is lawful, interest on overdue installments of interest, in
each case at the rate specified in the Notes, and such further amount as shall
be sufficient to cover the costs and expenses of collection, including the
reasonable compensation, expenses, disbursements and advances of the Trustee,
its agents and counsel.

             .9.   Trustee May File Proofs of Claim.  The Trustee may file such
             --------------------------------------
proofs of claim and other papers or documents as may be necessary or advisable
in order to have the claims of the Trustee (including any claim for the
reasonable compensation, expenses, disbursements and advances of the Trustee,
its agents and counsel, and any other amounts due the Trustee under Section
7.07) and the Holders allowed in any judicial proceedings relative to the
Company (or any other obligor of the Notes), its creditors or its property and
shall be entitled and empowered to collect and receive any monies, securities or
other property payable or deliverable upon conversion or exchange of the Notes
or upon any such claims and to distribute the same, and any custodian, receiver,
assignee, trustee, liquidator, sequestrator or other similar official in any
such judicial proceeding is hereby authorized by each Holder to make such
payments to the Trustee and, in the event that the Trustee shall consent to the
making of such payments directly to the Holders, to pay to the Trustee any
amount due to it for the reasonable compensation, expenses, disbursements and
advances of the Trustee, its agents and counsel, and any other amounts due the
Trustee under Section 7.07. Nothing herein contained shall be deemed to empower
the Trustee to authorize or consent to, or accept or adopt on behalf of any
Holder, any plan of reorganization, arrangement, adjustment or composition
affecting the Notes or the rights of any Holder thereof, or to authorize the
Trustee to vote in respect of the claim of any Holder in any such proceeding.

             .10.  Priorities.  If the Trustee collects any money pursuant to
             -----------------
this Article Six, it shall pay out the money in the following order:

          First:   to the Trustee for all amounts due under Section 7.07;

          Second:  to Holders for amounts then due and unpaid for principal of,
     premium, if any, and interest on the Notes in respect of which or for the
     benefit of which such money has been collected, ratably, without preference
     or priority of any kind, according to the amounts due and payable on such
     Notes for principal, premium, if any, and interest, respectively; and

          Third:   to the Company or any other obligors of the Notes, as their
     interests may appear, or as a court of competent jurisdiction may direct.

          The Trustee, upon prior written notice to the Company, may fix a
record date and payment date for any payment to Holders pursuant to this Section
6.10.

             .11.  Undertaking for Costs.  In any suit for the enforcement of
             ----------------------------
any right or remedy under this Indenture or in any suit against the
Trustee for any action taken or omitted by
<PAGE>

                                      61

it as Trustee, a court may require any party litigant in such suit to file an
undertaking to pay the costs of the suit, and the court may assess reasonable
costs, including reasonable attorneys' fees and expenses, against any party
litigant in the suit having due regard to the merits and good faith of the
claims or defenses made by the party litigant. This Section 6.11 does not apply
to a suit by the Trustee, a suit by a Holder pursuant to Section 6.07, or a suit
by Holders of more than 10% in principal amount of the outstanding Notes.

             .12.   Restoration of Rights and Remedies. If the Trustee or any
             -----------------------------------------
Holder has instituted any proceeding to enforce any right or remedy under this
Indenture and such proceeding has been discontinued or abandoned for any reason,
or has been determined adversely to the Trustee or to such Holder, then, and in
every such case, subject to any determination in such proceeding, the Company,
the Trustee and the Holders shall be restored severally and respectively to
their former positions hereunder and thereafter all rights and remedies of the
Company, Trustee and the Holders shall continue as though no such proceeding had
been instituted.

             .13.   Rights and Remedies Cumulative. Except as otherwise provided
             -------------------------------------
with respect to the replacement or payment of mutilated, destroyed, lost or
wrongfully taken Notes in Section 2.09, no right or remedy herein conferred upon
or reserved to the Trustee or to the Holders is intended to be exclusive of any
other right or remedy, and every right and remedy shall, to the extent permitted
by law, be cumulative and in addition to every other right and remedy given
hereunder or now or hereafter existing at law or in equity or otherwise. The
assertion or employment of any right or remedy hereunder, or otherwise, shall
not prevent the concurrent assertion or employment of any other appropriate
right or remedy.

             .14.   Delay or Omission Not Waiver.  No delay or omission of the
             -----------------------------------
Trustee or of any Holder to exercise any right or remedy accruing upon any Event
of Default shall impair any such right or remedy or constitute a waiver of any
such Event of Default or an acquiescence therein. Every right and remedy given
by this Article Six or by law to the Trustee or to the Holders may be exercised
from time to time, and as often as may be deemed expedient, by the Trustee or by
the Holders, as the case may be.

                                 ARTICLE SEVEN
                                    TRUSTEE

             .1.   General. The duties and responsibilities of the Trustee shall
             -------------
be as provided by the TIA and as set forth herein. Notwithstanding the
foregoing, no provision of this Indenture shall require the Trustee to expend or
risk its own funds or otherwise incur any financial liability in the performance
of any of its duties hereunder, or in the exercise of any of its rights or
powers, if it shall have reasonable grounds for believing that repayment of such
funds or adequate indemnity or security against such risk or liability is not
reasonably assured to it. Whether or not herein expressly so provided, every
provision of this Indenture relating to the conduct or affecting the liability
of or affording protection to the Trustee shall be subject to the provisions of
this Article Seven.
<PAGE>

                                      62

             .2.   Certain Rights of Trustee.  Subject to TIA Sections 315(a)
             -------------------------------
 through (d):

             (i)  the Trustee may conclusively rely, and shall be protected in
 acting or refraining from acting, upon any resolution, certificate, statement,
 instrument, opinion, report, notice, request, direction, consent, order, bond,
 debenture, note, other evidence of indebtedness or other paper or document
 reasonably believed by it to be genuine and to have been signed or presented by
 the proper person;

             (ii) before the Trustee acts or refrains from acting, it may
 require an Officers' Certificate or an Opinion of Counsel, which shall conform
 to Section 10.04. The Trustee shall not be liable for any reasonable action it
 takes or omits to take in good faith in reliance on such certificate or
 opinion;

             (iii) the Trustee may act through its attorneys and agents and
 shall not be responsible for the misconduct or negligence of any attorney or
 agent appointed with due care by it hereunder;

             (iv)  the Trustee shall be under no obligation to exercise any of
 the rights or powers vested in it by this Indenture at the request or direction
 of any of the Holders, unless such Holders shall have offered to the Trustee
 security or indemnity reasonably satisfactory to it against the costs, expenses
 and liabilities that might be incurred by it in compliance with such request or
 direction;

             (v)   the Trustee shall not be liable for any reasonable action it
 takes or omits to take in good faith that it believes to be authorized or
 within its rights or powers, provided that the Trustee's conduct does not
 constitute negligence or bad faith;

             (vi)  whenever in the administration of this Indenture the Trustee
shall deem it desirable that a matter be proved or established prior to taking,
suffering or omitting any action hereunder, the Trustee (unless other evidence
be herein specifically prescribed) may, in the absence of bad faith on its part,
conclusively rely upon an Officers' Certificate;

             (vii)  the Trustee shall not be bound to make any investigation
into the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, report, notice, request, direction, consent, order, bond,
debenture, note, other evidence of indebtedness or other paper or document, but
the Trustee, in its discretion, may make such further inquiry or investigation
into such facts or matters as it may see fit, and, if the Trustee shall
determine to make such further inquiry or investigation, it shall be entitled to
examine the books, records and premises of the Company personally or by agent or
attorney;

             (viii) The Trustee may consult with counsel of its selection and
the advice of such counsel or any Opinion of Counsel shall be full and complete
authorization and protection in respect of any action taken, suffered or omitted
by it hereunder in good faith and in reliance thereon;
<PAGE>

                                      63

            (ix)  the Trustee shall not be deemed to have notice of any Default
     or Event of Default unless a Responsible Officer of the Trustee has actual
     knowledge thereof or unless written notice of any event which is in fact
     such a default is received by the Trustee at the Corporate Trust Office of
     the Trustee, and such notice references the Notes and this Indenture;

             (x)  the rights, privileges, protections, immunities and benefits
     given to the Trustee, including, without limitation, its right to be
     indemnified, are extended to, and shall be enforceable by, the Trustee in
     each of its capacities hereunder, and to each agent, custodian and other
     Person employed to act hereunder; and

             (xi) the Trustee may request that the Company deliver an Officers'
     Certificate setting forth the names of individuals and/or titles of
     officers authorized at such time to take specified actions pursuant to this
     Indenture, which Officers' Certificate may be signed by any person
     authorized to sign an Officers' Certificate, including any person specified
     as so authorized in any such certificate previously delivered and not
     superseded.

             .3.   Individual Rights of Trustee.  The Trustee, in its individual
             ----------------------------------
or any other capacity, may become the owner or pledgee of Notes and may
otherwise deal with the Company or its Affiliates with the same rights it would
have if it were not the Trustee. Any Agent may do the same with like rights.
However, the Trustee is subject to TIA Sections 310(b) and 311.

             .4.   Trustee's Disclaimer. The Trustee (i) makes no representation
             --------------------------
as to the validity or adequacy of this Indenture or the Notes, (ii) shall not be
accountable for the Company's use or application of the proceeds from the Notes
and (iii) shall not be responsible for any statement in the Notes other than its
certificate of authentication.

             .5.   Notice of Default. If any Default or any Event of Default
             -----------------------
occurs and is continuing and if such Default or Event of Default is known to the
Trustee, the Trustee shall mail to each Holder in the manner and to the extent
provided in TIA Section 313(c) notice of the Default or Event of Default within
45 days after it occurs, unless such Default or Event of Default has been cured;
provided, however, that, except in the case of a default in the payment of the
principal of, premium, if any, or interest on any Note, the Trustee shall be
protected in withholding such notice if and so long as the board of directors,
the executive committee or a trust committee of directors and/or Responsible
Officers of the Trustee in good faith determine that the withholding of such
notice is in the interest of the Holders.

             .6.   Reports by Trustee to Holders. Within 60 days after each May
             -----------------------------------
15, beginning with May 15, 2001 the Trustee shall mail to each Holder as
provided in TIA Section 313(c) a brief report dated as of such May 15, if
required by TIA Section 313(a).

     A copy of each report at the time of its mailing to the Holders of
Securities shall be mailed to the Company and filed with the Commission and each
stock exchange on which the Securities are listed in accordance with TIA Section
313(d).  The Company shall promptly notify the Trustee when the Notes are listed
on any stock exchange or of any delisting thereof.
<PAGE>

                                      64

             .7.   Compensation and Indemnity. The Company shall pay to the
             --------------------------------
Trustee such compensation as shall be agreed upon in writing for its services
hereunder. The compensation of the Trustee shall not be limited by any law on
compensation of a trustee of an express trust. The Company shall reimburse the
Trustee upon request for all reasonable disbursements, expenses and advances
incurred or made by the Trustee without negligence or bad faith on its part.
Such expenses shall include the reasonable compensation and expenses of the
Trustee's agents and counsel.

     The Company shall indemnify each of the Trustee or any predecessor Trustee
and their agents for, and hold them harmless against, any and all loss or
liability or expense or damage or claim incurred by them without negligence or
bad faith on its part in connection with the acceptance or administration of
this Indenture and its duties under this Indenture and the Notes, including the
costs and expenses (including taxes other than taxes based upon, measured by or
determined by the income of the Trustee) of defending itself against any claim
or liability whether asserted by the Company, a Holder, or any other Person, and
of complying with any process served upon it or any of its officers in
connection with the exercise or performance of any of its powers or duties under
this Indenture and the Notes.  The Trustee shall notify the Company promptly of
any claim for which it may seek indemnity.  Failure by the Trustee to so notify
the Company shall not relieve the Company of its obligations hereunder, unless
the Company is materially prejudiced thereby.  The Company shall defend the
claim and the Trustee shall cooperate in the defense.  Unless otherwise set
forth herein, the Trustee may have separate counsel and the Company shall pay
the reasonable fees and expenses of such counsel.  The Company need not pay for
any settlement made without its consent, which consent shall not be unreasonably
withheld.

     To secure the Company's payment obligations in this Section 7.07, the
Trustee shall have a lien prior to the Notes on all money or property held or
collected by the Trustee, in its capacity as Trustee, except money or property
held in trust to pay principal of, premium, if any, and interest on particular
Notes.

     If the Trustee incurs expenses or renders services after the occurrence of
an Event of Default specified in clause (g) or (h) of Section 6.01, the expenses
and the compensation for the services will be intended to constitute expenses of
administration under Title 11 of the United States Bankruptcy Code or any
applicable federal or state law for the relief of debtors.

     The provisions of this Section 7.07 shall survive the termination of this
Indenture and the resignation or removal of the Trustee.

     The Trustee shall comply with the provisions of TIA Section 313(b)(2) to
the extent applicable.

             .8.   Replacement of Trustee. A resignation or removal of the
             ----------------------------
Trustee and appointment of a successor Trustee shall become effective only upon
the successor Trustee's acceptance of appointment as provided in this Section
7.08.
<PAGE>

                                      65

     The Trustee may resign at any time by so notifying the Company in writing
at least 30 days prior to the date of the proposed resignation.  The Holders of
a majority in principal amount of the outstanding Notes may remove the Trustee
by so notifying the Trustee in writing and may appoint a successor Trustee with
the consent of the Company.  The Company may remove the Trustee if:  (i) the
Trustee is no longer eligible under Section 7.10; (ii) the Trustee is adjudged a
bankrupt or an insolvent; (iii) a receiver or other public officer takes charge
of the Trustee or its property; or (iv) the Trustee becomes incapable of acting.

     If the Trustee resigns or is removed, or if a vacancy exists in the office
of Trustee for any reason, the Company shall promptly appoint a successor
Trustee.  Within one year after the successor Trustee takes office, the Holders
of a majority in principal amount of the outstanding Notes may appoint a
successor Trustee to replace the successor Trustee appointed by the Company.  If
the successor Trustee does not deliver its written acceptance required by the
next succeeding paragraph of this Section 7.08 within 30 days after the retiring
Trustee resigns or is removed, the retiring Trustee, the Company or the Holders
of a majority in principal amount of the outstanding Notes may, at the expense
of the Company, petition any court of competent jurisdiction for the appointment
of a successor Trustee.

     A successor Trustee shall deliver a written acceptance of its appointment
to the retiring Trustee and to the Company.  Immediately after the delivery of
such written acceptance, subject to the lien provided in Section 7.07, (i) the
retiring Trustee shall transfer all property held by it as Trustee to the
successor Trustee, (ii) the resignation or removal of the retiring Trustee shall
become effective and (iii) the successor Trustee shall have all the rights,
powers and duties of the Trustee under this Indenture.  A successor Trustee
shall mail notice of its succession to each Holder.  No successor Trustee shall
accept its appointment unless at the time of such acceptance such successor
Trustee shall be qualified and eligible under this Article.

     If the Trustee is no longer eligible under Section 7.10 or shall fail to
comply with TIA Section 310(b), any Holder who satisfies the requirements of TIA
Section 310(b) may petition any court of competent jurisdiction for the removal
of the Trustee and the appointment of a successor Trustee.  If at any time the
Trustee shall cease to be eligible in accordance with the provisions of this
Section 7.08, the Trustee shall resign immediately in the manner and with the
effect provided in this Section.

     The Company shall give notice of any resignation and any removal of the
Trustee and each appointment of a successor Trustee to all Holders.  Each notice
shall include the name of the successor Trustee and the address of its Corporate
Trust Office.

     Notwithstanding replacement of the Trustee pursuant to this Section 7.08,
the Company's obligation under Section 7.07 shall continue for the benefit of
the retiring Trustee.

             .9.   Successor Trustee by Merger, Etc. If the Trustee consolidates
             --------------------------------------
with, merges or converts into, or transfers all or substantially all of its
corporate trust business to, another corporation or national banking
association, the resulting, surviving or transferee corporation or national
banking association without any further act shall be the successor Trustee with
the same
<PAGE>

                                      66

     effect as if the successor Trustee had been named as the Trustee herein,
provided such corporation shall b
e otherwise qualified and eligible under this
Article.

             .10.   Eligibility.  This Indenture shall always have a Trustee who
             ------------------
satisfies the requirements of TIA Section 310(a)(1). The Trustee shall have a
combined capital and surplus of at least $25 million as set forth in its most
recent published annual report of condition that is subject to the requirements
of applicable Federal or state supervising or examining authority. If at any
time the Trustee shall cease to be eligible in accordance with the provisions of
this Section, the Trustee shall resign immediately in the manner and with the
effect specified in this Article.

             .11.   Money Held in Trust.  The Trustee shall not be liable for
             --------------------------
interest on any money received by it except as the Trustee may agree in writing
with the Company. Money held in trust by the Trustee need not be segregated from
other funds except to the extent required by law and except for money held in
trust under Article Eight of this Indenture.

                                 ARTICLE EIGHT
                             DISCHARGE OF INDENTURE

             .1.   Termination of Company's Obligations. Except as otherwise
             ------------------------------------------
 provided in this Section 8.01, the Company may terminate its obligations under
 the Notes and this Indenture if:

             (i) all Notes previously authenticated and delivered (other than
     destroyed, lost or stolen Notes that have been replaced or Notes that are
     paid pursuant to Section 4.01 or Notes for whose payment money or
     securities have theretofore been held in trust and thereafter repaid to the
     Company, as provided in Section 8.05) have been delivered to the Trustee
     for cancellation and the Company has paid all sums payable by it hereunder;
     or

             (ii) (A) the Notes mature within one year or all of them are to be
     called for redemption within one year under arrangements satisfactory to
     the Trustee for giving the notice of redemption, (B) the Company
     irrevocably deposits in trust with the Trustee during such one-year period,
     under the terms of an irrevocable trust agreement in form and substance
     satisfactory to the Trustee, as trust funds solely for the benefit of the
     Holders for that purpose, money or U.S. Government Obligations sufficient
     (in the opinion of a nationally recognized firm of independent public
     accountants expressed in a written certification thereof delivered to the
     Trustee), without consideration of any reinvestment of any interest
     thereon, to pay principal, premium, if, any, and interest on the Notes to
     maturity or redemption, as the case may be, and to pay all other sums
     payable by it hereunder, (C) no Default or Event of Default with respect to
     the Notes shall have occurred and be continuing on the date of such
     deposit, (D) such deposit will not result in a breach or violation of, or
     constitute a default under, this Indenture or any other agreement or
     instrument to which the Company is a party or by which it is bound and (E)
     the Company has delivered to the Trustee an Officers' Certificate and an
     Opinion
<PAGE>

                                      67

     of Counsel, in each case stating that all conditions precedent provided for
     herein relating to the satisfaction and discharge of this Indenture have
     been complied with.

     With respect to the foregoing clause (i), the Company's obligations under
Section 7.07 shall survive. With respect to the foregoing clause (ii), the
Company's obligations in Sections 2.02, 2.03, 2.04, 2.05, 2.06, 2.07, 2.08,
2.09, 2.14, 4.01, 4.02, 7.07, 7.08, 8.04, 8.05 and 8.06 shall survive until the
Notes are no longer outstanding. Thereafter, only the Company's obligations in
Sections 7.07, 8.04, 8.05 and 8.06 shall survive. After any such irrevocable
deposit, the Trustee upon request shall acknowledge in writing the discharge of
the Company's obligations under the Notes and this Indenture except for those
surviving obligations specified above.

          .2.  Defeasance and Discharge of Indenture. The Company will be deemed
          ------------------------------------------
to have paid and will be discharged from any and all obligations in respect of
the Notes on the 123rd day after the date of the deposit referred to in clause
(A) of this Section 8.02, and the provisions of this Indenture will no longer be
in effect with respect to the Notes (except for, among other matters, certain
obligations to register the transfer or exchange of the notes, to replace
stolen, lost or mutilated notes, to maintain paying agencies and to hold monies
for payment in trust), and the Trustee, at the expense of the Company, shall
execute proper instruments acknowledging the same if:

          (A)  with reference to this Section 8.02, the Company has irrevocably
     deposited or caused to be irrevocably deposited with the Trustee (or
     another trustee satisfying the requirements of Section 7.10) and conveyed
     all right, title and interest to the Trustee for the benefit of the
     Holders, under the terms of an irrevocable trust agreement in form and
     substance satisfactory to the Trustee as trust funds in trust, specifically
     pledged to the Trustee for the benefit of the Holders as security for
     payment of the principal of, premium, if any, and interest, if any, on the
     Notes, and dedicated solely to, the benefit of the Holders, in and to (1)
     money in an amount, (2) U.S. Government Obligations that, through the
     payment of interest, premium, if any, and principal in respect thereof in
     accordance with their terms, will provide, not later than one day before
     the due date of any payment referred to in this clause (A), money in an
     amount or (3) a combination thereof in an amount sufficient, in the opinion
     of a nationally recognized firm of independent public accountants expressed
     in a written certification thereof delivered to the Trustee, to pay and
     discharge, without consideration of the reinvestment of such interest and
     after payment of all federal, state and local taxes or other charges and
     assessments in respect thereof payable by the Trustee, the principal of,
     premium, if any, and interest on the outstanding Notes on the Stated
     Maturity of such principal or interest; provided that the Trustee shall
     have been irrevocably instructed to apply such money or the proceeds of
     such U.S. Government Obligations to the payment of such principal, premium,
     if any, and interest with respect to the Notes;

          (B)  the Company has delivered to the Trustee (1) either (x) an
     Opinion of Counsel to the effect that Holders will not recognize income,
     gain or loss for federal income tax purposes as a result of the Company's
     exercise of its option under this
<PAGE>

                                      68

     Section 8.02 and will be subject to federal income tax on the same amount
     and in the same manner and at the same times as would have been the case if
     such option had not been exercised, which Opinion of Counsel must be based
     upon (and accompanied by a copy of) a ruling of the Internal Revenue
     Service to the same effect unless there has been a change in applicable
     federal income tax law after the Closing Date such that a ruling is no
     longer required or (y) a ruling directed to the Trustee received from the
     Internal Revenue Service to the same effect as the aforementioned Opinion
     of Counsel and (2) an Opinion of Counsel to the effect that the creation of
     the defeasance trust does not violate the Investment Company Act of 1940
     and that after the passage of 123 days following the deposit (except, with
     respect to any trust funds for the account of any Holder who may be deemed
     to be an "insider" for purposes of the United States Bankruptcy Code, after
     one year following the deposit), the trust funds will not be subject to the
     effect of Section 547 of the United States Bankruptcy Code or Section 15 of
     the New York Debtor and Creditor Law in a case commenced by or against the
     Company under either such statute, and either (I) the trust funds will no
     longer remain the property of the Company (and therefore will not be
     subject to the effect of any applicable bankruptcy, insolvency,
     reorganization or similar laws affecting creditors' rights generally) or
     (II) if a court were to rule under any such law in any case or proceeding
     that the trust funds remained property of the Company, (a) assuming such
     trust funds remained in the possession of the Trustee prior to such court
     ruling to the extent not paid to the Holders, the Trustee will hold, for
     the benefit of the Holders, a valid and perfected security interest in such
     trust funds that is not avoidable in bankruptcy or otherwise except for the
     effect of Section 552(b) of the United States Bankruptcy Code on interest
     on the trust funds accruing after the commencement of a case under such
     statute and (b) the Holders will be entitled to receive adequate protection
     of their interests in such trust funds if such trust funds are used in such
     case or proceeding;

          (C)  immediately after giving effect to such deposit, on a pro forma
     basis, no Default or Event of Default shall have occurred and be continuing
     on the date of such deposit or during the period ending on the 123rd day
     after such date of such deposit, and such deposit shall not result in a
     breach or violation of, or constitute a default under, this Indenture or
     any other agreement or instrument to which the Company or any of its
     Subsidiaries is a party or by which the Company or any of its Subsidiaries
     is bound;

          (D)  if the Notes are then listed on a national securities exchange,
     the Company has delivered to the Trustee an Opinion of Counsel to the
     effect that the Notes will not be delisted as a result of such deposit,
     defeasance and discharge; and

          (E)  the Company has delivered to the Trustee an Officers' Certificate
     and an Opinion of Counsel, in each case stating that all conditions
     precedent provided for herein relating to the defeasance contemplated by
     this Section 8.02 have been complied with.

     Notwithstanding the foregoing, prior to the end of the 123day (or one year)
period referred to in clause (B)(2) of this Section 8.02, none of the Company's
obligations under this Indenture shall be discharged. Subsequent to the end of
such 123day (or one year) period with
<PAGE>

                                      69

respect to this Section 8.02, the Company's obligations in Sections 2.02, 2.03,
2.04, 2.05, 2.06, 2.07, 2.08, 2.09, 2.14, 4.01, 4.02, 8.04, 8.05, 8.06 and the
rights, powers, trusts, duties and immunities of the Trustee hereunder shall
survive until the Notes are no longer outstanding. Thereafter, only the
Company's obligations in Sections 7.07, 8.04, 8.05 and 8.06 shall survive. If
and when a ruling from the Internal Revenue Service or an Opinion of Counsel
referred to in clause (B)(1) of this Section 8.02 is able to be provided
specifically without regard to, and not in reliance upon, the continuance of the
Company's obligations under Section 4.01, then the Company's obligations under
such Section 4.01 shall cease upon delivery to the Trustee of such ruling or
Opinion of Counsel and compliance with the other conditions precedent provided
for herein relating to the defeasance contemplated by this Section 8.02.

     After any such irrevocable deposit, the Trustee upon request shall
acknowledge in writing the discharge of the Company's obligations under the
Notes and this Indenture except for those surviving obligations in the
immediately preceding paragraph.

          .3.  Defeasance of Certain Obligations. The Company may omit to comply
          --------------------------------------
with any term, provision or condition set forth in clauses (iii) and (iv) of
Section 5.01 and Sections 4.03 through 4.11 and clause (c) of Section 6.01 with
respect to clauses (iii) and (iv) of Section 5.01, clause (d) of Section 6.01
with respect to Sections 4.01, 4.02 and 4.12 through 4.19 and clauses (e) and
(f) of Section 6.01 shall be deemed not to be Events of Default, in each case
with respect to the outstanding Notes if:

          (i)  with reference to this Section 8.03, the Company has irrevocably
     deposited or caused to be irrevocably deposited with the Trustee (or
     another trustee satisfying the requirements of Section 7.10) and conveyed
     all right, title and interest to the Trustee for the benefit of the
     Holders, under the terms of an irrevocable trust agreement in form and
     substance satisfactory to the Trustee as trust funds in trust, specifically
     pledged to the Trustee for the benefit of the Holders as security for
     payment of the principal of, premium, if any, and interest, if any, on the
     Notes, and dedicated solely to, the benefit of the Holders, in and to (A)
     money in an amount, (B) U.S. Government Obligations that, through the
     payment of interest, premium, if any, and principal in respect thereof in
     accordance with their terms, will provide, not later than one day before
     the due date of any payment referred to in this clause (i), money in an
     amount or (C) a combination thereof in an amount sufficient, in the opinion
     of a nationally recognized firm of independent public accountants expressed
     in a written certification thereof delivered to the Trustee, to pay and
     discharge, without consideration of the reinvestment of such interest and
     after payment of all federal, state and local taxes or other charges and
     assessments in respect thereof payable by the Trustee, the principal of,
     premium, if any, and interest on the outstanding Notes on the Stated
     Maturity of such principal or interest; provided that the Trustee shall
     have been irrevocably instructed to apply such money or the proceeds of
     such U.S. Government Obligations to the payment of such principal, premium,
     if any, and interest with respect to the Notes;

          (ii) the Company has delivered to the Trustee an Opinion of Counsel to
     the effect that (A) the creation of the defeasance trust does not violate
     the Investment Company Act
<PAGE>

                                      70

     of 1940, (B) after the passage of 123 days following the deposit (except,
     with respect to any trust funds for the account of any Holder who may be
     deemed to be an "insider" for purposes of the United States Bankruptcy
     Code, after one year following the deposit), the trust funds will not be
     subject to the effect of Section 547 of the United States Bankruptcy Code
     or Section 15 of the New York Debtor and Creditor Law in a case commenced
     by or against the Company under either such statute, and either (1) the
     trust funds will no longer remain the property of the Company (and
     therefore will not be subject to the effect of any applicable bankruptcy,
     insolvency, reorganization or similar laws affecting creditors' rights
     generally) or (2) if a court were to rule under any such law in any case or
     proceeding that the trust funds remained property of the Company, (x)
     assuming such trust funds remained in the possession of the Trustee prior
     to such court ruling to the extent not paid to the Holders, the Trustee
     will hold, for the benefit of the Holders, a valid and perfected security
     interest in such trust funds that is not avoidable in bankruptcy or
     otherwise (except for the effect of Section 552(b) of the United States
     Bankruptcy Code on interest on the trust funds accruing after the
     commencement of a case under such statute) and (y) the Holders will be
     entitled to receive adequate protection of their interests in such trust
     funds if such trust funds are used in such case or proceeding, (C) the
     Holders will not recognize income, gain or loss for federal income tax
     purposes as a result of such deposit and defeasance of certain covenants
     and Events of Default and will be subject to federal income tax on the same
     amount and in the same manner and at the same times as would have been the
     case if such deposit and defeasance had not occurred and (D) the Trustee,
     for the benefit of the Holders, has a valid first priority security
     interest in the trust funds;

          (iii)  immediately after giving effect to such deposit on a pro forma
     basis, no Default or Event of Default shall have occurred and be continuing
     on the date of such deposit or during the period ending on the 123rd day
     after such date of such deposit, and such deposit shall not result in a
     breach or violation of, or constitute a default under, this Indenture or
     any other agreement or instrument to which the Company or any of its
     Subsidiaries is a party or by which the Company or any of its Subsidiaries
     is bound;

          (iv)   if the Notes are then listed on a national securities exchange,
     the Company has delivered to the Trustee an Opinion of Counsel to the
     effect that the Notes will not be delisted as a result of such deposit,
     defeasance and discharge; and

          (v)    the Company has delivered to the Trustee an Officers'
     Certificate and an Opinion of Counsel, in each case stating that all
     conditions precedent provided for herein relating to the defeasance
     contemplated by this Section 8.03 have been complied with.

          .4.    Application of Trust Money. Subject to Section 8.06, the
          ---------------------------------
Trustee or Paying Agent shall hold in trust money or U.S. Government Obligations
deposited with it pursuant to Section 8.01, 8.02 or 8.03, as the case may be,
and shall apply the deposited money and the money from U.S. Government
Obligations in accordance with the Notes and this Indenture to the payment of
principal of, premium, if any, and interest on the Notes; but such money need
not be segregated from other funds except to the extent required by law.
<PAGE>

                                      71

          .5.  Repayment to Company. Subject to Sections 7.07, 8.01, 8.02 and
          -------------------------
8.03, the Trustee and the Paying Agent shall promptly pay to the Company upon
request set forth in an Officers' Certificate any excess money held by them at
any time and thereupon shall be relieved from all liability with respect to such
money. The Trustee and the Paying Agent shall pay to the Company upon request
any money held by them for the payment of principal, premium, if any, or
interest that remains unclaimed for two years; provided that the Trustee or
Paying Agent before being required to make any payment may cause to be published
at the expense of the Company once in a newspaper of general circulation in The
City of New York or mail to each Holder entitled to such money at such Holder's
address (as set forth in the Security Register) notice that such money remains
unclaimed and that after a date specified therein (which shall be at least 30
days from the date of such publication or mailing) any unclaimed balance of such
money then remaining will be repaid to the Company. After payment to the
Company, Holders entitled to such money must look to the Company for payment as
general creditors unless an applicable law designates another Person, and all
liability of the Trustee and such Paying Agent with respect to such money shall
cease.

          .6.  Reinstatement. If the Trustee or Paying Agent is unable to
          ------------------
apply any money or U.S. Government Obligations in accordance with Section 8.01,
8.02 or 8.03, as the case may be, by reason of any legal proceeding or by reason
of any order or judgment of any court or governmental authority enjoining,
restraining or otherwise prohibiting such application, the Company's obligations
under this Indenture and the Notes shall be revived and reinstated as though no
deposit had occurred pursuant to Section 8.01, 8.02 or 8.03, as the case may be,
until such time as the Trustee or Paying Agent is permitted to apply all such
money or U.S. Government Obligations in accordance with Section 8.01, 8.02 or
8.03, as the case may be; provided that, if the Company has made any payment of
principal of, premium, if any, or interest on any Notes because of the
reinstatement of its obligations, the Company shall be subrogated to the rights
of the Holders of such Notes to receive such payment from the money or U.S.
Government Obligations held by the Trustee or Paying Agent.

                                 ARTICLE NINE
                      AMENDMENTS, SUPPLEMENTS AND WAIVERS

          .1.  Without Consent of Holders. The Company, when authorized by a
          -------------------------------
resolution of its Board of Directors (as evidenced by a Board Resolution
delivered to the Trustee), and the Trustee may amend or supplement this
Indenture or the Notes without notice to or the consent of any Holder:

          (1)    to cure any ambiguity, defect or inconsistency in this
     Indenture; provided that such amendments or supplements shall not, in the
     good faith opinion of the Board of Directors as evidenced by a Board
     Resolution, adversely affect the interests of the Holders in any material
     respect;

          (2)    to comply with Article Five;
<PAGE>

                                      72

          (3)    to comply with any requirements of the Commission in connection
     with the qualification of this Indenture under the TIA;

          (4)    to evidence and provide for the acceptance of appointment
     hereunder by a successor Trustee;

          (5)    to provide for uncertificated Notes in addition to or in place
     of certificated Notes;

          (6)    to add one or more subsidiary guarantees on the terms required
     by this Indenture; or

          (7)    to make any change that, in the good faith opinion of the Board
     of Directors as evidenced by a Board Resolution, does not materially and
     adversely affect the rights of any Holder.

          .2.  With Consent of Holders. Subject to Sections 6.04 and 6.07 and
          ----------------------------
without prior notice to the Holders, the Company, when authorized by its Board
of Directors (as evidenced by a Board Resolution delivered to the Trustee), and
the Trustee may amend this Indenture and the Notes with the written consent of
the Holders of a majority in aggregate principal amount of the Notes then
outstanding, and the Holders of a majority in aggregate principal amount of the
Notes then outstanding by written notice to the Trustee may waive future
compliance by the Company with any provision of this Indenture or the Notes.

     Notwithstanding the provisions of this Section 9.02, without the consent of
each Holder affected, an amendment or waiver, including a waiver pursuant to
Section 6.04, may not:

          (i)    change the Stated Maturity of the principal of, or any
     installment of interest on, any Note;

          (ii)   reduce the principal amount of, premium, if any, or interest on
     any Note;

          (iii)  change any place or currency of payment of principal of,
     premium, if any, or interest on, any Note;

          (iv)   impair the right to institute suit for the enforcement of any
     payment on or after the Stated Maturity (or, in the case of redemption, on
     or after the Redemption Date) of any Note;

          (v)    reduce the percentage or principal amount of outstanding Notes
     the consent of whose Holders is necessary to modify or amend this Indenture
     or to waive compliance with certain provisions of or certain Defaults under
     this Indenture;

          (vi)   waive a default in the payment of principal of, premium, if
     any, or interest on, any Note; or
<PAGE>

                                      73

          (vii)  modify any of the provisions of this Section 9.02, except to
     increase any such percentage or to provide that certain other provisions of
     this Indenture cannot be modified or waived without the consent of the
     Holder of each outstanding Note affected thereby.

     It shall not be necessary for the consent of the Holders under this Section
9.02 to approve the particular form of any proposed amendment, supplement or
waiver, but it shall be sufficient if such consent approves the substance
thereof.

     After an amendment, supplement or waiver under this Section 9.02 becomes
effective, the Company shall mail to the Holders affected thereby a notice
briefly describing the amendment, supplement or waiver. The Company will mail
supplemental indentures to Holders upon request. Any failure of the Company to
mail such notice, or any defect therein, shall not, however, in any way impair
or affect the validity of any such supplemental indenture or waiver.

          .3.    Revocation and Effect of Consent. Until an amendment or waiver
          ---------------------------------------
becomes effective, a consent to it by a Holder is a continuing consent by the
Holder and every subsequent Holder of a Note or portion of a Note that evidences
the same debt as the Note of the consenting Holder, even if notation of the
consent is not made on any Note. However, any such Holder or subsequent Holder
may revoke the consent as to its Note or portion of its Note. Such revocation
shall be effective only if the Trustee receives the notice of revocation before
the date the amendment, supplement or waiver becomes effective. An amendment,
supplement or waiver shall become effective on receipt by the Trustee of written
consents from the Holders of the requisite percentage in principal amount of the
outstanding Notes.

     The Company may, but shall not be obligated to, fix a record date for the
purpose of determining the Holders entitled to consent to any amendment,
supplement or waiver. If a record date is fixed, then, notwithstanding the last
two sentences of the immediately preceding paragraph, those persons who were
Holders at such record date (or their duly designated proxies) and only those
persons shall be entitled to consent to such amendment, supplement or waiver or
to revoke any consent previously given, whether or not such persons continue to
be Holders after such record date. No such consent shall be valid or effective
for more than 90 days after such record date.

     After an amendment, supplement or waiver becomes effective, it shall bind
every Holder unless it is of the type described in the second paragraph of
Section 9.02. In case of an amendment or waiver of the type described in the
second paragraph of Section 9.02, the amendment or waiver shall bind each Holder
who has consented to it and every subsequent Holder of a Note that evidences the
same indebtedness as the Note of the consenting Holder.

          .4.    Notation on or Exchange of Notes. If an amendment, supplement
          ---------------------------------------
or waiver changes the terms of a Note, the Trustee may require the Holder to
deliver such Note to the Trustee. At the Company's expense, the Trustee may
place an appropriate notation on the Note about the changed terms and return it
to the Holder and the Trustee may place an appropriate notation on any Note
thereafter authenticated. Alternatively, if the Company or the Trustee so
determines, the Company in exchange for the Note shall issue and the Trustee
shall authenticate
<PAGE>

                                      74

a new Note that reflects the changed terms. Failure to make the appropriate
notation, or issue a new Note, shall not affect the validity and effect of such
amendment, supplement or waiver.

          .5.    Trustee to Sign Amendments, Etc. The Trustee shall be entitled
          --------------------------------------
to receive, and shall be fully protected in relying upon, an Opinion of Counsel
stating that the execution of any amendment, supplement or waiver authorized
pursuant to this Article Nine is authorized or permitted by this Indenture and
that it will be valid and binding upon the Company. Subject to the preceding
sentence, the Trustee shall sign such amendment, supplement or waiver if the
same does not adversely affect the rights, duties, liabilities or immunities of
the Trustee. The Trustee may, but shall not be obligated to, execute any such
amendment, supplement or waiver that affects the Trustee's own rights, duties or
immunities under this Indenture or otherwise.

          .6.    Conformity with Trust Indenture Act. Every supplemental
          ------------------------------------------
indenture executed pursuant to this Article Nine shall conform to the
requirements of the TIA as then in effect.

                                  ARTICLE TEN
                                 MISCELLANEOUS

          .1.    Trust Indenture Act of 1939. Prior to the effectiveness of the
          ----------------------------------
Registration Statement, this Indenture shall incorporate and be governed by the
provisions of the TIA that are required to be part of and to govern indentures
qualified under the TIA. After the effectiveness of the Registration Statement,
this Indenture shall be subject to the provisions of the TIA that are required
to be a part of this Indenture and shall, to the extent applicable, be governed
by such provisions.

          .2.    Notices. Any notice or communication shall be sufficiently
          --------------
given if in writing and delivered in person, mailed by first-class mail or sent
by telecopier transmission addressed as follows:

     if to the Company:
     -----------------

     CFW Communications Company
     401 Spring Lane, Suite 300
     Waynesboro, Virginia  22980
     Telecopier No.:  (540) 9463599
     Attention:  Chief Financial Officer

<PAGE>

                                      75

     if to the Trustee:
     -----------------

     The Bank of New York
     101 Barclay Street
     Floor 21W
     New York, New York  10286
     Telecopier No.:  (212) 8155915
     Attention:  Corporate Trust Trustee Administration

     The Company or the Trustee by notice to the other may designate additional
or different addresses for subsequent notices or communications.

     Any notice or communication mailed to a Holder shall be mailed to it at its
address as it appears on the Security Register by first-class mail and shall be
sufficiently given to him if so mailed within the time prescribed. Any notice or
communication shall also be so mailed to any Person described in TIA Section
313(c), to the extent required by the TIA. Copies of any such communication or
notice to a Holder shall also be mailed to the Trustee and each Agent at the
same time.

     Failure to mail a notice or communication to a Holder as provided herein or
any defect in any such notice or communication shall not affect its sufficiency
with respect to other Holders. Except for a notice to the Trustee, which is
deemed given only when received, and except as otherwise provided in this
Indenture, if a notice or communication is mailed in the manner provided in this
Section 10.02, it is duly given, whether or not the addressee receives it.

     Where this Indenture provides for notice in any manner, such notice may be
waived in writing by the Person entitled to receive such notice, either before
or after the event, and such waiver shall be the equivalent of such notice.
Waivers of notice by Holders shall be filed with the Trustee, but such filing
shall not be a condition precedent to the validity of any action taken in
reliance upon such waiver.

     In case by reason of the suspension of regular mail service or by reason of
any other cause it shall be impracticable to give such notice by mail, then such
notification as shall be made with the approval of the Trustee shall constitute
a sufficient notification for every purpose hereunder.

     Holders may communicate pursuant to TIA Section 312(b) with other Holders
with respect to their rights under this Indenture or the Notes. The Company, the
Trustee, the Registrar and anyone else shall have the protection of TIA Section
312(c).

          .3.    Certificate and Opinion as to Conditions Precedent. Upon any
          ---------------------------------------------------------
request or application by the Company to the Trustee to take any action under
this Indenture, the Company shall furnish to the Trustee:
<PAGE>

                                      76

          (i)   an Officers' Certificate stating that, in the opinion of the
     signers, all conditions precedent, if any, provided for in this Indenture
     relating to the proposed action have been complied with; and

          (ii)  an Opinion of Counsel stating that, in the opinion of such
     Counsel, all such conditions precedent have been complied with.

          .4.   Statements Required in Certificate or Opinion. Each certificate
          ---------------------------------------------------
or opinion with respect to compliance with a condition or covenant provided for
in this Indenture shall include:

          (i)   a statement that each person signing such certificate or opinion
     has read such covenant or condition and the definitions herein relating
     thereto;

          (ii)  a brief statement as to the nature and scope of the examination
     or investigation upon which the statement or opinion contained in such
     certificate or opinion is based;

          (iii) a statement that, in the opinion of each such person, he has
     made such examination or investigation as is necessary to enable him to
     express an informed opinion as to whether or not such covenant or condition
     has been complied with; and

          (iv)  a statement as to whether or not, in the opinion of each such
     person, such condition or covenant has been complied with; provided,
     however, that, with respect to matters of fact, an Opinion of Counsel may
     rely on an Officers' Certificate or certificates of public officials.

          .5.   Rules by Trustee, Paying Agent or Registrar. The Trustee may
          -------------------------------------------------
make reasonable rules for action by or at a meeting of Holders. The Paying Agent
or Registrar may make reasonable rules for its functions.

          .6.   Payment Date Other Than a Business Day. If an Interest Payment
          --------------------------------------------
Date, Redemption Date, Payment Date, Stated Maturity or date of maturity of any
Note shall not be a Business Day, then payment of principal of, premium, if any,
or interest on such Note, as the case may be, need not be made on such date, but
may be made on the next succeeding Business Day with the same force and effect
as if made on the Interest Payment Date, Payment Date or Redemption Date, or at
the Stated Maturity or date of maturity of such Note; provided that no interest
shall accrue for the period from and after such Interest Payment Date, Payment
Date, Redemption Date, Stated Maturity or date of maturity, as the case may be.

          .7.   Governing Law. This Indenture and the Notes shall be governed by
          -------------------
the laws of the State of New York without regard to conflicts of law thereof.
The Trustee, the Company and the Holders agree to submit to the jurisdiction of
the courts of the State of New York in any action or proceeding arising out of
or relating to this Indenture or the Notes.
<PAGE>

                                      77

          .8.   No Adverse Interpretation of Other Agreements. This Indenture
          ---------------------------------------------------
may not be used to interpret another indenture, loan or debt agreement of the
Company or any Subsidiary of the Company. Any such indenture, loan or debt
agreement may not be used to interpret this Indenture.

          .9.   No Recourse Against Others. No recourse for the payment of the
          --------------------------------
principal of, premium, if any, or interest on any of the Notes, or for any claim
based thereon or otherwise in respect thereof, and no recourse under or upon any
obligation, covenant or agreement of the Company contained in this Indenture or
in any of the Notes, or because of the creation of any Indebtedness represented
thereby, shall be had against any incorporator or against any past, present or
future partner, stockholder, other equity holder, officer, director, employee or
controlling person, as such, of the Company or of any successor Person, either
directly or through the Company or any successor Person, whether by virtue of
any constitution, statute or rule of law, or by the enforcement of any
assessment or penalty or otherwise; it being expressly understood that all such
liability is hereby expressly waived and released as a condition of, and as a
consideration for, the execution of this Indenture and the issue of the Notes.

          .10.  Successors. All agreements of the Company in this Indenture and
          ----------------
the Notes shall bind its successors. All agreements of the Trustee in this
Indenture shall bind its successor.

          .11.  Duplicate Originals. The parties may sign any number of copies
          -------------------------
of this Indenture. Each signed copy shall be an original, but all of them
together represent the same agreement.

          .12.  Separability. In case any provision in this Indenture or in the
          ------------------
Notes shall be invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or
impaired thereby.

          .13.  Table of Contents, Headings, Etc. The Table of Contents,
          --------------------------------------
CrossReference Table and headings of the Articles and Sections of this Indenture
have been inserted for convenience of reference only, are not to be considered a
part hereof and shall in no way modify or restrict any of the terms and
provisions hereof.
<PAGE>

                                      78

                                  SIGNATURES

     IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be
duly executed, all as of the date first written above.

                                      CFW COMMUNICATIONS COMPANY

                                      By:
                                         ---------------------------------------
                                         Name:
                                         Title:

                                      THE BANK OF NEW YORK

                                      By:
                                         ---------------------------------------
                                         Name:
                                         Title:

<PAGE>

                                                                       EXHIBIT A
                                                                       ---------

                                [FACE OF NOTE]

                          CFW COMMUNICATIONS COMPANY

                           13% Senior Note due 2010

                                              [CUSIP] [CINS] [ISIN] $280,000,000

No. ___

     CFW COMMUNICATIONS COMPANY, a Virginia corporation (the "Company," which
term includes any successor under the Indenture hereinafter referred to), for
value received, promises to pay to CEDE & CO., or its registered assigns, the
principal sum of TWO HUNDRED AND EIGHTY MILLION DOLLARS ($280,000,000) on August
15, 2010.

     Interest Payment Dates:  February 15 and August 15, commencing February 15,
2001.

     Regular Record Dates:    February 1 and August 1.

     Reference is hereby made to the further provisions of this Note set forth
on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.
<PAGE>

                                      A-2

     IN WITNESS WHEREOF, the Company has caused this Note to be signed manually
or by facsimile by its duly authorized officers.

                              CFW COMMUNICATIONS COMPANY

                              By:
                                 -----------------------------------------------
                                 Name:
                                 Title:

                              By:
                                 -----------------------------------------------
                                 Name:
                                 Title:

                   (Trustee's Certificate of Authentication)

This is one of the 13% Senior Notes due 2010 described in the within-mentioned
Indenture.

Date:  July 26, 2000          THE BANK OF NEW YORK
                                as Trustee

                              By:
                                 -----------------------------------------------
                                 Authorized Signatory
<PAGE>

                                      A-3

                            [REVERSE SIDE OF NOTE]

                          CFW COMMUNICATIONS COMPANY

                           13% Senior  Note due 2010

1. Principal and Interest.
   ----------------------

     The Company will pay the principal of this Note on August 15, 2010.

     The Company promises to pay interest on the principal amount of this Note
on each Interest Payment Date, as set forth below, at the rate per annum shown
above.

     Interest will be payable semiannually (to the holders of record of the
Notes at the close of business on the February 1 or August 1 immediately
preceding the Interest Payment Date) on each Interest Payment Date, commencing
February 15, 2001 and no interest shall be paid on this Note prior to February
15, 2001, except as provided in the next paragraph.

     If an exchange offer (the "Exchange Offer") registered under the Securities
Act is not consummated or a shelf registration statement (the "Shelf
Registration Statement") under the Securities Act with respect to resales of the
Notes is not declared effective by the Commission, on or before six months after
the earlier of (i) the closing date of the RichmondNorfolk Acquisition and (ii)
the Termination Date, in accordance with the terms of the Registration Rights
Agreement dated July 26, 2000 between the Company and Morgan Stanley & Co.
Incorporated, First Union Securities, Inc. and SunTrust Equitable Securities
Corporation, the annual interest rate borne by the Notes shall be increased by
0.5% from the rate shown above accruing from six months after the earlier to
occur of (i) the RichmondNorfolk Acquisition or (ii) the Termination Date,
payable in cash semiannually, in arrears, on each Interest Payment Date, until
the Exchange Offer is consummated or the Shelf Registration Statement is
declared effective. The Holder of this Note is entitled to the benefits of such
Registration Rights Agreement.

     Interest on the Notes will accrue from the most recent date to which
interest has been paid or, if no interest has been paid, from July 26, 2000;
provided that, if there is no existing default in the payment of interest and
this Note is authenticated between a Regular Record Date referred to on the face
hereof and the next succeeding Interest Payment Date, interest shall accrue from
such Interest Payment Date. Interest will be computed on the basis of a 360day
year comprised of twelve 30day months.

     The Company shall pay interest on overdue principal and premium, if any,
and interest on overdue installments of interest, to the extent lawful, at a
rate per annum that is 2% in excess of the rate otherwise payable.
<PAGE>

                                      A-4

2. Method of Payment.
   -----------------

     The Company will pay interest (except defaulted interest) on the principal
amount of the Notes as provided above on each February 15 and August 15,
commencing February 15, 2001 to the persons who are Holders (as reflected in the
Security Register at the close of business on the February 1 or August 1
immediately preceding the Interest Payment Date), in each case, even if the Note
is cancelled on registration of transfer or registration of exchange after such
record date; provided that, with respect to the payment of principal, the
Company will make payment to the Holder that surrenders this Note to a Paying
Agent on or after February 15, 2001.

     The Company will pay principal, premium, if any, and as provided above,
interest in money of the United States that at the time of payment is legal
tender for payment of public and private debts. However, the Company may pay
principal, premium, if any, and interest by its check payable in such money. It
may mail an interest check to a Holder's registered address (as reflected in the
Security Register). If a payment date is a date other than a Business Day at a
place of payment, payment may be made at that place on the next succeeding day
that is a Business Day and no interest shall accrue for the intervening period.

3. Paying Agent and Registrar.
   --------------------------

     Initially, the Trustee will act as authenticating agent, Paying Agent and
Registrar. The Company may change any authenticating agent, Paying Agent or
Registrar without notice. The Company, any Subsidiary or any Affiliate of any of
them may act as Paying Agent, Registrar or co-Registrar.

4. Indenture; Limitations.
   ----------------------

     The Company issued the Notes under an Indenture dated as of July 26, 2000
(the "Indenture"), between the Company and The Bank of New York, trustee (the
"Trustee"). Capitalized terms herein are used as defined in the Indenture unless
otherwise indicated. The terms of the Notes include those stated in the
Indenture and those made part of the Indenture by reference to the Trust
Indenture Act. The Notes are subject to all such terms, and Holders are referred
to the Indenture and the Trust Indenture Act for a statement of all such terms.
To the extent permitted by applicable law, in the event of any inconsistency
between the terms of this Note and the terms of the Indenture, the terms of the
Indenture shall control.

     The Notes are general unsecured obligations of the Company.

     The Company may, subject to Article Four of the Indenture and applicable
law, issue additional Notes under the Indenture.
<PAGE>

                                      A-5

5. Optional Redemption.
   -------------------

     The Notes are redeemable, at the Company's option, in whole or in part, at
any time or from time to time, on or after August 15, 2005 and prior to
maturity, upon not less than 30 nor more than 60 days' prior notice mailed by
first class mail to each Holder's last address, as it appears in the Security
Register, at the following Redemption Prices (expressed in percentages of
principal amount), plus accrued and unpaid interest to the Redemption Date
(subject to the right of Holders of record on the relevant Regular Record Date
that is prior to the Redemption Date to receive interest due on an Interest
Payment Date), if redeemed during the 12month period commencing August 15 of the
years set forth below:

                     Year                         Redemption Price
                     ----                         ----------------

          2005.............................           106.500%
          2006.............................           104.333
          2007.............................           102.167
          2008 and thereafter..............           100.000%

     At any time prior to ________, 2003, the Company may redeem up to 35% of
the aggregate principal amount of the Notes with the proceeds of one or more
Public Equity Offerings, at any time as a whole or from time to time in part, at
a Redemption Price (expressed as a percentage of principal amount of 113.000%,
plus accrued and unpaid interest to the Redemption Date (subject to the rights
of Holders of record on the relevant Regular Record Date that is prior to the
Redemption Date to receive interest due on an Interest Payment Date); provided
that (i) at least 65% of the aggregate principal amount of Notes originally
issued on the Closing Date remains outstanding after each such redemption and
(ii) notice of such redemption shall be mailed within 60 days of the related
Public Equity Offering.

     In addition, the Securities will be subject to mandatory redemption (the
"Special Redemption") at 101% of the principal amount thereof plus accrued
 ------------------
interest to the redemption date (the "Special Redemption Price") in the event
                                      ------------------------
that the Escrow Agent has not received the Officers' Certificate (as defined in
the Escrow Agreement) provided for in the Escrow Agreement on or prior to
October 2, 2000, subject to an extension, in accordance with the provisions of
the Escrow Agreement, until December 17, 2000 (such date, as extended, being the
"Termination Date").
 ----------------

     Notes in original denominations larger than $1,000 may be redeemed in part.
On and after the Redemption Date, interest ceases to accrue on Notes or portions
of Notes called for redemption, unless the Company defaults in the payment of
the Redemption Price.
<PAGE>

                                      A-6

1. Repurchase upon Change of Control.
   ---------------------------------

     Upon the occurrence of any Change of Control, each Holder shall have the
right to require the repurchase of its Notes by the Company in cash pursuant to
the offer described in the Indenture at a purchase price equal to 101% of the
principal amount thereof plus accrued and unpaid interest, if any, to the date
of purchase (the "Payment Date").

     A notice of such Change of Control will be mailed within 30 days after any
Change of Control occurs to each Holder at its last address as it appears in the
Security Register. Notes in original denominations larger than $1,000 may be
sold to the Company in part. On and after the Payment Date, interest ceases to
accrue on Notes or portions of Notes surrendered for purchase by the Company,
unless the Company defaults in the payment of the purchase price.

2. Denominations; Transfer; Exchange.

     The Notes are in registered form without coupons in denominations of $1,000
of principal amount and multiples of $1,000 in excess thereof. A Holder may
register the transfer or exchange of Notes in accordance with the Indenture. The
Registrar may require a Holder, among other things, to furnish appropriate
endorsements and transfer documents and to pay any taxes and fees required by
law or permitted by the Indenture. The Registrar need not register the transfer
or exchange of any Notes selected for redemption. Also, it need not register the
transfer or exchange of any Notes for a period of 15 days before the day of
mailing of a notice of redemption of Notes selected for redemption.

3. Persons Deemed Owners.
   ---------------------

     A Holder shall be treated as the owner of a Note for all purposes.

4. Unclaimed Money.
   ---------------

     If money for the payment of principal, premium, if any, or interest remains
unclaimed for two years, the Trustee and the Paying Agent will pay the money
back to the Company at its request. After that, Holders entitled to the money
must look to the Company for payment, unless an abandoned property law
designates another Person, and all liability of the Trustee and such Paying
Agent with respect to such money shall cease.

5. Discharge Prior to Redemption or Maturity.
   -----------------------------------------

     If the Company deposits with the Trustee money or U.S. Government
Obligations sufficient to pay the then outstanding principal of, premium, if
any, and accrued interest on the Notes (a) to redemption or maturity, the
Company will be discharged from the Indenture and the Notes, except in certain
circumstances for certain provisions thereof, and (b) to the Stated Maturity,
the Company will be discharged from certain covenants set forth in the
Indenture.
<PAGE>

                                      A-7

6. Amendment; Supplement; Waiver.
   -----------------------------

     Subject to certain exceptions, the Indenture or the Notes may be amended or
supplemented with the consent of the Holders of at least a majority in principal
amount of the Notes then outstanding, and any existing default or compliance
with any provision may be waived with the consent of the Holders of at least a
majority in principal amount of the Notes then outstanding. Without notice to or
the consent of any Holder, the parties thereto may amend or supplement the
Indenture or the Notes to, among other things, cure any ambiguity, defect or
inconsistency and make any change that does not materially and adversely affect
the rights of any Holder.

7. Restrictive Covenants.
   ---------------------

     The Indenture imposes certain limitations on the ability of the Company and
its Restricted Subsidiaries, among other things, to Incur additional
Indebtedness, make Restricted Payments, suffer to exist restrictions on the
ability of Restricted Subsidiaries to make certain payments to the Company,
issue Capital Stock of Restricted Subsidiaries, Guarantee Indebtedness of the
Company, engage in transactions with Affiliates, suffer to exist or incur Liens,
enter into sale-leaseback transactions, use the proceeds from Asset Sales, or
merge, consolidate or transfer substantially all of its assets. Within 45 days
after the end of each fiscal quarter (90 days after the end of the last fiscal
quarter of each year), the Company shall deliver to the Trustee an Officers'
Certificate stating whether or not the signers thereof know of any Default or
Event of Default under such restrictive covenants.

8. Successor Persons.
   -----------------

     When a successor person or other entity assumes all the obligations of its
predecessor under the Notes and the Indenture, the predecessor person will be
released from those obligations.

9. Defaults and Remedies.
   ---------------------

     Any of the following events constitutes an "Event of Default" under the
     Indenture:

          (a) default in the payment of principal of (or premium, if any, on)
     any Note when the same becomes due and payable at maturity, upon
     acceleration, redemption or otherwise;

          (b)  default in the payment of interest on any Notes when the same
     becomes due and payable, and such default continues for a period of 30
     days; provided that a failure to make any of the first four scheduled
     interest payments on the Notes in a timely manner will constitute an Event
     of Default with no grace or cure period;
<PAGE>

                                      A-8

          (c)  default in the performance or breach of the provisions of the
     Indenture applicable to mergers, consolidations and transfers of all or
     substantially all of the assets of the Company or the failure to make or
     consummate an Offer to Purchase in accordance with the Section 4.11 or
     Section 4.12 or the Indenture;

          (d)  the Company defaults in the performance of or breaches any other
     covenant or agreement of the Company in the Indenture or under the Notes
     (other than a default specified in clause (a), (b) or (c) above) and such
     default or breach continues for a period of 30 consecutive days after
     written notice by the Trustee or the Holders of 25% or more in aggregate
     principal amount of the Notes;

          (e)  there occurs with respect to any issue or issues of Indebtedness
     of the Company or any Significant Subsidiary having an outstanding
     principal amount of $10.0 million or more in the aggregate for all such
     issues of all such Persons, whether such Indebtedness now exists or shall
     hereafter be created, (I) an event of default that has caused the holder
     thereof to declare such Indebtedness to be due and payable prior to its
     Stated Maturity and such Indebtedness has not been discharged in full or
     such acceleration has not been rescinded or annulled within 30 days of such
     acceleration and/or (II) the failure to make a principal payment at the
     final (but not any interim) fixed maturity and such defaulted payment shall
     not have been made, waived or extended within 30 days of such payment
     default;

          (f)  any final judgment or order (not covered by insurance) for the
     payment of money in excess of $10.0 million in the aggregate for all such
     final judgments or orders against allsuch Persons (treating any
     deductibles, selfinsurance or retention as not so coverred) shall be
     rendered against the Company or any Significant Subsidiary and shall not be
     paid or discharged, and there shall be any period of 30 consecutive days
     following entry of the final judgment or order that causes the aggregate
     amount for all such final judgments or orders outstanding and not paid or
     discharged against all such Persons to exceed $10.0 million during which a
     stay of enforcement of such final judgment or order, by reason of a pending
     appeal or otherwise, shall not be in effect;

          (g)  a court having jurisdiction in the premises enters a decree or
     order for (A) relief in respect of the Company or any Significant
     Subsidiary in an involuntary case under any applicable bankruptcy,
     insolvency or other similar law now or hereafter in effect, (B) appointment
     of a receiver, liquidator, assignee, custodian, trustee, sequestrator or
     similar official of the Company or any Significant Subsidiary or for all or
     substantially all of the property and assets of the Company or any
     Significant Subsidiary or (C) the winding up or liquidation of the affairs
     of the Company or any Significant Subsidiary and, in each case, such decree
     or order shall remain unstayed and in effect for a period of 30 consecutive
     days;

<PAGE>

                                      A-9

          (h)  the Company or any Significant Subsidiary (A) commences a
     voluntary case under any applicable bankruptcy, insolvency or other similar
     law now or hereafter in effect, or consents to the entry of an order for
     relief in an involuntary case under any such law, (B) consents to the
     appointment of or taking possession by a receiver, liquidator, assignee,
     custodian, trustee, sequestrator or similar official of the Company or any
     Significant Subsidiary or for all or substantially all of the property and
     assets of the Company or any Significant Subsidiary or (C) effects any
     general assignment for the benefit of creditors; or

          (i)  the Escrow Agreement shall cease to be in full force and effect
     or enforceable in accordance with its terms, other than in accordance with
     its terms.

     If an Event of Default, as defined in the Indenture, occurs and is
continuing, the Trustee may, and at the direction of the Holders of at least 25%
in aggregate principal amount of the Notes then outstanding shall, declare all
the Notes to be due and payable. If a bankruptcy or insolvency default with
respect to the Company occurs and is continuing, the Notes automatically become
due and payable. Holders may not enforce the Indenture or the Notes except as
provided in the Indenture. The Trustee may require indemnity satisfactory to it
before it enforces the Indenture or the Notes. Subject to certain limitations,
Holders of at least a majority in principal amount of the Notes then outstanding
may direct the Trustee in its exercise of any trust or power.

10. Trustee Dealings with the Company.
    ---------------------------------

     The Trustee under the Indenture, in its individual or any other capacity,
may make loans to, accept deposits from and perform services for the Company or
its Affiliates and may otherwise deal with the Company or its Affiliates as if
it were not the Trustee.

11. No Recourse Against Others.
    --------------------------

     No incorporator or any past, present or future partner, stockholder, other
equityholder, officer, director, employee or controlling person, as such, of the
Company or of any successor Person shall have any liability for any obligations
of the Company under the Notes or the Indenture or for any claim based on, in
respect of or by reason of, such obligations or their creation. Each Holder by
accepting a Note waives and releases all such liability. The waiver and release
are part of the consideration for the issuance of the Notes.

12. Authentication.
    --------------

     This Note shall not be valid until the Trustee or authenticating agent
signs the certificate of authentication on the other side of this Note.
<PAGE>

                                     A-10

13.  Abbreviations.
     -------------

     Customary abbreviations may be used in the name of a Holder or an assignee,
such as:  TEN COM (= tenants in common), TEN ENT (= tenants by the entireties),
JT TEN (= joint tenants with right of survivorship and not as tenants in
common), CUST (= Custodian) and U/G/M/A (= Uniform Gifts to Minors Act).

     The Company will furnish a copy of the Indenture to any Holder upon written
request and without charge.  Requests may be made to CFW Communications Company,
401 Spring Lane, Suite 300, Waynesboro, Virginia 72980; Attention: Chief
Financial Officer.

19.  Governing Law.
     -------------

     This Note shall be governed by the laws of the State of New York without
regard to conflicts of law thereof. The Trustee, the Company and the Holders
agree to submit to the jurisdiction of the courts of the State of New York in
any action or proceeding arising out of or relating to this Note.

                           [FORM OF TRANSFER NOTICE]

     FOR VALUE RECEIVED the undersigned registered holder hereby sell(s),
assign(s) and transfer(s) unto

Insert Taxpayer Identification No.
---------------------------------

________________________________________________________

Please print or typewrite name and address including zip code of assignee

________________________________________________________

the within  Note and all rights thereunder, hereby irrevocably constituting and
appointing  ___________________________________________________________________
attorney to transfer said  Note on the books of the Company with full power of
substitution in the premises.

                    [THE FOLLOWING PROVISION TO BE INCLUDED
                    ON ALL NOTES OTHER THAN EXCHANGE NOTES,
                      UNLEGENDED OFFSHORE GLOBAL NOTES AND
                      UNLEGENDED OFFSHORE PHYSICAL NOTES]

     In connection with any transfer of this  Note occurring prior to the date
which is the earlier of (i) the date the Shelf Registration Statement is
declared effective or (ii) the end of the
<PAGE>

                                     A-11

period referred to in Rule 144(k) under the Securities Act, the undersigned
confirms that without utilizing any general solicitation or general advertising
that:

                                  [Check One]

[_] (a)   this Note is being transferred in compliance with the exemption from
          registration under the Securities Act of 1933 provided by Rule 144A
          thereunder.

                                       or
                                       --

[_] (b)   this Note is being transferred other than in accordance with (a) above
          and documents are being furnished which comply with the conditions of
          transfer set forth in this Note and the Indenture.
<PAGE>

                                     A-12

If none of the foregoing boxes is checked, the Trustee or other Registrar shall
not be obligated to register this  Note in the name of any Person other than the
Holder hereof unless and until the conditions to any such transfer of
registration set forth herein and in Section 2.08 of the Indenture shall have
been satisfied.

Date: ________________        __________________________________________________
                              NOTICE: The signature to this assignment must
                              correspond with the name as written upon the face
                              of the within-mentioned instrument in every
                              particular, without alteration or any change
                              whatsoever.

TO BE COMPLETED BY PURCHASER IF (a) ABOVE IS CHECKED.

     The undersigned represents and warrants that it is purchasing this  Note
for its own account or an account with respect to which it exercises sole
investment discretion and that it and any such account is a "qualified
institutional buyer" within the meaning of Rule 144A under the Securities Act of
1933 and is aware that the sale to it is being made in reliance on Rule 144A and
acknowledges that it has received such information regarding the Company as the
undersigned has requested pursuant to Rule 144A or has determined not to request
such information and that it is aware that the transferor is relying upon the
undersigned's foregoing representations in order to claim the exemption from
registration provided by Rule 144A.

Date: ________________        __________________________________________________
                              NOTICE:  To be executed by an executive officer

<PAGE>

                                     A-13

                       OPTION OF HOLDER TO ELECT PURCHASE

     If you wish to have this  Note purchased by the Company pursuant to Section
4.11 or 4.12 of the Indenture, check the Box:  ?

     If you wish to have a portion of this  Note purchased by the Company
pursuant to Section 4.11 or 4.12 of the Indenture, state the amount:
$___________________.

Date: ___________________

Your Signature: _____________________________________________________________

           (Sign exactly as your name appears on the other side of this Note)

Signature Guarantee: ______________________________
<PAGE>

                                                                      EXHIBIT B
                                                                      ---------

                              Form of Certificate
                              -------------------

                                                                 _________, ____

The Bank of New York
101 Barclay Street
Floor 21-W
New York, New York  10286
Attention:  Corporate Trust Trustee Administration

                Re:  CFW Communications Company (the "Company")
                    13% Senior Notes due 2010 (the "Notes")
                    --------------------------------------

Dear Sirs:

     This letter relates to U.S. $_______________ principal amount of Notes
represented by a  Note (the "Legended Note") which bears a legend outlining
restrictions upon transfer of such Legended Note.  Pursuant to Section 2.02 of
the Indenture dated as of July 26, 2000 (the "Indenture") relating to the Notes,
we hereby certify that we are (or we will hold such securities on behalf of) a
person outside the United States to whom the Notes could be transferred in
accordance with Rule 904 of Regulation S promulgated under the U.S. Securities
Act of 1933.  Accordingly, you are hereby requested to exchange the legended
certificate for an unlegended certificate representing an identical principal
amount of Notes, all in the manner provided for in the Indenture.

     You and the Company are entitled to rely upon this letter and are
irrevocably authorized to produce this letter or a copy hereof to any interested
party in any administrative or legal proceedings or official inquiry with
respect to the matters covered hereby.  Terms used in this certificate have the
meanings set forth in Regulation S.

                              Very truly yours,

                              [Name of Holder]

                              By: _________________________
                                  Authorized Signature

<PAGE>

                                                                      EXHIBIT C
                                                                      ---------

                           Form of Certificate to Be
                          Delivered in Connection with
                   Transfers to Non-QIB Accredited Investors
                   ----------------------------------------

                                                                 _________, ____

The Bank of New York
101 Barclay Street
Floor 21-W
New York, New York  10286
Attention:  Corporate Trust Trustee Administration

                Re:  CFW Communications Company (the "Company")

                    13% Senior Notes due 2010 (the "Notes")

Dear Sirs:

     In connection with our proposed purchase of $__________________ aggregate
principal amount of the Notes, we confirm that:

     14.  We understand that any subsequent transfer of the Notes is subject to
certain restrictions and conditions set forth in the Indenture dated as of July
26, 2000 (the "Indenture") relating to the Notes and the undersigned agrees to
be bound by, and not to resell, pledge or otherwise transfer the Notes except in
compliance with such restrictions and conditions and the Securities Act of 1933,
amended (the "Securities Act").

     15.  We understand that the offer and sale of the Notes have not been
registered under the Securities Act, and that the Notes may not be offered or
sold except as permitted in the following sentence.  We agree, on our own behalf
and on behalf of any accounts for which we are acting as hereinafter stated,
that if we should sell any Notes within the time period referred to in Rule
144(k) of the Securities Act, we will do so only (A) to the Company or any
subsidiary thereof, (B) in accordance with Rule 144A under the Securities Act to
a "qualified institutional buyer" (as defined therein), (C)  to an institutional
"accredited investor" (as defined below) that, prior to such transfer, furnishes
(or has furnished on its behalf by a U.S. broker-dealer) to you and to the
Company a signed letter substantially in the form of this letter and, if such
transfer is in respect of an aggregate principal amount of less than $100,000,
an opinion of counsel acceptable to the Company that such transfer is in
compliance with the Securities Act, (D) outside the United States in accordance
with Rule 904 of Regulation S under the Securities Act, (E) pursuant to the
exemption from registration provided by Rule 144 under the Securities Act (if
available) or (F) pursuant to an effective registration statement under the
Securities Act,
<PAGE>

                                      C-2

and we further agree to provide to any person purchasing any of the Notes from
us a notice advising such purchaser that resales of the Notes are restricted as
stated herein.

     16.  We understand that, on any proposed resale of any Notes, we will be
required to furnish to you and the Company such certifications, legal opinions
and other information as you and the Company may reasonably require to confirm
that the proposed sale complies with the foregoing restrictions.  We further
understand that the Notes purchased by us will bear a legend to the foregoing
effect.

     17.  We are an institutional "accredited investor" (as defined in Rule
501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act) and have
such knowledge and experience in financial and business matters as to be capable
of evaluating the merits and risks of our investment in the Notes, and we and
any accounts for which we are acting are each able to bear the economic risk of
our or its investment.

     18.  We are acquiring the Notes purchased by us for our own account or for
one or more accounts (each of which is an institutional "accredited investor")
as to each of which we exercise sole investment discretion.

     You and the Company are entitled to rely upon this letter and are
irrevocably authorized to produce this letter or a copy hereof to any interested
party in any administrative or legal proceedings or official inquiry with
respect to the matters covered hereby.

                              Very truly yours,

                              [Name of Transferee]

                              By: ______________________
                                  Authorized Signature

<PAGE>

                                                                       EXHIBIT D
                                                                       ---------
                     Form of Certificate to Be Delivered in
               Connection with Transfers Pursuant to Regulation S
               --------------------------------------------------

                                                                 _________, ____

The Bank of New York
101 Barclay Street
Floor 21-W
New York, New York  10286
Attention:  Corporate Trust Trustee Administration

                Re:  CFW Communications Company (the "Company")
                    13% Senior Notes due 2010 (the "Notes")

Dear Sirs:

     In connection with our proposed sale of U.S.$__________________ aggregate
principal amount of the Notes, we confirm that such sale has been effected
pursuant to and in accordance with Regulation S under the Securities Act of 1933
and, accordingly, we represent that:

     (1) the offer of the Notes was not made to a person in the United States;

     (2) at the time the buy order was originated, the transferee was outside
the United States or we and any person acting on our behalf reasonably believed
that the transferee was outside the United States;

     (3) no directed selling efforts have been made by us in the United States
in contravention of the requirements of Rule 903(b) or Rule 904(b) of Regulation
S, as applicable; and

     (4) the transaction is not part of a plan or scheme to evade the
registration requirements of the U.S. Securities Act of 1933.

     You and the Company are entitled to rely upon this letter and are
irrevocably authorized to produce this letter or a copy hereof to any interested
party in any administrative or legal proceedings or official inquiry with
respect to the matters covered hereby.  Terms used in this certificate have the
meanings set forth in Regulation S.

                              Very truly yours,

                              [Name of Transferor]

                              By: _________________________
                              Authorized Signature

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}]]